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Plasmodium knowlesi is one of six Plasmodium species responsible for causing 
malaria in humans. Symptoms of the disease arise from the blood stage of the 
parasite’s life cycle, when a form of the parasite, known as a merozoite, invades a red 
blood cell (RBC), develops and multiplies within it, and then bursts (egresses) from 
the host cell, releasing more invasive merozoites. Invasion progresses through several 
key steps, which can be visualised using live microscopy: weak parasite-host cell 
interactions, stronger interactions causing cell deformation and parasite re-orientation, 
and finally parasite entry and resealing of the host cell. Throughout invasion, the 
parasite secretes numerous proteins from specialised secretory organelles, called 
micronemes and rhoptries, which facilitate each step. Two protein families that have 
been shown to be essential for merozoite invasion are the Duffy binding protein (DBP) 
and reticulocyte binding like (RBL) proteins. In P. falciparum, these families consist 
of multiple members, with significant redundancy, which has led to difficulty 
assigning specific functions to each member, or even family. P. knowlesi, on the other 
hand, has a smaller repertoire of proteins within each family consisting of three DBPs 
(PkDBPα, PkDBPβ, and PkDBPγ) and two RBLs, the Normocyte binding proteins Xa 
and Xb (PkNBPXa and PkNBPXb). Of these proteins, only two are required for 
human red cell invasion: PkDBPα and PkNBPXa. 
The first part of this study investigates how wild type parasites invade human 
erythrocytes, taking advantage of the large size and distinctly polarised shape of P. 
knowlesi merozoites to dissect the morphological steps of invasion in much greater 
detail than previously achieved for P. falciparum. Live microscopy has clarified the 
order of early events leading up to internalisation and revealed a new pre-
internalisation step, gliding motility, which is required for deformation and enhances 
parasite-host cell interactions. The second part of this study uses this new 
understanding of invasion as a framework to investigate the roles of PkDBPα and 
PkNBPXa by performing live microscopic analysis of tagged and conditional 
knockout (cKO) parasite lines. Multi- tagged lines show both proteins share a similar 
localisation pre egress, but exhibit distinct localisations once released from apical 
organelles. Finally, live imaging has revealed distinct roles for both families, showing 
that PkNBPXa is essential for host cell deformation, while PkDBPα performs a 
function downstream of this process.  
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Chapter 1: General introduction 
1.1 An introduction to malaria 
Despite significant efforts towards its eradication, malaria remains a deadly threat to 
almost half the globe, spanning countries across Africa, South America, and Southeast 
Asia. Disease severity can range from mild, flu-like symptoms with fevers and chills to 
life-threatening developments, including severe anaemia, respiratory failure, and coma, 
leading to death (WHO, 2019). In 2018, WHO estimated 228 million cases worldwide, 
resulting in the deaths of approximately 405,000 people, with over two-thirds of these 
deaths attributable to infants and young children (WHO 2019).  
Not only does malaria result in the tragic loss of life, but this disease also has a 
profound economic effect. The direct costs of malaria prevention and treatment are 
estimated to be over 12 billion USD per year (CDC, 2020). However, this figure does 
not take into account the overall loss of capital a nation experiences as a result of 
illness and death reducing the workforce and, more indirectly, interrupting access to 
education. The ensuing poverty, however, in turn directly impacts public health, as 
individuals and entire nations are less able to afford nutritious food, quality housing, 
and accessible healthcare (WHO Strategic Advisory Group on Malaria, 2020). 
The etiological agent of malaria, Plasmodium, is an apicomplexan parasite transmitted 
to its vertebrate host by the female Anopheles mosquito (WHO, 2019). Six 
Plasmodium species are known to commonly infect humans (Rutledge et al., 2017). Of 
these, P. falciparum has the highest incidence and is the predominant cause of malaria 
in Africa, responsible for 99.7% of cases within this region. P. vivax, the second 
biggest contributor to disease burden, is the most prevalent species, giving rise to cases 
within 95 countries across the globe (Howes et al., 2016). However, the four remaining 
species, P. ovale curtisi, P. ovale wallikeri, P. malariae, and the zoonotic parasite, P. 
knowlesi, still contribute a considerable disease burden, and must not be ignored in the 
strive towards malaria eradication (WHO 2019; Rutledge et al., 2017).  
Over the past 20 years, significant progress has been made towards reducing the 
number of cases of malaria globally. From 2000-2015, the number of deaths attributed 
to malaria decreased by roughly 50% (WHO, 2016). However, over 80 countries are 
still fighting to eradicate malaria, with 19 countries accounting for 85% of all global 
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cases. Additionally, despite persistent efforts to tackle malaria cases in each of these 
regions, the number of cases and deaths worldwide has plateaued in recent years, in 
stark contrast to the rapid decline seen over the previous decade (WHO, 2019). 
Numerous control strategies are currently employed by endemic nations to treat 
clinical cases and prevent malaria transmission. Some of these include antimalarial 
treatment regimens to cure active cases or treat vulnerable populations prophylactically 
during high transmission seasons. Further preventative measures include the use of 
insecticide sprays and insecticide-treated bed nets, both of which impede transmission 
via mosquito bite (WHO, 2019). However, the progression from control to elimination 
status is hindered for many endemic nations due to several parasitological challenges. 
Firstly, resistance to front line antimalarials, including artemisinin and partner drugs, 
continues to rise (Noedl et al., 2008; Ashley et al., 2014; Mairet-Khedim et al., 2020). 
Secondly, asymptomatic carriers and zoonotic sources create permanent reservoirs of 
infective parasites (Galatas et al., 2016; Grigg et al., 2017). Finally, hypnozoites, 
dormant forms of the parasite, cause relapsing P. vivax and P. ovale cases (Richter et 
al., 2010; Adams and Mueller, 2017). All of these challenges point to the need for an 
effective malaria vaccine: a tool that is not yet in our grasp. 
The clinical symptoms of malaria arise from Plasmodium parasites invading 
erythrocytes, replicating within them, and finally bursting free to invade new host cells 
(Cowman et al., 2017). This work focuses on two protein families critical to 
erythrocyte invasion: the reticulocyte binding like (RBL) and the Duffy binding like 
(DBP) proteins. Both families are key determinants of host cell tropism and contribute 
to parasite virulence, for instance by restricting some species to grow in very young 
erythrocytes, while permitting others to invade a much wider range of host cells (Tham 
et al., 2012; Cowman et al., 2017). Critically, as exposure to the RBLs and DBPs has 
been associated with natural immunity from malaria, both families are prime vaccine 
candidates (Tham et al., 2012). However, precisely how the RBL and DBP ligands 
facilitate erythrocyte invasion is still uncertain. Previous attempts to investigate these 
complicated and sometimes large protein families have been hindered in part by a lack 
of appropriate genetic tools (Chan et al., 2019; Tham et al., 2012). However, in recent 
years the development of CRISPR Cas9 and Dimerisable Cre recombinase (DiCre) 
genome editing tools has revolutionised the way we can use experimental genetics in 
malaria and overcome many of the barriers to studying complex gene families like 
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these (Andenmatten et al., 2013; Collins et al., 2013; Lee et al., 2019). Furthermore, 
the recent adaptation of P. knowlesi, the species utilised in this study, to in vitro culture 
has provided another model of the asexual stages and invasion (Moon et al., 2013). 
Now with new tools in hand, thoroughly dissecting the roles of the RBL and DBP 
ligands will enable us to gain a greater understanding of invasion biology and help us 
to assess their suitability as vaccine candidates.  
1.2 P. knowlesi: an emerging problem 
Unlike the other species pathogenic to humans, the primary hosts of P. knowlesi are 
the long-tailed and pig-tailed macaques (Singh and Daneshvar, 2013). Early studies of 
this pathogen in the 1960s concluded that human infections, while possible, were 
uncommon (reviewed in Singh & Daneshvar, 2013). However, more recent studies 
investigating unusually severe cases of P. malariae in Malaysian Borneo, lead to the 
discovery that many of these cases had been misdiagnosed and were actually P. 
knowlesi infections (Millar and Cox-Singh, 2015). Since this study, many more have 
followed and established that P. knowlesi infections are widespread and are an 
emerging cause of potentially deadly infections throughout South-east Asia, despite a 
marked decrease in the incidence of the other Plasmodium species (Cox Singh et al., 
2008; William et al., 2014, 2013; Yusof et al., 2014; Herdiana et al., 2016; Lubis et al., 
2017; Yusof et al., 2014; Cooper et al., 2020).  
The majority, if not all, human P. knowlesi infections are thought to arise from an 
Anopheles mosquito first biting an infected macaque and then transmitting parasites to 
the human host.  This phenomenon means P. knowlesi infections are geographically 
restricted by the requirement for overlapping human, macaque, and vector populations, 
resulting in transmission being limited to S E Asia (Manin et al., 2016). Practically 
speaking, this also means that risk factors for contracting P. knowlesi include working 
in and around forested areas, farmlands, and plantations, where both macaques and 
mosquito vectors are present (Barber et al., 2012; Grigg et al., 2017). Importantly, 
since transmission between macaques cannot be curtailed with normal control 
measures, such as treatment with drugs, or using bed-nets, macaques remain a constant 
source of infection to humans within a given region (Grigg et al., 2017). Therefore, the 
development of a vaccine may be the only way to prevent P. knowlesi infections 
without also impacting macaque populations. 
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A potential reason for the rise in P. knowlesi infections is continuous deforestation, 
which ultimately brings human and macaque/vector populations into closer contact 
(Barber et al., 2012; Fornace et al., 2016; Brock et al., 2019; Stark et al., 2019). So in 
addition to the cases that can be traced directly back to workers returning from forested 
regions, there are also increasing numbers of ‘peri-domestic’ infections occurring: 
infections acquired within villages, as a result of macaques also living in and moving 
through the surrounding areas (Barber et al., 2012; Manin et al., 2016; Grigg et al., 
2017). One study has even shown that the abundance of Anopheles balabacensis, the 
primary vector for P. knowlesi transmission in Sabah, Malaysia, increases when forest 
areas are disturbed. This can occur, for instance, by wheel ruts left in the mud by 
workers that fill with water, providing the perfect mosquito breeding conditions (Brant 
et al., 2016). So overall, the habitat changes of both primary host and vector have 
likely contributed significantly to the increase of zoonotic infections.  
The recent increases in cases and their severity may also be indicative of changes in 
host-pathogen interactions and the emergence of some human-human transmission 
(Cooper et al., 2020). There is also evidence that the current increasing risk from P. 
knowlesi may be partly due to an indirect consequence of successfully controlling 
other human malaria parasites (William et al., 2013; William et al., 2014; Cooper et 
al., 2020). Recently, P. vivax antibodies targeting several erythrocyte invasion antigens 
demonstrated cross-inhibitory action against P. knowlesi parasites in culture. Thus the 
spread and intensity of P. knowlesi infections may be curbed by cross-immunity to P. 
vivax (Muh et al., 2020; Ndegwa et al., 2020), which is closely related and shares key 
erythrocyte invasion pathways mediated by DBP ligands (Haynes et al., 1988; Pain et 
al., 2008; Wertheimer and Barnwell, 1989). Encouragingly, this means that it may be 
possible to target both P. vivax and P. knowlesi with a single vaccine. So, as endemic 
regions strive towards elimination of all malaria species, renewed efforts towards a 
better understanding of shared erythrocyte invasion pathways and mechanisms of 
cross-resistance will be vital to the development of an efficacious vaccine.  
1.3 The Plasmodium Life cycle 
The life cycle of Plasmodium parasites is incredibly complex, consisting of two main 
phases: one taking place in the Anopheles mosquito vector, and the other taking place 
within a vertebrate host (Cowman et al., 2012; Figure 1.1). During each phase of the 
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life cycle, the parasite extensively remodels itself, taking on unique morphologies 
perfectly suited to survive and proliferate in each given environment. On the one hand, 
this complexity presents a challenge to understanding the fundamental biology driving 
the transition of one step to the next. However, on the other hand, a multi-step life 
cycle also presents many opportunities to exploit a variety of potential drug and 
vaccine targets (Phillips et al., 2017). 
Figure 1.1 Plasmodium Life cycle (taken from Cowman et al., 2012). The Plasmodium 
life cycle can be divided into two phases, the first taking place in the mosquito vector and the 
second in the vertebrate host. Infection of the vertebrate host begins upon injection of 
sporozoites into the host’s bloodstream. Sporozoites travel to the liver, where they invade 
hepatocytes and grow and divide intracellularly to form hepatic schizonts, containing 
hundreds of merozoites. Release of merozoites into the bloodstream begins the erythrocytic 
cycle (the blood stage), during which merozoites invade erythrocytes, develop from ring-
stage parasites into mature schizonts, and egress, to release a fresh round of merozoites. 
These merozoites go on to invade more erythrocytes, thus continuing this cycle of invasion 
and egress. Additionally, some blood-stage parasites will develop into gametocytes, which 
are taken up during a mosquito’s blood meal. This event triggers their development into 
gametes, which subsequently fuse to form zygotes. Zygotes then develop into motile 
ookinetes, which traverse through the midgut wall, where they form oocysts. Oocysts mature 
to produce thousands of sporozoites, which upon release travel to the mosquito’s salivary 
glands, ready for injection into the next host.  
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1.3.1 The vertebrate phase 
1.3.1.1 The liver stage 
Infection of the mammalian host, in the case of P. knowlesi either a macaque or a 
human, begins when a mosquito injects sporozoites into the host’s dermis during a 
blood meal. Sporozoites are motile, extracellular forms of the parasite, which use a 
unique form of locomotion known as gliding motility to move through the dermis until 
they reach blood vessels (Amino et al., 2006). Once in the bloodstream, they are 
carried along until they encounter the liver, where they traverse through a layer of 
endothelial cells and macrophages, known as the sinusoidal wall (Pradel and Frevert, 
2001; Ishino et al., 2004; Tavares et al., 2013). After sporozoites have breached this 
barrier, they traverse through several hepatocytes, before finally invading a hepatocyte 
and taking up residence within a parasitophorous vacuole (PV), a membrane-enclosed 
home (Mota et al., 2001).  
Subsequently, the parasite then proceeds to undergo multiple rounds of asexual 
replication to produce large, hepatic schizonts, containing potentially thousands of 
merozoites: specialist blood-stage invasive forms.  Once maturation is complete (6-7 
days for P. falciparum) (Vaughan et al., 2012) the parasite’s parasitophorous vacuole 
membrane (PVM) ruptures and the host cell membrane pinches off around groups of 
merozoites, forming what are known as merosomes. These packages of merozoites are 
released into the bloodstream, which ensures their safe passage past macrophages 
lining the liver sinusoids. Finally, once clear of the liver, merosomes rupture to release 
free merozoites into the bloodstream, which go on to invade erythrocytes, beginning 
the blood stage of the parasite’s lifecycle (Sturm et al., 2006; Baer et al., 2007). 
Importantly, for both P. vivax and P. ovale, a proportion of sporozoites instead develop 
into dormant, uni-nucleate forms called hypnozoites (Dembélé et al., 2014; Krotoski et 
al., 1982; Richter et al., 2010; Robinson et al., 2015). Hypnozoites are resistant to most 
antimalarial drugs and can remain quiescent within the liver for weeks, even months, 
depending on the specific strain involved. However, upon activation, hypnozoites 
develop into hepatic schizonts, which release a fresh round of merozoites into the 
bloodstream, causing relapsing infections, which can also be transmitted to others via 
mosquito bite (Dembélé et al., 2014; Adams and Mueller, 2017). As a result, relapsing 
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infections create a significant hurdle to elimination efforts, again highlighting the need 
for an effective vaccine.  
1.3.1.2 The blood-stage 
Disease symptoms emerge as the blood stage of the parasite’s life cycle begins. 
Merozoites invade erythrocytes in a highly efficient manner, usually within minutes of 
rupturing, or egressing, from their host cells (Boyle et al., 2010b). For P. falciparum, 
egress is an explosion-like event, which may propel merozoites into fresh erythrocytes 
(Glushakova et al., 2005; Gilson and Crabb, 2009). Once the free merozoite encounters 
a new erythrocyte, invasion is governed by a series of molecular steps, which rely 
upon key interactions between merozoite-derived ligands and corresponding receptors 
on the host cell surface (Cowman et al., 2017). Importantly, this means that this step 
has a major role in determining host cell tropism, both in terms of host species and 
erythrocyte age; as if the correct host cell receptors are not available, erythrocytes can 
be refractory to invasion.  
Once a merozoite has invaded its host cell, like the invasive sporozoite, it resides 
within a (PV) ( Bannister et al., 1975; Aikawa et al., 1978). Over the following 24-72 
hours (depending on the species) the merozoite proceeds to develop from a ring-stage 
parasite into a trophozoite. Finally, during a process referred to as schizogony, several 
rounds of asynchronous nuclear division and organelle biogenesis ensue. This is 
followed by the formation of individual, membrane-bound merozoites (Bannister et al., 
2000). The number of merozoites produced per schizonts is also species-dependent. 
For instance, each P. knowlesi schizont can contain up to 16 daughter merozoites, 
while P. falciparum schizonts sometimes produce double this number (Cowman and 
Crabb, 2006; Lee et al., 2009). Finally, once a schizont has fully matured, individual 
merozoites escape from the erythrocyte, when first the PVM and then the host cell 
membrane ruptures, releasing free merozoites into the bloodstream during egress 
(Wickham et al., 2003; Hale et al., 2017). Notably, the window of time between egress 
and re-invasion is the only point within the erythrocytic cycle that the parasite is 
extracellular, and thus directly exposed to the host immune system. For this reason, 
merozoite invasion ligands are critical targets for vaccine development (Wright and 
Rayner, 2014; Weiss et al., 2015). 
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1.3.1.3 Gametocytogenesis: preparing to change host 
After invasion, a small proportion of merozoites will develop into male and female 
gametocytes, instead of schizonts, in a process called gametocytogenesis. These are in 
turn taken up by another female Anopheles mosquito, marking the beginning of the 
sexual phase of the parasite’s life cycle. Interestingly, the morphology and maturation 
time of gametocytes varies between species. P. falciparum gametocytes mature 
through five different morphological stages over 9-12 days, with the final stage taking 
on a crescent-shaped appearance (Hawking et al., 1971; Sinden, 1982). These mature 
forms are infective for several days (Smalley and Sinden, 1977). For other 
Plasmodium species, gametocytes appear to mature at a much faster rate, take on a 
rounder morphology, and are infective for a shorter duration. For instance, P. knowlesi 
gametocytes mature over a 30-hour period, giving rise to infectious gametocytes 
surviving for only a few hours (Hawking et al., 1968). 
1.3.2 The mosquito phase 
Once taken up in the mosquito blood meal, gametocytes are “activated” within the 
mosquito midgut by the lower temperature and the presence of the mosquito factor 
xanthurenic acid. This event triggers gametogenesis: the transformation of 
gametocytes into gametes (Bennink et al., 2016; Billker et al., 1997; Garcia et al., 
1998). For male gametocytes, this process involves three rounds of mitotic division 
and the synthesis of eight flagella, to produce eight motile microgametes, which exit 
the host erythrocyte during exflagellation (Janse et al., 1988, 1986). Female 
gametocytes must also exit the host cell and begin translation of previously repressed 
transcripts, which are now required for fertilization steps and beyond (Mair et al., 
2006).  
Subsequently, male and female gametes then fuse to form a zygote, which is quickly 
followed by meiotic division and the differentiation of the zygote into another invasive 
zoite stage: the ookinete (Janse 1986; Janse 1988; Sinden, 1982). The ookinete can 
then escape the harsh conditions of the mosquito midgut by gliding through the blood 
meal to the midgut wall, after which it traverses through the midgut epithelial cells to 
reach the midgut basal lamina (Vlachou et al., 2004). The parasite then transforms 
again, this time into the stationary oocyst. Several rounds of mitotic division and 
organelle replication ensue, to form thousands of sporozoites in a process called 
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sporogony (Canning and Sinden, 1973). Finally, once released from the oocyst, 
individual sporozoites travel to the mosquito’s salivary glands, again using gliding 
motility, where they remain until they are injected into a new host during another 
blood meal (Pimenta et al., 1994). 
1.4 Combating malaria with blood-stage vaccines? 
An efficacious, long-lasting vaccine has the potential to prevent severe disease and 
parasite transmission. Three basic categories of Plasmodium vaccines are being 
proposed. These include vaccines to target pre-erythrocytic stages (sporozoites and 
infected hepatocytes), blood stages (merozoites and infected erythrocytes), and finally, 
parasite transmission (sexual stages) (Draper et al., 2018; Beeson et al., 2019). 
Although a transmission-blocking vaccine would be a highly advantageous tool to curb 
malaria incidence, targeting the sexual stages alone would not prevent an already 
infected person from experiencing disease symptoms. Thus efforts over the previous 
decades have focused primarily on developing vaccines aimed at preventing liver and 
blood-stage infections: both options that in theory could also block transmission 
(Beeson et al., 2019).  
For P. falciparum, the most successful pre-erythrocytic vaccine is RTS,S/AS01, the 
first (and only) malaria vaccine to reach stage IV clinical trials so far. This vaccine 
induces antibodies targeting the C-terminus of the P. falciparum circumsporozoite 
protein (PfCSP), which coats the outer surface of sporozoites  (Draper et al., 2018). 
However, vaccination with RTS,S provides only moderate protection from clinical 
malaria cases, with phase III trials recording an efficacy of up to 56% in young 
children within the first year post-vaccination (RTS, S Clinical Trials Partnership, 
2011). Additionally, immunity wanes quickly, with efficacy dropping below 30% 
without a booster, and below 40% even with a booster, over a 48-month follow-up 
period from the first vaccination (RTS, S Clinical Trials Partnership, 2015). Work to 
develop a more efficacious pre-erythrocytic P. falciparum vaccine, as well as a P. 
vivax equivalent, is currently underway (Kisalu et al., 2018; Tan et al., 2018). 
However, the ‘leakiness’ of the RTS,S vaccine highlights the need to continue to strive 
for a blood-stage vaccine. Even if no blood-stage antigen can induce complete 
protection from disease, the best candidates could still potentially be used along with 
sporozoite and sexual stage antigens to produce a combination vaccine: one which 
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targets all stages of the parasite life cycle, providing the maximum protection possible 
(Draper et al., 2018; Beeson et al., 2019).  
1.5.1 Challenges associated with blood-stage vaccine design 
Encouragingly, natural immunity to severe Plasmodium infections is associated with 
antibodies targeting blood-stage antigens (Cohen et al., 1961; Healer et al., 2018). 
However, the challenge going forward is to develop a vaccine that does not merely 
mimic this natural immunity but improves upon it. Several difficulties have hindered 
vaccine development efforts. Firstly, many blood-stage antigens, such as the highly 
expressed and immunogenic merozoite surface protein 1 (MSP1) and apical membrane 
antigen 1 (AMA-1), are highly polymorphic. Therefore, attempts to generate a vaccine 
that induces strain-transcending protection based on either of these candidates, have 
not been successful thus far (Ogutu et al., 2009; Sheehy et al., 2012; Thera et al., 
2011). Secondly, merozoites often use highly redundant sets of ligands to achieve the 
same molecular goal; so targeting one particular ligand frequently results in the use of 
alternative ligand-receptor interactions This phenomenon is especially true for P. 
falciparum strains, which express multiple RBL and DBP members (reviewed in Tham 
et al., 2012). Therefore a clear understanding of invasion biology is required to 
determine which parasite ligands are absolutely essential for invasion. However, even 
if a critical ligand with highly conserved epitopes is identified, a third problem still 
exists: the fact that merozoites are exposed to the host immune system for a very short 
(1-2 min) duration (Gilson and Crabb, 2009; Boyle et al., 2010). Therefore, the ideal 
vaccine immunogen also needs to be able to induce high titres of protective antibodies, 
which can rapidly access and bind to their target antigen in an extremely efficient 
manner (Draper et al., 2018).  
The use of structural techniques to guide vaccine design and to overcome these 
challenges is becoming increasingly important (Kwong, 2017). These methods involve 
isolating antibody-producing immune cells from human volunteers vaccinated with 
either attenuated whole parasites or recombinant parasite antigens and then using 
immunoglobulin mRNA sequences from these immune cells to express recombinant 
antibodies. A series of recombinant protein screens and growth inhibitory activity 
(GIA) assays subsequently identifies which antibodies demonstrate the best binding 
affinity and kinetics to target recombinant antigens as well as how successfully they 
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inhibit parasite growth in vitro. Finally, antibody-antigen complexes are examined by 
X-ray crystallography to identify specific epitopes bound by the best performing 
antibodies. Thus critical antigen residues can be considered for inclusion within a 
subunit vaccine, whilst residues which may be immuno-dominant but do not invoke a 
protective response can potentially be excluded. Such methods have been used to 
identify important PfCSP epitopes not featured in RTS,S, but which may be included 
in subsequent versions (Kisalu et al. 2018; Tan et al., 2018). Excitingly, structural 
based techniques are also being applied to blood-stage antigen design, including the 
leading P. falciparum vaccine candidate, PfRh5 (Alanine et al., 2019).
1.5.2 Targeting the P. falciparum Rh5 complex 
The current leading blood-stage P. falciparum vaccine candidate, the reticulocyte 
binding protein homolog 5 (PfRh5) is an essential merozoite invasion ligand 
(discussed in more detail in section 1.6.2.3), which is secreted by the parasite, 
immediately before erythrocyte entry and just in time to interact with its host cell 
receptor, Basigin (Rodriguez et al., 2008; Baum et al., 2009; Crosnier et al., 2011). 
Once secreted to the merozoite surface, it exists as part of a complex with the P. 
falciparum Rh5-interacting protein (PfRipr) and the P. falciparum cysteine-rich 
protective antigen (PfCyRPA). Both partner proteins are also critical to invasion, 
although their precise functions are still being determined (Chen et al., 2011; Reddy et 
al., 2015). 
Surprisingly, although PfRh5 is essential, it appears to be extremely well conserved 
among P. falciparum isolates and does not appear to succumb to the strong immune 
selection associated with many blood-stage antigens (Douglas et al., 2011; Pearson et 
al., 2019). In line with this, anti-PfRh5 antibodies can be detected in serum samples 
from patients who have experienced clinical malaria episodes, although at significantly 
lower levels compared to other merozoite antigens, including PfMSP1 and PfAMA-1 
(Douglas et al., 2011; Tran et al., 2014). The reasons for this may be that Rh5 
expression levels are significantly lower and that this ligand is exposed to the host 
immune system for an even shorter duration than MSP1 and AMA-1, both of which 
are present on the merozoite surface at an earlier point (Baum et al., 2009; Ragotte et 
al., 2020; Riglar et al., 2011a). Excitingly, though, phase Ia trials have shown that 
vaccination with full-length PfRh5 induces a much stronger Rh5-specific immune 
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response than is seen in the context of a natural infection. Furthermore, IgG antibodies 
isolated from vaccinated individuals showed promising inhibitory action against P. 
falciparum growth in vitro, for multiple different strains, giving hope that at last 
generating a blood-stage vaccine, which induces an immune response superior to 
natural immunity may be possible (Payne et al., 2017b). Recombinant human 
monoclonal antibodies, generated in a follow on study, also supported these results and 
demonstrated that the most potent inhibitory antibodies prevent PfRh5 from binding to 
its erythrocyte receptor, Basigin ( Crosnier et al., 2011; Alanine et al., 2019).  
Like PfRh5, PfRipr and PfCyRPA are also highly conserved and do not appear to 
invoke a strong immune response over the course of a natural infection (Richards et 
al., 2013; Partey et al., 2018; Pearson et al., 2019). To date, no human vaccination 
trials have been performed for either candidate. However, mouse monoclonal 
antibodies raised against both proteins show promising inhibitory potential, although 
their precise mechanisms of neutralization remain mostly unclear (Ragotte et al., 
2020). Going forward, a better understanding of which epitopes are targeted by 
inhibitory antibodies in the context of human vaccination will provide critical 
information needed to develop PfRipr and PfCyRPA based vaccines. Importantly, 
since different combinations of antibodies targeting all three members of the Rh5 
complex can have a synergistic effect, it may be that the best course of action is to 
include components of all three members into a single vaccine (Reddy et al., 2015; 
Healer et al., 2019).  
1.5.3 Towards non-falciparum vaccines 
Despite the exciting progress made over the last few years towards generating a blood-
stage vaccine for P. falciparum, efforts to develop a P. vivax vaccine have lagged far 
behind, and the other four species infecting humans have been entirely ignored. One of 
the main reasons for this is because up until 2013, only P. falciparum asexual stages 
could be maintained in continuous culture. An in vitro culture system now also exists 
for P. knowlesi; however, the remaining four species, including P. vivax, still cannot be 
maintained long-term in vitro (Moon et al., 2013). Therefore, for these species, 
attempts to perform GIA assays, such as are routinely performed for P. falciparum, are 
difficult at best, and have traditionally been reliant upon the availability of clinical 




Importantly, protection from P. vivax is associated with antibodies, which target 
PvDBP, the only DBP ligand expressed by this species ( Miller and Carter, 1976; King 
et al., 2008; Cole-Tobian et al., 2009; Nicolete et al., 2016). Likewise, anti-PvDBP 
antibodies, purified from vaccinated animals as well as human volunteers, have been 
shown to inhibit the binding of recombinant PvDBP to its host cell receptor, the Duffy 
antigen receptor for chemokines (DARC), in protein binding assays (Moreno et al., 
2008; Payne et al., 2017a; Singh et al., 2018). For these reasons, PvDBP is the lead 
blood-stage candidate for P. vivax. However, it is important to note that we still do not 
understand the precise role of PvDBP during invasion, or how this ligand might act in 
conjunction with other invasion ligands. Understanding these critical details could 
enable the development of multi-component vaccines, targeting sequential steps of 
invasion. Therefore, there is an urgent need to understand the functions of current 
vaccine candidates and to identify new vaccine candidates, especially for the 
remaining neglected species.  
1.5 Erythrocyte Invasion 
1.5.1 The merozoite: an invasion machine 
A detailed understanding of how merozoites invade erythrocytes is critical to the 
development of clinical interventions, such as monoclonal therapies (Kisalu et al., 
2018; Maskus et al., 2016), new drugs (Burns et al., 2019), and vaccines (Draper et al., 
2018). As such, invasion has been the subject of intense research for over 60 years. At 
least 50 parasite-derived proteins are predicted to play a direct role during invasion 
(Wright and Rayner 2014). Many of these ligands (Fig 1.2) are present on the surface 
of the merozoite prior to egress, such as the merozoite surface proteins (MSPs). 
Others, however, are secreted from the merozoite’s apical organelles throughout each 
step of invasion, so that they can interact with their corresponding erythrocyte 
receptors as required (Cowman et al., 2017). Others still, lying under the merozoite’s 
plasma membrane, form the basis of the parasite’s molecular motor, which drives host 
cell entry (Frénal et al., 2017). Unravelling the individual roles of these proteins and 
determining their relative importance has been challenging and is far from being 
entirely understood.  
29	
	
The merozoite is a highly polarized cell (Figure 1.2), marked by three polar rings and a 
collection of secretory organelles, known as the apical complex, at one end and a 
nucleus and endomembrane system towards the other. (Hepler et al., 1966; Aikawa, 
1967, 1966; Aikawa et al., 1978; Bannister et al., 1975, 2000). These secretory 
organelles include the exonemes, whose contents play important roles during egress, 
and are therefore secreted into the PV before host cell rupture (Janse and Waters, 
2007; Yeoh et al., 2007). Another class of apical organelles, the dense granules, secrete 
their contents after invasion is completed, in line with their proposed roles of host cell 
remodelling, PV development, and nutrient uptake (Torii et al., 1989; Hanssen et al., 
2013; Morita et al., 2018) Finally, the rhoptries and micronemes secrete ligands the 
merozoite requires to attach to and invade a new host cell (Cowman et al., 2017).  
Three interconnected structures are collectively responsible for the morphology and 
motility of all apicomplexan zoites, including merozoites. Firstly, all zoites possess a 
double membrane structure, the inner membrane complex (IMC), which lies directly 
underneath the plasma membrane (PM). (Hepler et al.,1966; Aikawa, 1966 &1967; 
Bannister et al., 1975). Secondly, 2-3 subpellicular microtubules are attached to the 
largest of the apical polar rings and run beneath the pellicle, down the longitudinal axis 
of the merozoite. Finally, both the pellicle and subpellicular microtubules are 
connected via an intermediate network of filamentous proteins making up the 
merozoite cytoskeleton, known as the subpellicular network (SPN) (Bannister and 
Mitchell, 1995; Mann and Beckers, 2001; Tremp et al., 2014). Notably, the space 
between the PM and IMC houses the parasite’s acto-myosin motor, which the 
merozoite uses to actively drive itself into the host cell by a mechanism referred to as 






Figure 1.2. The Plasmodium merozoite (Adapted from Cowman and Crabb, 2006). The invasive 
form of the blood stages, the merozoite, is a polarized cell, containing an apical complex and 
specialized secretory organelles (rhoptries, micronemes, and dense granules) at one end, and a 
nucleus and endo-membrane system towards the other. While proteins making up the merozoite’s 
“fuzzy” surface coat may mediate the initial, weak host cell interactions, ligands released from the 
secretory organelles govern subsequent steps required for host cell selection, moving junction 
formation, and internalisation. Secretory organelles are hypothesized to release their contents in an 
orderly manner, exposing ligand subsets only as required for specific roles, and thus protecting them 
from the host immune system (Harvey et al., 2012).	
1.5.1.1 The rhoptries 
Each merozoite possesses two club-shaped rhoptries (Figure 1.3), which have a 
narrow ‘neck’ region facing towards the merozoite apex, and a wider ‘bulb’ region at 
the opposite end (Hepler et al., 1966; Aikawa, 1966 & 1967; Bannister 1975).  These 
large, electron-dense organelles were first implicated in invasion when it was 
discovered that their contents appeared to be secreted during red cell entry, a process 
marked by a reduction in electron density and total organelle volume as invasion 
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progresses (Bannister et al., 1975; Hanssen et al., 2013). Furthermore, when invasion 
is stalled by the addition of cytochalasin D, a potent inhibitor of actin polymerisation, 
membranous whorls, which might ordinarily contribute to the expansion of the PVM, 
are extruded from the merozoite into the erythrocyte as small vacuoles (Bannister et 
al., 1986; Hanssen et al., 2013; Miller et al., 1979). A rhoptry bulb protein, RAP1, has 
since been localized to these whorls, supporting the hypothesis that they are at least in 
part, rhoptry derived (Riglar et al., 2011).  
Many molecular studies aimed at characterizing rhoptry contents have followed these 
early investigations. For P. falciparum, proteins predicted to be involved in host cell 
selection, such as the RBL ligands (also called the reticulocyte binding like 
homologs/Rh ligands) are localized to the extremities of the rhoptry necks. Next, the 
rhoptry neck (RON) proteins, several of which play a role in moving junction 
formation, lie posterior to the RBLs, but still within the rhoptry necks (Duraisingh et 
al., 2003a; Zuccala et al., 2012). Finally, rhoptry proteins responsible for the later steps 
of invasion, the formation of the PV as entry progresses, and even during subsequent 
parasite development, are localized to the rhoptry bulb (Richard et al., 2010; Riglar et 
al., 2011b; Zuccala et al., 2012; Sherling et al., 2017; Ghosh et al., 2017). So overall, it 
appears that rhoptry proteins are organized spatially so that they can be secreted just in 
time to perform their respective roles (Zuccala et al., 2012). However, exceptions to 
this rule exist, such as PfRON12, which is localized to the rhoptry neck, but secreted 
post invasion. Thus it does not play a role during the early steps of invasion, as might 
have been predicted by its localization (Knuepfer et al., 2014). Although membranous 
‘whorls’ have also been observed within the rhoptries (Bannister et al., 1986), no clear 
membrane divisions between different regions of the rhoptries have been established. 
Thus, it is not clear how rhoptry organization is achieved, or how a specific ligand 
could be withheld, while others are simultaneously secreted.  At the commencement of 
invasion, it has been proposed that both rhoptries are fused together, to form one 
organelle (Hanssen et al., 2013). From this point, the now single rhoptry tip appears to 
be continuous with the merozoite’s plasma membrane, exposing internal rhoptry 
contents to the merozoite surface (Hanssen et al., 2013). However, it is not clear what 
the significance of merging both rhoptries is, or whether any protein secretion 
commences from individual rhoptries before this fusion event.  
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1.5.1.2 The micronemes 
Surrounding the rhoptries are up to 40, smaller, tear-drop shaped micronemes (Figure 
1.3) (Bannister et al., 2003). Micronemal ligands perform a variety of roles (reviewed 
in Cowman et al., 2017), some of which overlap functionally or act in conjunction with 
rhoptry neck proteins. Significant examples include the DBP ligands, also proposed to 
be involved in host cell selection, as well as apical membrane antigen 1 (AMA-1), a 
critical component of the moving junction (Lee Sim et al., 1992; Adams et al., 1990; 
Healer et al., 2002). 
Like the rhoptries, the mechanism of micronemal secretion is not entirely clear. The 
tips of micronemes and rhoptries are often seen to be in close contact at the merozoite 
apex. So one hypothesis is that secretion may occur via the rhoptries, by micronemes 
fusing with and secreting their contents into the rhoptry tips (Bannister et al., 2003). 
However, no data, even from a more recent study of invasion utilizing 3D electron 
tomography, has been able to confirm this theory (Hanssen et al., 2013). Additionally, 
another study exploring apical secretion by the related apicomplexan parasite, 
Toxoplasma gondii, showed that micronemal secretion could occur independently of 
rhoptry secretion, in genetic mutants with mis-localised rhoptries (Mueller et al., 
2013). So an alternative theory is that Plasmodium micronemes simply release their 
contents by directly fusing with the plasma membrane. However, if this is the case, is 
there an order to microneme and rhoptry secretion, or can both organelle classes be 
secreted concurrently?  
Figure 1.3.  The apical organelles of 
Plasmodium merozoites (Adapted 
from Hanssen et al., 2013). A 
computational section through the 
merozoite’s apical tip taken with cryo-
electron tomography. Large rhoptries 
(rh) are surrounded by smaller 
micronemes (mi). Also depicted are the 
merozoite’s inner membrane complex 




Whether micronemal secretion might lead to rhoptry secretion or vice versa is a hotly 
debated topic. For instance, one study showed that secretion of a key P. falciparum 
DBP ligand, PfEBA-175 from the micronemes is triggered at egress by a complex Ca2+ 
signalling cascade and that the subsequent interaction of EBA-175 with its RBC 
receptor, glycophorin A, triggers the release of PfRh2b, an RBL ligand from the 
rhoptry neck (Singh et al., 2010). However, conflicting studies demonstrated at least 
partial secretion of the micronemal ligand, PfAMA-1, pre-egress (Treeck et al., 2009; 
Riglar et al., 2011) and that PfEBA-175 release was not triggered by egress, but rather 
by the binding of another rhoptry RBL ligand, PfRh1, to its RBC receptor (Gao et al., 
2013). 
An additional interesting note is that, unlike their P. falciparum counterparts, the P. 
knowlesi and P. vivax RBL homologs are not localized to the rhoptries, but are instead 
localized to the micronemes (Meyer et al., 2009; Han et al., 2016). Thus for both of 
these species, the RBL and DBL ligands may be released at the same time, from the 
same set of organelles, in line with their predicted roles as mediators of host cell 
selection and the steps leading up to moving junction formation. However, if like their 
P. falciparum homologs these two families are released in a specific order relative to 
each other, an alternative explanation could be that merozoites may contain sub-
populations of micronemes, which are released sequentially. 
T. gondii tachyzoites appear to produce micronemal subsets, as do Plasmodium 
sporozoites (Arredondo et al., 2018; Kremer et al., 2013). Indeed, evidence for 
micronemal sub-populations in P. falciparum is growing (Hans et al., 2013) and could 
explain the early release of PfAMA-1, relative to PfEBA-175 (Riglar et al., 2011).  
Dual immuno-EM labelling of AMA-1 and EBA-175 in P. falciparum schizonts also 
lends support to this theory. Healer et al. (2002) showed that the majority of 
micronemes within a given schizont contained either EBA-175 or AMA-1, but rarely 
both antigens together. So, regardless of whether EBA-175 secretion occurs before or 
after rhoptry neck proteins, physical separation of both micronemal proteins could at 
least explain their different secretion profiles. Furthermore, EM tomograms depicting 
merozoites caught at various stages of invasion show the presence of individual 
micronemes throughout invasion, which could indicate that micronemes are secreted in 
several waves (Hanssen et al., 2013).   
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So overall, despite the extensive research into the composition of microneme and 
rhoptry contents, as well as the timing and order of their release, many questions 
remain unanswered. However, a carefully orchestrated sequence of secretion events is 
thought not only to underpin each mechanical step of invasion but also to prevent 
critical invasion ligands from being exposed to the host immune system any longer 
than necessary (Harvey et al., 2012; Cowman et al., 2017). Therefore, a greater 
understanding of secretion will aid our understanding of the individual roles of 
invasion ligands.  
1.5.2 An overview of the molecular steps of invasion 
Both live microscopy and electron microscopy have been fundamental in revealing the 
overall mechanics of invasion (Aikawa et al., 1978; Miller et al., 1979; Dvorak et al., 
1975; Gilson and Crabb, 2009; Yahata et al., 2012; Weiss et al., 2015). The very first 
video microscopy study detailing these events featured P. knowlesi merozoites and 
showed that invasion begins with weak, reversible contact between parasite and host 
cell along any point of the merozoite. Subsequently, stronger interactions are formed, 
causing “waves of deformation” along the surface of the RBC, that in many instances 
result in the RBC completely wrapping around the merozoite (Dvorak et al., 1975; 
Gilson and Crabb, 2009). Either during this phase or potentially just after, the parasite 
re-orientates itself, so that its apical end is in contact with the RBC (Aikawa et al., 
1978; Dvorak et al. 1975; Gilson and Crabb, 2009). Electron micrographs by Aikawa 
et al. (1978) showed that next, an electron-dense interface, subsequently called the 
moving junction, forms between parasite and host cell (Figure 1.4). After these 
preparatory steps, the merozoite proceeds to enter the host cell, through an 
invagination of the erythrocyte membrane. As it does so, the moving junction travels 
back across the merozoite until entry is complete, the host cell is re-sealed, and the 
merozoite is engulfed within a PV (Aikawa et al., 1978). Finally, the erythrocyte 
membrane shrivels and shrinks, forming spicules, in a step called echinocytosis. 
However, this phase is temporary and within minutes the erythrocyte returns to its 
original morphology, marking the end of invasion (Dvorak et al., 1975; Gilson and 
Crabb, 2009). Since these early studies, great effort has focused on understanding the 
molecular events underlying each morphological step of invasion, described in more 
detail below. 
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Figure 1.4 Electron micrograph showing moving junction progression (taken from Aikawa et 
al. 1978) Merozoite invasion of RBCs proceeds after the formation of a circular interface 
between parasite (marked ‘Mz’) and host cell, called the moving junction (marked ‘C’). This 
electron dense structure travels across the parasite throughout invasion and seals the parasite into a 
parasitophorous vacuole upon closure, when invasion is complete.	
The early, reversible contacts between parasite and host cell may be mediated by the 
Merozoite Surface Proteins (MSPs), which are associated with the merozoite surface 
membrane (Aikawa et al., 1978; Holder and Freeman, 1984; Lin et al., 2014; Weiss et 
al., 2015). MSP1 is the most abundant protein found on the merozoite surface, 
appearing by EM as a ‘fuzzy coat’ that decorates the parasite’s plasma membrane 
(Holder and Freeman, 1982). PfMSP1 may bind to either Band 3 or glycophorin A on 
the erythrocyte surface (Baldwin et al., 2015; Goel et al., 2003). Additionally, PfMSP1 
has been shown to interact with heparin-like molecules, a hypothesis that is supported 
by live microscopy showing that P. falciparum merozoites cannot invade host cells in 
the presence of heparin (Boyle et al., 2010a). However, a more recent study produced a 
functional KO of PfMSP1 for the first time and demonstrated that these parasites can 
still invade host erythrocytes without surface-bound PfMSP1 (Das et al., 2015). 
Surprisingly, PfMSP1 instead plays a critical role during egress, potentially by 
interacting with spectrin to destabilize the host cell cytoskeleton. So while MSP1 may 
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still play a helpful, but non-essential role during invasion, in an unexpected turn of 
events, the surface localization of PfMSP1 is instead vital for egress.   
Following weak binding, the merozoite must then form a series of stronger interactions 
with the host cell, committing itself to invasion. The interactions between the Duffy 
binding like (DBP) and Reticulocyte binding like (RBL) proteins with their respective 
host cell receptors (discussed extensively in section 1.5.4) are predicted to perform this 
role and align the merozoite for host cell entry (Weiss et al., 2015). However, for P. 
falciparum one atypical RBL ligand lacking a transmembrane domain, PfRH5, is 
predicted to act downstream of the other RBL/DBP ligands. Once secreted from the 
rhoptry neck, this essential protein forms a complex with The P. falciparum Cysteine-
Rich Protective Antigen (PfCyRPA) and the P. falciparum Rh5-interacting protein 
(PfRipr), before binding to its host cell receptor, Basigin ( Hayton et al., 2008; Baum 
et al., 2009; Chen et al., 2011; Reddy et al., 2015). Recent work has shown that this 
complex is likely required for a merozoite-host cell fusion event indicative of rhoptry 
secretion (Weiss et al., 2015; Volz et al., 2016). This phenomenon can be visualized by 
pre-loading erythrocytes with a fluorescent calcium-sensitive dye, Fluo-4-AM (Weiss 
et al., 2015). Several seconds before internalization ensues, a punctate calcium signal 
can be observed at the merozoite’s apex, indicating that merozoite derived calcium, 
likely stemming from secretion of the calcium rich rhoptries, is coming into contact 
with the dye from the erythrocyte cytosol. Thus, the PfRh5 complex likely acts just 
before the formation of the moving junction.  
Junction formation begins when the merozoite secretes rhoptry neck proteins, RON2, 
RON4, and RON5 into the erythrocyte, where they assemble as a complex, associated 
with the erythrocyte membrane (Alexander et al., 2006; Cao et al., 2009; Lamarque et 
al., 2011; Richard et al., 2010b; Riglar et al., 2011a; Srinivasan et al., 2011). Studies 
using T. gondii tachyzoites as a model for host cell invasion have shown that TgRON2 
is inserted into the erythrocyte membrane, while TgRON4 and TgRON5 localise to the 
cytosolic face of the erythrocyte membrane, where they potentially interact with 
RON2, anchoring it to the underlying host cell cytoskeleton (Lamarque et al., 2011; 
Straub et al., 2011; Takemae et al., 2013). Once associated with the erythrocyte 
membrane, both membrane-embedded PfRON2 and TgRON2 act as receptors for their 
respective AMA-1 homologs. PfAMA-1 binding to PfRON2 forms the nascent 
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junction, effectively beginning the next phase of invasion: internalisation (Lamarque et 
al. 2011; Srinivasan et al., 2011). 
During internalisation, the merozoite actively drives itself into an invagination of the 
RBC membrane, which becomes the PV, using a molecular motor (Aikawa et al., 
1978; Baum et al., 2006b). As invasion progresses, several rhomboid-like and 
subtilisin-like proteases mediate shedding of merozoite surface proteins, as well as 
trans-membrane adhesive ligands secreted from the apical organelles to the merozoite 
surface (Baker et al., 2006; Harris et al., 2005; O’Donnell et al., 2006). Cleavage 
events likely release AMA-1, as well as other junction/motor associated ligands from 
their respective host cell receptors as the moving junction sweeps across the 
merozoite’s body, thus enabling smooth passage into the host cell. Additionally, 
proteolytic cleavage may aid the re-sealing of the host cell membrane, and the release 
of the PVM enclosed parasite into the erythrocyte so that it can continue its 
development into a ring-stage parasite. Recently the subtilisin-like protease, SUB2, 
which cleaves the ectodomains of MSP1, AMA-1, and PTRAMP from the merozoite 
surface, has been implicated in this process (Harris et al., 2005; Green et al., 2006b). 
Conditional PfSUB2 knockout parasites exhibit a severe invasion phenotype, where 
although some parasites can enter erythrocytes, host cells soon lyse, sometimes 
ejecting merozoites in the process (Collins et al., 2020). Thus protease-mediated 
shedding also appears to be an important step for host cell re-sealing, and the presence 
of bulky, un-processed ligands at the ‘end’ of the junction may hinder this process. 
1.5.3 Powering invasion and motility 
Gliding motility is a unique form of movement by which apicomplexan zoites travel in 
a polarized fashion across cellular surfaces without any obvious morphological 
changes, such as the extension of pseudopodia, or use of cellular projections, such as 
cilia or flagella (Frenal et al., 2017). Gliding has perhaps been best described for T. 
gondii tachyzoites and P. berghei sporozoites, both of which exhibit helical motion in 
3D environments (Bichet et al., 2014; Håkansson et al., 1999; Kudryashev et al., 2012; 
Vanderberg, 1974). Video microscopy of invading T. gondii tachyzoites shows that 
invasion also progresses by this corkscrew-like motion (Bichet et al., 2014; Pavlou et 
al., 2018). Importantly, treatment of both sporozoites and tachyzoites with either 
cytochalasin D, which inhibits actin polymerization, or butanedione monoxime, a 
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myosin inhibitor, stalls both extracellular motility and host cell invasion, suggesting 
that both events are driven by an acto-myosin based motor (Ryning and Remington, 
1978Stewart et al., 1986; Dobrowolski et al., 1997; Håkansson et al., 1999; 
Matuschewski et al., 2001). 
Later work discovered that the components of this motor, collectively called the 
“glideosome”, are localized to the space between the parasite’s IMC and plasma 
membrane (Figure 1.5) and are generally conserved between apicomplexan zoites, 
including merozoites (Opitz and Soldati, 2002; Baum et al., 2006b; Frenal et al., 
2017). According to the linear motor model (Figure 1.5), gliding is a substrate-
dependent process. Transmembrane micronemal ligands are secreted at the apical end 
of the zoite, where they bind to receptors on the surface of the host cell via their 
ectodomains while connecting to the acto-myosin motor through their cytoplasmic tails 
(Frenal et al., 2017). Subsequently, MyoA engagement with actin pulls both actin and 
the receptor bound-ligand rearwards and in the process, drives the zoite forwards. 
Finally, the external domains of surface-bound ligands are cleaved by parasite-derived 
proteases, thus disengaging them from their host cell receptors (Harris et al., 2005; 
O’Donnell et al., 2006; Baker et al. 2006; Frenal et al., 2017). Importantly, deletion of 
key motor components, including PfMyoA (Robert-Paganin et al., 2019), PfGAP45 
(Perrin et al., 2018), and PfACT1 (Das et al., 2017), completely inhibits P. falciparum 
merozoites from invading host erythrocytes, demonstrating the essentiality of the acto-
myosin motor for erythrocyte invasion, even though merozoites are not thought to 
glide across extra-cellular surfaces (Baum et al., 2006b). However, very interestingly, 
studies examining mutant T. gondii parasites show that although deletion of multiple 
motor components, including the non-redundant TgACT1, severely impairs parasite 
motility, KO parasites still exhibit a residual capacity for extracellular gliding and 
invasion (Andenmatten et al., 2013; Egarter et al., 2014; Bichet et al., 2016; Whitelaw 
et al., 2017). These results suggest that while on the whole, the acto-myosin motor is 
incredibly important; it may not be the only contributor to parasite motility.  
One such alternative mechanism, predicted to act synergistically with the acto-myosin 
motor, is the fountain model, which involves a retrograde flow of membrane and 
micronemal proteins from the apical to the basal end of the zoite, independently of 
motor function, followed by recycling of membrane and adhesins by endocytosis (Gras 
et al., 2019). This hypothesis is supported by studies showing that nano-beads bound 
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to parasite surfaces are trans-located to the basal end of the zoite (also known as 
“capping”) regardless of treatment with cytochalasin D, or the deletion of motor 
complex members, demonstrating that a continuous, retrograde membrane flow occurs 
without the aid of a molecular motor (Quadt et al., 2016; Whitelaw et al., 2017). 
However, without a functioning motor, zoites struggle to attach to surfaces, and 
therefore fail to generate the force required for efficient movement. Thus it appears 
that both the apicomplexan zoite’s motor and a secretory-endocytosis cycle may 
together drive motility (Gras et al., 2019).  
Currently, it is not clear which adhesive ligands mediate merozoite motility. 
Plasmodium sporozoites and ookinetes and Toxoplasma tachyzoites all rely on 
members of the TRAP family, binding to as of yet, unknown receptors (Frenal et al., 
2017). Plasmodium merozoites also express a TRAP homolog, merozoite TRAP 
(MTRAP), in addition to a TRAP-like ligand, the Plasmodium thrombospondin related 
apical merozoite protein (PTRAMP) (Thompson et al., 2004; Baum et al., 2006b). 
However, MTRAP appears to be dispensable for the asexual stages, and no clear link 
between PTRAMP and the merozoite motor has been demonstrated yet (Bargieri et al., 
2016; Diaz et al., 2016). Another prominent theory is that the cytoplasmic tail of 
AMA-1 interacts with actin, either directly or indirectly, and thus links the moving 
junction with the molecular motor, providing traction for entry (Cowman et al., 2017). 
As invasion progresses, the RON2/AMA-1 interface between merozoite and host cell 
appears to progress rearwards over the zoite body (Riglar et al., 2011). A ring of actin 
also travels over the parasite, closely following this junction, and supporting the theory 
that the two may be connected (Riglar et al., 2011; Angrisano et al., 2012). Additional 
studies around the same time pointed to both TgAMA-1 and PfAMA-1, as well as 
several Tg/PfTRAP proteins connecting to actin via an intermediate, actin binding 
protein, aldolase (Jewett and Sibley, 2003; Sheiner et al., 2010; Srinivasan et al., 2011; 
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Figure 1.5 Gliding motility of apicomplexan zoites (Adapted from Frenal et al., 2017) Zoite 
motility (including T. gondii tachyzoites, pictured above) involves the coordinated interaction 
between transmembrane adhesins, secreted from the micronemes to the merozoite surface, and the 
zoite’s molecular motor, localized beneath the parasite’s plasma membrane. Micronemal adhesins, 
such as members of the TRAP family of ligands, bind to host cell receptors via their ecto-domains, 
while at the same time connecting to the motor through their cytoplasmic tails. While the exact 
topology and arrangement of motor components is still debated, a leading theory is that MyoA is 
anchored to the IMC through several glideosome-associated ligands. Engagement of the MyoA head 
with filamentous actin drags the adhesin-bound actin backwards, and the zoite forwards. Adhesins 
are subsequently disengaged from their respective receptors by the action of rhomboid-like 
proteases, releasing their ecto-domains into the culture supernatant.	
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Diaz et al., 2016). However, since these findings, it has been shown that aldolase is not 
required for T. gondii invasion of host cells (Shen and Sibley, 2014). TgMIC2, a T. 
gondii TRAP homolog, may instead connect to the motor via the glideosome-
associated connector (GAC), another actin binding protein. However, so far, no data 
has been published regarding whether Tg/PfAMA-1 follows suit (Jacot et al., 2016). 
Therefore, the questions of which ligands drive internalization, and how the acto-
myosin motor may be connected to the moving junction remain open for debate.  
1.5.4 The RBL and DBP ligands 
The molecular steps of invasion preceding PfRh5-Basigin interactions and junction 
formation are considerably less well defined. For P. falciparum, members of the RBL 
and DBP families are hypothesized to facilitate erythrocyte deformation and merozoite 
re-orientation (Weiss et al., 2015). However, although these families are conserved 
across all malaria parasite species, significant redundancy within and possibly between 
the two families has hampered dissection of their roles.  
The P. knowlesi Duffy binding protein alpha (PkDBPα) was the first DBP member to 
be identified, followed by its closely related P. vivax ortholog, PvDBP (Haynes et al., 
1988; Wertheimer and Barnwell et al., 1989). Importantly, both PkDBPα and PvDBP 
bind to the Duffy antigen receptor for chemokines (DARC receptor) on the surface of 
RBCs, a step that is required for invasion and that limits the proliferation of these two 
species to growth in Duffy positive erythrocytes (Miller et al., 1975; Haynes et al., 
1988; Wertheimer and Barnwell, 1989). Binding to DARC occurs via a shared 5’ 
cysteine-rich region, later termed the ‘Duffy binding like’ or DBL domain when 
homologous sequences were identified in P. falciparum and P. yoelii invasion ligands, 
all of which bind to a variety of additional host cell receptors (Fang et al., 1991; 
Adams et al., 1992; Prasad et al., 2003). So as the nomenclature implies, DBP family 
members contain at least one DBL domain, with some P. falciparum members 
possessing two domains. Additionally, DBP ligands also generally share a signal 
peptide, a C-terminal cysteine-rich domain of unknown function as of yet, a single 
transmembrane domain, and a short cytoplasmic tail (Adams et al., 1992; Tolia et al., 
2005). Interestingly, each human Plasmodium species expresses a differing number of 
DBP ligands. So, for instance, while P. vivax expresses a single DBP ligand (PvDBP), 
P. knowlesi expresses three DBPs (PkDBPα, PkDBPβ, and PkDBPγ), and P.
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falciparum parasites can express up to four members (EBA-175, EBA-140, EBA-181, 
and EBL-1) (Cowman et al., 2017; See Table 1.1 for abbreviations and individual 
references).  
Ligand Erythrocyte Receptor References 
P. falciparum (Erythrocyte binding antigen/ligand, PfEBA/EBL)
EBA-175 Glycophorin A (GPA) Camus and Hadley, 1985; Lee Sim et al., 
1992 
EBA-140 Glycophorin C (GPC) Adams et al., 2001; Lobo et al., 2003 
EBA-181 Unknown Adams et al., 2001 
EBL-1 Glycophorin B (GPB) Peterson and Wellems, 2000; Mayer et 
al., 2009 
P. vivax (Duffy binding protein, PvDBP)
PvDBP Duffy antigen for chemokines (DARC) Wertheimer and Barnwell et al., 1989; 
Barnwell et al., 1989 
P. knowlesi (Duffy Binding Protein, PkDBP)
DBPa Duffy antigen for chemokines (DARC) Miller et al., 1975; Haynes et al., 1988 
DBPb Unknown Adams et al., 1990 
DBPy Unknown Adams et al., 1990 
The importance of PvDBP-DARC (or PkDBPα-DARC) interactions cannot be 
understated. Within human populations, DARC expression on the surface of 
erythrocytes is determined primarily by two co-dominant alleles, FY*A, and FY*B, 
encoding the Fya and Fyb antigens, respectively. However, a single mutation within 
the promoter region of the FY*B allele (FYES) severely reduces the expression of this 
receptor, and individuals who possess two mutant copies (FYES/FYES) are described as 
“Duffy negative” (Tournamille et al., 1995). For many years, the prevailing view has 
been that Duffy negative individuals are completely protected from P. vivax and P. 
knowlesi infections. Indeed, from a clinical standpoint, this is very apparent, as P. 
vivax infections in Sub-Saharan Africa, where the prevailing genotype is reported to be 
FY*BES/FY*BES, are virtually non-existent (Miller et al., 1976; Howes et al., 2011). 
However, more recently, asymptomatic cases of P. vivax, as well as very rare instances 
of symptomatic cases, have been reported for Duffy negative individuals living within 
Table 1.1. The Duffy binding like protein (DBP) homologs of P. falciparum, P.vivax, and 
P. knowlesi
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mixed Duffy populations (Cavasini et al., 2007; Ménard et al., 2010; Woldearegai et 
al., 2013; Lo et al., 2019). Although these parasites may indeed rely on alternative 
molecular invasion pathways yet to be determined (Popovici et al., 2020), another 
explanation is that a subset of very young reticulocytes from Duffy negative 
individuals is capable of expressing lower, but significant levels of DARC as 
compared to their Duffy positive counterparts. So, this small subset of cells may 
support even more restricted parasite replication in Duffy negative individuals, leading 
to mostly asymptomatic infections, which are not detected outside of active screening 
measures (Dechavanne et al., 2018). It is still unclear, though, whether the very low 
parasitaemias resulting from these infections could support transmission. Thus the 
hypothesis that P. vivax and P. knowlesi transmission appears to be severely restricted 
in populations where the Duffy negative phenotype prevails, likely still holds true.  
The first RBL proteins were identified in P. vivax and were found to bind specifically 
to reticulocytes, hence the family name that has come to include orthologs from 
additional species, some of which do not bind to reticulocyte specific receptors but 
instead mediate invasion of normocytes (Galinski et al., 1992; Tham et al., 2012; Chan 
et al., 2020). The sequences of different RBL members vary considerably between 
species, both at a nucleotide level and amino acid level. However, most RBL genes 
share a similar structure including a short exon encoding a signal peptide, followed by 
a much longer exon, encoding an RBC binding domain towards the N-terminus of the 
protein, and a single C-terminal transmembrane domain followed by a short 
cytoplasmic tail (Chan et al., 2020). Like the DBPs, the number of RBLs human 
Plasmodium species express varies considerably (See table 1.2). P. knowlesi expresses 
two RBL ligands, the normocyte binding proteins (NBPXa and NBPXb), while P. 
vivax expresses five full-length reticulocyte binding proteins (PvRBP1a, PvRBP1b, 
PvRBP2a, PvRBP2b, and PvRBP2c), and P. falciparum can express up to five 
reticulocyte binding like homologs (PfRh1, PfRh2a, PfRh2b, PfRh4, and PfRh5) 
(Cowman et al., 2017; Chan et al., 2020; See Table 1.2 for abbreviations and 
individual references). 
Importantly, for P. vivax the interactions of its RBL ligands with reticulocyte specific 
receptors, such PvRBP2b binding to TfR1 (Transferrin receptor 1), limit this species to 
growth in reticulocytes (Gruszczyk et al., 2018). Practically speaking, this means that 
P. vivax infections rarely achieve parasite densities in the peripheral blood that are
	
comparable to those reached by unchecked P. falciparum parasites, which can use their 
RBL ligands to proliferate in normocytes (Lim et al., 2016; Malleret et al., 2014). As a 
result, P. vivax disease symptoms are typically, although not always, milder than those 
seen for P. falciparum. Thus the RBL ligands are important determinants of host cell 
tropism and key moderators of parasite virulence. Most research addressing the 
molecular functions of the RBL/DBL families has been performed in the context of P. 
falciparum. 
Table 1.2. The reticulocyte binding like (RBL) homologs of P. falciparum, P.vivax, and P. knowlesi 
Most research addressing the molecular functions of the RBL/DBL families has been 
performed in the context of P. falciparum. Simultaneously inhibiting the majority of 
PfRBL/DBP-receptor interactions prevents the formation of the moving junction 
between merozoite and host cell (Riglar et al., 2011). Additionally, video microscopy 
shows that under these conditions, parasites cannot deform host cells (Weiss et al., 
2015; Tham et al., 2015). Therefore, the P. falciparum RBL and DBP families are 
hypothesized to be required for deformation, and potentially also re-orientation. 
However, determining the individual roles of each RBL and DBP protein has been 
challenging, as all of the P. falciparum members can be disrupted individually, except 
for the atypical RBL, PfRh5. Unlike the other RBL family members, this ligand is 
Ligand Erythrocyte Receptor References 
P. falciparum (Reticulocyte binding like homolog, PfRh)
Rh1 Unknown Rayner et al., 2001 
Rh2a Unknown Rayner et al., 2000 
Rh2b Unknown Rayner et al., 2000 
Rh4 Complement receptor 1 (CR1) Kaneko et al., 2002; Tham et al., 2010 
Rh5 Basigin Baum et al., 2009; Crosnier et al., 2011 
P. vivax (Reticulocyte binding protein, PvRBP)
PvRBP1a Unknown Galinski et al., 1992 
PvRBP1b Unknown Carlton et al., 2008 
PvRBP2a Unknown Carlton et al., 2008 
PvRBP2b Transferrin receptor 1 (TfR1) Carlton et al., 2008; Gruszczyk et al., 2018 
PvRBP2c Unknown Galinski et al., 1992 
P. knowlesi (Normocyte Binding protein, PkNBP)
NBPXa Unknown Meyer et al. 2009 
NBPXb Unknown Meyer et al. 2009 
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soluble, lacks a transmembrane domain, and acts downstream of deformation 
(Duraisingh et al., 2003a; Duraisingh et al., 2003b; Gilberger et al., 2003; Maier et al., 
2003; Stubbs et al., 2005; Weiss et al., 2015). Since none of the remaining RBL/DBL 
proteins are essential in their own right, a high level of redundancy is thought to exist 
within each family.  This is further illustrated by the fact that not every P. falciparum 
strain expresses every member of each family (Thompson et al., 2001; Stubbs et al., 
2005; Triglia et al., 2005; Duraisingh et al., 2003a; See table 1.3).  
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Table 1.3. Expression patterns of RBL and DBP members vary between P. falciparum strains
P. falciparum strains
Ligands 3D7 W2mef D10 T994 7G8 References 
Rh1 Yes (low) Yes Yes (low) Yes Yes Rayner et al., 2000; Duraisingh et al., 2003a/b; Triglia et al., 2005 
Rh2a Yes Yes Yes No Yes Rayner et al., 2000; Durasingh et al., 2003a/b; Triglia et al., 2005; 
Rh2b Yes Yes No No Yes Rayner et al., 2000; Duraisingh et al., 2003a/b; Triglia et al., 2005; 
Rh4 Yes No Yes 
Yes 
Yes Stubbs et al., 2005; Baum et al., 2005; Tham et al., 2011 
Rh5 Yes Yes Yes Yes Yes Baum et al., 2009 
EBA-175 Yes Yes Yes Yes Yes 
Lee Sim et al., 1992; Durasingh et al., 2003; Tham et al., 2011; 
EBA-140 Yes Yes No ? Yes Thompson et al., 2001; Maier et al., 2009; 
EBA-181 Yes Yes Yes ? Yes Gilberger et al., 2003; Maier et al., 2009; Baum et al., 2005 
EBL-1 No Yes Putative ? Putative 
Peterson and Wellems, 2000; Cowman et al., 2017 
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Furthermore, redundancy may also exist between the two families, potentially acting 
as a failsafe mechanism and allowing the parasite to achieve the same goals via 
alternative molecular pathways if one particular invasion pathway is unavailable 
(Weiss et al., 2015; Cowman et al., 2017). This is evident in studies of P. falciparum 
invasion into enzyme-treated erythrocytes that have been stripped of specific invasion 
receptors (Dolan et al., 1990). For instance, PfW2mef parasites ordinarily rely on the 
EBA proteins, particularly EBA-175 binding to its host cell receptor, Glycophorin A 
(GPA), to invade host erythrocytes (Duraisingh et al., 2003b; Stubbs et al., 2005). 
However, treatment of erythrocytes with neuraminidase strips them of the EBA (and 
PfRh1) receptors, while leaving the remaining PfRh receptors unscathed (Sim et al., 
1994; Mayer et al., 2001; Rayner et al., 2001; Duraisingh et al., 2003a; Gilberger et al., 
2003; Stubbs et al., 2005; DeSimone et al., 2009; Mayer et al., 2009). Initially, W2mef 
parasites exhibit very poor growth in neuraminidase treated cells. However, after a 
prolonged period of slow growth, PfW2mef parasites do eventually adapt to efficiently 
invade these cells (Dolan et al., 1990). Close examination of adapted parasites reveals 
that they significantly up-regulate their expression of PfRh4, which enables them to 
achieve replication rates in treated cells comparable to those seen in untreated cells. 
Similarly, deletion of EBA-175 in the W2mef background also results in up-regulation 
of PfRh4, even when parasites are grown in untreated RBCs. Therefore, it appears that 
PfRh4 can directly complement PfEBA-175 in this strain, demonstrating that at least 
these two proteins may perform overlapping functions (Dolan et al., 1990; Duraisingh 
et al., 2003b; Stubbs et al., 2005; Gaur et al., 2006).   
However, it remains unclear whether all P. falciparum RBL/DBPs perform entirely 
complementary roles, functioning additively together to enhance overall invasion 
efficiency, or whether some members may perform unique functions, even on top of 
shared roles. For instance, deletion of either PfRh2a or PfRh2b in the adapted W2mef 
background results in a small, but significant reduction in invasion efficiency into 
neuraminidase treated erythrocytes compared to the parental line, indicating that each 
protein does likely play at least a minor role under these conditions (DeSimone et al., 
2009). However, W2mef Rh4 KO parasites cannot adapt to growth in neuraminidase 
treated RBCs, which suggests that even the combined action of PfRh2a and PfRh2b 
cannot compensate for the loss of PfRh4, and by extension, EBA-175. Therefore 
PfRh2a/b may be performing different roles (Stubbs et al., 2005).  Finally, processed 
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products of PfEBA-175 and PfRh1 have been localized to the moving junction of 
merozoites halted mid-invasion (O’Donnell et al., 2006; Triglia et al., 2009; Gunalan et 
al., 2020). Thus although the primary function of the PfRBL/DBPs is likely host cell 
selection, some may play a secondary role during moving junction formation and 
progression. 
Interestingly, although studies investigating the RBL and DBP families of non-P. 
falciparum species have lagged behind their P. falciparum counterparts, the limited 
data available so far suggests that both families may perform distinct roles in some 
species, including one of the rodent malaria species, P. yoelii, as well as P. knowlesi. 
P. yoelii parasites possess a large multi-gene RBL family, referred to as the Py235 
family, but only a single DBP ligand, PyEBL (Prasad et al., 2003; Gunalan et al., 
2013). Studying the Py235 family has been a particularly complicated endeavour, as 
each merozoite within a given schizont is predicted to express only a small subset of 
the Py235 genes. Thus many different variant merozoites are present in any given 
culture (Preiser et al., 1999; Gunalan et al., 2013).  Therefore, it has not been possible 
so far to assign a specific role to individual PyRBLs. However, analysis of PyEBL null 
parasites shows that these parasites cannot invade host erythrocytes, but they can 
strongly deform them. These results suggest that despite expressing a multitude of 
different Py235 ligands, none of these ligands can act as a substitute for PyEBL, unlike 
PfRh4 complementing PfEBA-175. Additionally, these results indicate that PyEBL 
appears to perform a role downstream of deformation, either during re-orientation, or 
beyond (Kegwara et al., 2018).
P. knowlesi parasites also require only one DBP protein (PkDBPα) and very likely only 
one RBL protein (PkNBPXa) to invade human erythrocytes. Importantly, deletion of 
either gene encoding PkNBPXa or PkDBPα restricts P. knowlesi parasites to growth in 
macaque RBCs, demonstrating that at least in the context of human erythrocyte 
invasion, that the PkDBP ligands cannot act as substitutes for the PkRBLs and vice 
versa (Singh et al., 2005; Moon et al., 2016). Importantly, the remaining DBP proteins, 
DBPβ and DBPγ, have been shown to bind to macaque RBCs. Furthermore, 
simultaneously deleting both genes does not impair the ability of P. knowlesi parasites 
to invade human erythrocytes, confirming that their primary role is probably to 
facilitate invasion of macaque erythrocytes (Dankwa et al., 2016; Mohring et al., 
2019). Similarly, PkNBPXb also likely performs a role during macaque erythrocyte
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invasion, as protein derived from parasite supernatants has been shown to bind to 
macaque erythrocytes (Meyer et al., 2009). However, whether PkNBPXb also 
contributes to human erythrocyte invasion in any vital way remains to be seen. 
Overall, the PkDBP and PkRBL families seem to exhibit far less functional 
redundancy, both within families, and certainly between families, compared to P. 
falciparum.   
Little is known about the specific role of NBPXa in P. knowlesi, other than the fact 
that NBPXa null parasites cannot invade human erythrocytes, and by smear, 
merozoites are observed to stick to the outside surfaces of RBCs instead of 
internalizing and forming new rings (Moon et al., 2016). Whether NBPXa KO 
parasites can deform their host cells, apically re-orientate, and even form the 
beginnings of the moving junction, remains to be seen. To date, no video microscopy 
of DBPα null parasites has been performed either; however, wild type P. knowlesi 
parasites have been reported to be able to deform Duffy negative erythrocytes (Miller 
et al., 1975). Therefore, like PyEBL, PkDBPα might perform a role during re-
orientation or even beyond, but PkDBPα-DARC interactions do not appear to be 
required for host cell deformation. Thus for at least two species, the DBP proteins 
appear to act downstream of deformation.  
Importantly, the fact that P. vivax generally expresses only one essential DBP protein, 
PvDBP, which shares the same human erythrocyte receptor as PkDBPα (Miller et al., 
1975; Haynes et al., 1988; Barnwell et al., 1989; Wertheimer and Barnwell et al., 
1989), indicates that this species may also follow suit, and highlights the need to study 
the RBL and DBP families in non-P. falciparum species to better understand their 
functions – especially if P. falciparum may actually be a variation to the rules. For 
several years, the P. falciparum RBL/DBP ligands were considered top vaccine 
candidates, as antibodies against these ligands are associated with protective immunity 
(Tham et al, 2012). However, redundancy between family members has meant that 
targeting even a combination of PfRBL/DBP ligands is unlikely to be successful in 
protecting against multiple P. falciparum strains (Beeson et al., 2016; Duffy and 
Gorres, 2020). In contrast, if the remaining human malaria species do rely on specific 
RBL/DBP combinations, designing vaccines targeting strategic RBL and DBP 
combinations may provide efficacious, strain transcending protection. Thus, there is 
an urgent need to re-visit the functions of these families – both to answer basic 
questions 
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regarding how merozoites invade erythrocytes, and to determine whether targeting 
both families in tandem is a feasible vaccine strategy.  
1.6 P. knowlesi as a model for erythrocyte invasion 
Despite early work on P. knowlesi in the late 1970s providing foundational knowledge 
about the mechanics of invasion, the majority of work since has been directed towards 
P. falciparum (Dvorak et al., 1975; Bannister et al., 1975; Aikawa et al., 1978). This is
likely in part because before the adaptation of P. knowlesi to growth in human
erythrocytes, long-term maintenance could only be achieved by in vivo infections and
later by culturing in rhesus erythrocytes (Butcher, 1979; Kocken et al., 2002; Grüring
et al., 2014; Moon et al., 2013). So, with the adaptation of P. falciparum to in vitro
culture and the need to develop antimalarial drugs and vaccine candidates targeting
this devastating pathogen, the attention of the malaria community turned instead to P.
falciparum (Haynes et al., 1976; Trager and Jensen, 1976). The recent adaptation of P.
knowlesi to growth in human erythrocytes (Moon et al., 2013) has provided the means
to study the P. knowlesi asexual stages, including erythrocyte invasion once again.
Importantly, P. knowlesi is a much closer relative to P. vivax than the divergent P.
falciparum (Pain et al. 2008) and therefore provides a better model for many aspects of
P. vivax biology, including their shared DBP-DARC invasion pathways (Haynes et al.,
1988; Wertheimer and Barnwell et al., 1989). Furthermore, P. knowlesi transfections
are much more efficient than their P. falciparum counterparts (Kocken et al., 2002;
Moon et al., 2013). This fact, in combination with P. knowlesi’s genome being much
more GC rich than P. falciparum (Pain et al., 2008) means that on a practical level,
from transfection construct design to the use of genetic techniques such as CRISPR
Cas9, which relies upon strategically located ‘NGG’ sites within target loci (Mojica et
al. 2009; Jinek et al. 2012), P. knowlesi provides a much more efficient platform for
genetic manipulation and reverse genetics studies (Mohring et al., 2019).
In addition to these benefits, the biology of P. knowlesi parasites also provides several 
other clear advantages over P. falciparum with regards to studying erythrocyte 
invasion and the molecular steps it entails. Firstly, P. knowlesi merozoites are double 
the size of their P. falciparum counterparts (2-3 µm vs 1-1.5 µm in length), a feature, 
which should dramatically enhance live imaging techniques that have been so critical 
towards discovering what is now known about invasion dynamics (Gilson and Crabb, 
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2009; Dasgupta et al., 2014; Weiss et al., 2015; Lyth et al., 2018). Secondly, while P. 
falciparum merozoites are characteristically round, P. knowlesi merozoites exhibit 
elongated teardrop-like morphologies (Dasgupta et al., 2014; Lyth et al., 2018). 
Attempting to discern which end of the merozoite is the apical end when imaging P. 
falciparum merozoites is often very difficult (Gilson and Crabb, 2009; Weiss et al., 
2015). However, accurately phenotyping mutant parasite lines frequently depends on 
doing just this! For instance, while overall inhibition of the PfDBP/RBL families 
clearly prevents merozoites from deforming host cells, it is difficult to tell by video 
microscopy whether re-orientation can occur or not under these conditions. Therefore, 
examining both wild type and mutant P. knowlesi lines will enable clarification on 
these matters, as it should, in theory, be considerably easier to observe re-orientation or 
the lack of it for this species.   
Finally, P. knowlesi is especially well suited for the study of the RBL/DBP families by 
virtue of its limited repertoire and limited redundancy of ligands required for invasion 
of human erythrocytes. In contrast, studying the role of the larger and redundant RBL/
DBP repertoire of P. falciparum has relied upon combinations of single genetic 
modifications, enzymatic treatment of RBCs, and inhibitory antibodies (Mayer et al., 
2001; Rayner et al., 2001; Duraisingh et al., 2003a; Gilberger et al., 2003; Stubbs et 
al., 2005; DeSimone et al., 2009; Weiss et al., 2015). In any case, determining the 
individual roles of every RBL/DBL ligand using these techniques has simply not been 
possible. Even with the genetic toolkit available today, thoroughly characterizing the P. 
falciparum RBL/DBPs using reverse genetics would likely be a complicated 
endeavour. In contrast, the relative simplicity of the P. knowlesi RBL/DBL families 
means that determining the roles of these ligands and dissecting the early steps of 
invasion will likely be a considerably more straightforward process.
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1.7 Project Aims and Objectives 
The aims of this project are two-fold. The first is to characterize how P. knowlesi 
merozoites invade human erythrocytes, particularly focusing on the mechanical steps 
leading to internalization. This aim will be achieved by using live microscopy to 
record wild type P. knowlesi merozoites invading human erythrocytes and undertaking 
a thorough analysis of parasite-host cell interactions. Although P. knowlesi merozoites 
have already been filmed while invading macaque erythrocytes, very few invasions 
were captured at the time (Dvorak et al., 1975). Analysis of a greater number of events 
will help to address some outstanding questions regarding the mechanics of invasion, 
likely applicable to all Plasmodium species, regardless of host cell preference. 
Additionally, though, PkA1-H.1 parasites have never been filmed while invading 
human erythrocytes. A thorough analysis of the kinetics of human erythrocyte invasion 
may provide insight into the ways this zoonotic parasite has adapted to growth in 
human erythrocytes. Overall, this aim will seek to address the following questions: 
1) What is the order of the mechanical steps (deformation, re-orientation, and the
calcium flux) leading up to internalisation?
2) Is re-orientation a distinct step to host cell deformation?
3) Which pre-internalisation step is the point of no return, or commitment to
invasion? For instance, can merozoites detach from host cells and interact with
other host cells after triggering a calcium flux, or re-orientating?
4) Do P. knowlesi merozoites require more contacts overall, or extended
interactions with human erythrocytes for successful invasions, compared to
what is seen for P. falciparum?
Aim number two is to understand the role(s) that the P. knowlesi Duffy binding protein 
alpha (PkDBPα) and normocyte binding protein Xa (PkNBPXa) proteins fulfil during 
merozoite invasion of human erythrocytes. This aim will be achieved firstly by 
attempting to generate conditional PkNBPXa and PkDBPα KO lines, using the 
inducible DiCre system (Andenmatten et al., 2013; Collins et al., 2013) and 
phenotyping these lines using a live microscopy approach. Secondly, attempts will be 
made to tag both PkDBPα and PkNBPXa, along with known moving junction markers 
PkAMA-1 and PkRON2, with epitope and fluorescent tags. Tagged lines will be used 
to localize PkNBPXa and PkDBPα before and after egress as well as during invasion, 
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using a combination of immunofluorescence and live imaging techniques. In doing so, 
aim number two will attempt to address the following questions:  
1) Can PkDBPα null parasites deform host erythrocytes to the same degree as
wild type parasites?
2) Can merozoites undergo apical re-orientation in the absence of DBPα-DARC
interactions?
3) Which steps of invasion are impeded when PkNBPXa is absent?
4) Do PkNBPXa and PkDBPα co-localise to the same micronemes in schizonts,
or do they appear to occupy discrete subsets of micronemes?
5) What is the localization of PkNBPXa and PkDBPα once secreted from
micronemal stores and during each step of invasion?
6) Is there a definitive order to the secretion of the P. knowlesi RBL/DBP ligands?
The results from aim number one are addressed in chapter 3, and those from aim 
number two, in chapter 4. Overall, dissecting the individual events of invasion in 
greater detail, particularly those leading up to host cell entry, will provide valuable 
insight into the ways in which merozoites of all Plasmodium species navigate 
commitment to invasion. This, in turn, could aid drug and vaccine designs. In 
particular, the essential nature of PkDBPα and PkNBPXa means that both antigens 
have the potential to be excellent candidates for a P. knowlesi vaccine. Thus 
determining when these ligands act, what their individual roles are, and whether 
targeting both antigens at once could inhibit multiple, successive invasion steps could 
provide further critical information regarding their suitability as vaccine candidates.  
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Chapter 2: Materials and Methods 
2.1 Bioinformatics 
2.1.1 DNA and protein sequence analysis 
P. knowlesi gene sequences were obtained from the PlasmoDB database
(https://plasmodb.org/plasmo/app). DNA and protein sequence alignments were
performed using Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/). Putative
protein transmembrane domains were identified using TMPred (https://embnet.vital-
it.ch/software/TMPRED_form.html).
2.1.2 Generation of a recodonised mNeonGreen sequence 
 The mNeonGreen sequence (Shaner et al., 2013) was recodonised for P. knowlesi 
expression using the SMS reverse translate program (found at 
http://www.bioinformatics.org/sms2/rev_trans.html) followed by manual curation to 
increase GC content of primer binding sites. GeneArt synthesized the recodonised 
sequence.  
2.1.3 Assessment of potential Cas9 target sites 
Cas9 target sequences were assessed for their uniqueness using Protospacer 
Workbench software (version 0.0.1 alpha) (MacPherson and Scherf, 2015). Guides 
with off target sequences scoring less than 0.3 were accepted. 
2.2 Molecular biology techniques 
2.2.1 Polymerase chain reaction (PCR) 
All PCR products used for molecular cloning were amplified by CloneAmp HiFi 
polymerase (Clonetech) from either parasite genomic DNA (gDNA) or plasmid DNA, 
according to the manufacturer’s instructions. A typical reaction was run with 32 cycles 
of: 5 s at 98°C, 15 sec at 55°C, and 5-30 s at 72°C (extension time of 5 s/kb).  
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Table	2.1.	List	of		Cas9	repair	templates	generated	in	this	study	
2.2.2 Generation of Cas9 repair templates 
Donor DNA templates used to modify PkDBPα, PkNBPXa, PkRON2, and PkAMA-1 
with either tags or LoxP sites (Table 2.1) were generated by overlapping PCR and then 
either transfected as PCR products or cloned into plasmid backbones for sequencing 
prior to transfection.  
Construct name Purpose Transfected as? 
NBPXa-mNG Modifying PkNBPXa C-term with an 
mNeonGreen tag 
PCR product 
pL_PkDBPα-mNG Modifying PkDBPα C-term with an 
mNeonGreen tag 
Plasmid 
AMA1-mNG Modifying AMA1 C-term with an 
mNeonGreen tag 
PCR product 
RON2-mNG Modifying RON2 C-term with an 
mNeonGreen tag 
PCR product 
AMA1-HA Modifying AMA1 C-term with HA tag PCR product 
RON2-HA Modifying RON2 C-term with HA tag PCR product 
NBPXa-mCh Modifying PkNBPXa C-term with mCh 
tag 
PCR product 
pL_NBPXaCtermHA/LoxP Modifying PkNBPXa C-term with a HA 
tag/stop codon/LoxP sequence 
Plasmid 
pL_NBPXaNtermLoxP1 Inserting a LoxP sequence into the 
PkNBPXa intron (position 1) 
Plasmid 
pL_NBPXaNtermLoxP2 Inserting a LoxP sequence into the 
PkNBPXa intron (position 2) 
Plasmid 
pL_floxedRecDBPα Replacing the WT PkDBPα sequence 
with a floxed and C-terminally HA 
tagged recodonised version 
Plasmid 
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2.2.2.1 Generation of constructs by overlapping PCR 
Donor DNA templates to target PkDBPα, PkNBPXa, PkRON2, and PkAMA-1 with 
either tags or LoxP sequences (Table 2.1) were generated using a series of 
overlapping, nested PCR steps. Firstly, homology regions (HR1 and HR2) targeting 
each locus were amplified from parasite gDNA with at least 20-30 bp overhangs to the 
intervening tag or LoxP module, using primers listed in Table 2.2. All HRs were 
designed to be at least 400 bp long and all apart from those targeting PkDBPα were 
amplified from WT gDNA. HRs targeting PkDBPα were instead amplified from 
gDNA extracted (see section 2.3.5) from the recodonised PkDBPα line. The 
intervening mNeonGreen, mCherry, and LoxPint sequences were amplified from 
plasmids using primers listed in Table 2.2. Subsequently, all HR, tag, and LoxPint 
PCR products were purified by gel extraction (Qiagen) to remove all primers and any 
non-specific amplicons.  
Next, if the overhangs attached to each HR covered the entire intervening tag or LoxP 
sequence, HR1 and HR2 products were fused together with a nested PCR step. Primers 
for this step were positioned 50-100 bp inside of each HR. This methodology was used 
to generate PkRON2-HA and PkAMA1-HA tagging constructs. On the other hand, if 
the overhangs between HR1 and HR2 did not quite cover the entire tag/LoxP insert, as 
was the case when both an 27bp HA tag and a 34 bp LoxP site were inserted between 
two homology arms, a second amplification step was carried out to extend the 
overhang of HR1. Once gel purified, the extended HR1 and accompanying HR2 were 
fused together as above, with a nested PCR step. Finally, for longer inserts (fluorescent 
tags or LoxPint modules), which could not be added to homology regions with primers 
alone, HR1 was fused to the insert in a nested PCR step. After gel purifying this 
product, each HR1/insert fusion was joined to its respective HR2, in a final nested 
PCR step, to create the finished product. All homology regions, inserts, intermediate 
products, and final constructs are listed in Table 2.2, along with the primer pairs used 
to generate them and the expected PCR product sizes. All primer sequences are listed 















mNG PCR product MH297 MH295 836 mNeonGreen plasmid 
mCherry tag 
mCh PCR product MH1057 MH295 514 mCherry plasmid 
PkNBPXa-mNG 
HR1 MH227 MH229 514 Wt gDNA 
HR2 MH306 MH231 553 Wt gDNA 
HR1/mNG MH227 MH296 1222 HR1 + mNG PCR products 
Full MH298 MH299 1566 HR1/mNG + HR2 PCR products 
PkDBPα-mNG 
HR1 MH221 MH223 524 RecDBPα gDNA 
HR2 MH224 MH225 521 RecDBPα gDNA 
HR1/mNG MH221 MH296 1232 HR1 + mNG PCR products 
Full MH222 MH226 1637 HR1/mNG + HR2 PCR products 
PkRON2-mNG 
HR1 MH847 MH337 1089 Wt gDNA 
HR2 MH1062 MH851 1005 Wt gDNA 
HR1/mNG MH847 MH296 1797 HR1 + mNG PCR products 
Full MH848 MH852 2579 HR1/mNG + HR2 PCR products 
PkAMA1-mNG 
HR1 MH841 MH331 868 Wt gDNA 
HR2 MH1063 MH845 878 Wt gDNA 
HR1/mNG MH841 MH296 1576 HR1 + mNG PCR products 
Full MH842 MH846 2217 HR1/mNG + HR2 PCR products 
PkRON2-HA 
HR1 MH847 MH849 1092 Wt gDNA 
HR2 MH850 MH851 1007 Wt gDNA 
Full MH848 MH852 1874 HR1 + HR2 PCR products 
PkAMA-1-HA 
HR1 MH841 MH843 872 Wt gDNA 
HR2 MH844 MH845 880 Wt gDNA 
Full MH842 MH846 1512 HR1 + HR2 PCR products 
PkNBPXa N-term LoxP1 insert 
HR1 MH953 MH963 1011 Wt gDNA 
HR2 MH962 MH957 1000 Wt gDNA 
Full MH954 MH958 1651 HR1 + HR2 PCR products 
PkNBPXa N-term LoxP2 insert 
HR1 MH953 MH967 1037 Wt gDNA 




2.2.2.3 Cloning of pL_PkDBPα-mNG plasmid 
The final PCR amplification step of the PkDBPα-mNG construct added a SacII 
restriction site to the 5’ end of the construct and an EcoR1 site to the 3’ end. This 
construct and vector pPkB1 (Appendix Figure 1A) were digested with SacII/ EcoR1 
(NEB), purified by gel extraction (Qiagen), and ligated together using T4 DNA Ligase 
(Promega), according to the manufacturer’s instructions to create final vector 
pL_PkDBPα-mNG (Appendix Figure 1B) 
2.2.2.3 Cloning of pL_NBPXaCtermHA/LoxP, pL_NBPXaNtermLoxP1, and 
pL_NBPXaNtermLoxP2 plasmids 
The final PCR amplification step of PkNBPXa-NtermLoxP1, PkNBPXa-NtermLoxP2, 
and PkNBPXa-CtermLoxP/HA constructs added a SacII restriction site to the 5’ ends 
of constructs and a NotI restriction site to the 3’ ends. These PCR products, along with 
vector backbone pPkB1 (Appendix Figure 1A), were subsequently digested with 
restriction enzymes SacII and Not1 (NEB). Gel purified inserts and vector (Qiagen) 
were ligated together using T4 DNA Ligase (Promega) according to the 
Full MH954 MH958 1651 HR1 + HR2 PCR products 
PkNBPXa C-termLoxP insert 
HR1 MH835 MH238 858 Wt gDNA 
HR1e MH835 MH837 895 HR1 PCR product 
HR2 MH838 MH839 852 Wt gDNA 
Full MH975 MH1023 1507 HR1e + HR2 PCR products 
PkDBPα N-term LoxPint Insert 
HR1 FM62 MH1347 628 RecDBPα gDNA 
HR2 MH1350 MH1367 1824 RecDBPα gDNA 
NBPXaLoxPint1 module MH1348 CH204 721 Pl_NBPXaLoxPint1 plasmid 
HR1/NBPXa_LoxPint1 FM62 MH1349 872 NBPXaLoxPint1 + HR1 PCR products 
Full FM62 MH1367 2669 HR1/NBPXaLoxPint1 + HR2 PCR 
products 
PkDBPα C-term/HA/LoxP Insert 
Insert MH1341 MH1343 1591 RecDBPα gDNA 
Insert extended MH1342 MH1344 1566 Insert PCR product 
PkNBPXa mCherry 
HR1 MH227 MH229 514 Wt gDNA 
HR2 MH1058 MH231 524 Wt gDNA 
HR1/mCh MH227 MH1059 1219 HR1 + mCh PCR products 




manufacturer’s instructions, creating plasmids pL_NBPXaNtermLoxP1, 
pL_NBPXaNtermLoxP2, and pL_NBPXaCtermHA/LoxP (Appendix Figure 2).  
2.2.2.4 Cloning of pL_floxedRecDBPα plasmid 
PkDBPα_NtermLoxP and PkDBPαCtermHA/LoxP PCR products were cloned into 
vector pPkg5_DBPα (Mohring et al., 2019; Appendix Figure 3A), which contains a 
copy of a recodonised PkDBPα sequence. The PkDBPαCtermHA/LoxP PCR product 
and vector pPkg5_DBPα were first digested with NotI and BbvCI restriction enzymes 
(NEB) and gel purified (Qiagen). Digestion of pPkg5_DBPα removed a 1410 bp 
fragment that was replaced the digested PkDBPαCtermHA/LoxP PCR product by 
ligating vector and insert together with T4 DNA Ligase (Promega), to create vector 
pL_DBPα_CtermHA/LoxP. Next, the PkDBPα_NtermLoxP PCR product and 
pL_DBPα_CtermHA/LoxP vector were digested with BbvCI and SpeI restriction 
enzymes (NEB). An 1813 bp product was removed from pL_DBPα_CtermHA/LoxP 
and replaced with digested PkDBPα_NtermLoxP, creating the final vector, 
pL_floxedRecDBPα (Appendix Figure 3B).  
2.2.3 Generation of Cas9 guide plasmids 
All Cas9 guide sequences were inserted into pCas9/sg (Mohring et al., 2019; 
Appendix, Figure 4A), which contains the Cas9 and sgRNA cassettes as well as 
positive (hdhfr) and negative (yfcu) selection markers. The DBPα RNA targeting 
sequence was inserted into pCas9/sg using a protocol developed by Marcus Lee 
(unpublished). This insert was prepared using complementary primers (MH359 and 
MH360 from Appendix Table 2) containing the DBPα target sequence with 4bp 
overhangs to BtgZI cut sites, generated upon digestion of pCas9/sg. Primers were 
mixed and phosphorylated with T4 Polynucleotide Kinase (PNK) according to the 
supplier’s instructions, for 30 mins at 37°C. Phosphorylated primers were 
subsequently annealed by incubation at 95°C for 5 mins and allowed to slowly cool 
down to room temperature. This annealed primer mix was then diluted 1:200 in 
distilled water, and 1µl was ligated into 50 ng digested and dephosphorylated 
(Antarctic phosphatase, NEB) vector using T4 DNA ligase (Promega). T4 DNA ligase 
was subsequently heat inactivated at 65°C, and each reaction digested with NruI 
(NEB) to remove uncut vector before transformation.  
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All other Cas9 guide sequences were inserted into pCas9/sg by annealing 
complementary primers (Table 2.3) carrying the 20 bp guide sequence and flanked by 
15bp overhangs to BtgZI digested pCas9/sg, as outlined in Mohring et al. (2019 & 
2020). Annealed oligos were inserted into digested pCas9/sg by Infusion cloning 
(TaKaRa). Primers carrying the guide sequences are listed in Appendix, Table 2. 
Target Fwd primer Rev primer 
PkNBPXa-Cterm MH235 MH236 
PkNBPXa-Nterm1 (LoxPint1) MH964 MH965 
PkNBPXa-Nterm2 (LoxPint2) MH968 MH969 
PkRON2 C-term FM512 FM513 
PkAMA-1 C-term FM510 FM511 
 
Initially, because of difficulty cloning the PkNBPXa C-terminal guide sequence into 
pCas9/sg (using either of the above methods), this guide was instead inserted into a 
second Cas9 vector, pL_11HF (Avnish Patel, LSHTM; See Appendix Figure 4B). The 
pL_11HF plasmid contains all component of pCas9/sg, but has a different, smaller 
backbone and a high fidelity (HF) Cas9 sequence instead of the wild type version. 
Insertion of the PkNBPXa C-terminal guide into PL_11HF was achieved by 
amplifying the entire guide cassette using overlapping primers containing the 
PkNBPXa RNA targeting sequence (Table 2.4). This PCR product was digested with 




Table 2.3. Primers used to generate pCas9/sg inserts. All primer sequences can be found in 






2.2.4 Bacterial transformation 
Donor DNA plasmids were transformed into DH5α bacterial cells (Invitrogen), and 
pCas9/sg plasmids were transformed into XL10 Gold competent cells (Agilent) 
according to the supplier’s instructions. 
2.2.5 Plasmid purification 
Plasmid DNA was isolated for cloning purposes using a Qiaprep mini-prep kit 
(Qiagen), according to the manufacturer’s instructions. Large-scale plasmid production 
was performed using a high-speed plasmid maxi-prep kit (Qiagen), also according to 
the manufacturer’s instructions.  
2.3 P. knowlesi cell culture 
2.3.1 In vitro maintenance and synchronization of P. knowlesi parasites 
Blood stage A1-H.1 P. knowlesi parasites were cultured in human erythrocytes (UK 
National Blood Transfusion Service) at a 2% haematocrit with custom made RPMI-
1640 medium, supplemented with 10% Horse Serum (v/v) and 0.292 grams/litre (2 
mM) L-glutamine according to previously established methods (Moon et al., 2013). 
Parasites were tightly synchronized for experiments by one of two different methods. 
The first (Moon et al., 2013) involves two rounds of density gradient centrifugation 
steps using 55% Nycodenz (Axis-Shield). Mature schizonts collected from the first 
centrifugation step were allowed to egress and re-invade fresh red cells over a 2 h 
window. Newly formed 1-2 h ring stages were then collected after the second density 
gradient centrifugation step and cultured until maturation again. Alternatively, after the 







HR1 FM400 MH236 442 pL_11HF 
HR2 MH235 MH295 704 pL_11HF 
Full FM401 FM285 662 HR1 + HR2 PCR products 
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re-invasion period, parasites were incubated with 140mM guanidine hydrochloride for 
10 minutes, according to a protocol outlined by Ngernna et al., (2019), which killed all 
parasites older than 5 hours, leaving only young rings behind. 
2.3.2 Transfection of P. knowlesi parasites 
Transfections were performed with 10 µl mature schizonts, 10 µg of the Cas9 plasmid, 
and 20 µg of the donor DNA using the Amaxa 4-D Nucleofactor X machine (Pulse 
code FP158) and P3 Primary Cell Kit (Lonza), according to protocols described by 
Moon et al. (2013) and Mohring et al. (2019). Donor DNA was transfected in either 
plasmid form or as a PCR construct. To prepare PCR constructs for transfection, six to 
eight 50µl final PCR reactions (Table 2) were pooled. All PCR constructs and 
plasmids were concentrated by ethanol precipitation and re-suspended in sterile TE 
buffer prior to transfection, according to methods outlined in Mohring et al. (2019). 
Parasites were mixed with fresh erythrocytes (50 % haematocrit) immediately after 
transfection for 1 h to allow for re-invasion. Haematocrit was subsequently adjusted to 
4% for continuous growth. Transfected parasites were cultured with 100 nM 
pyrimethamine for 5 days following transfection in order to select for parasites that 
had taken up the Cas9 plasmid. Parasites were then grown for a week without any 
drugs before being treated with 1 µM 5-Fluorocytosine for 7 days (Mohring et al., 
2019). Finally, transgenic parasites were cloned by limiting dilution (Moon et al., 
2013). 
2.3.3 Rapamycin treatment of conditional knockout lines 
Immediately after synchronization, ring stage P. knowlesi cultures were split into two 
and incubated in complete media containing rapamycin (Sigma-Aldrich) or the 
equivalent volume of its carrier, DMSO, as a control. For IFA excision assays, 
parasites were treated with 10-200 nM rapamycin in 0.005-0.1% (v/v) DMSO or the 
equivalent volume of DMSO only. Treated parasites were incubated with drug at 37°C 
for either the entire cycle or for 3 hours only, before drug or DMSO containing media 
was removed and parasites were re-suspended in fresh, drug-free complete media.  
For the single cycle multiplication assay in human and macaque cells (section 2.3.4), 
parasites were treated with 100 nM rapamycin or 0.1% (v/v) DMSO for 3 hours, 
before drug or DMSO containing media was removed and parasites were re-suspended 
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in fresh, drug-free complete media. For the two-cycle growth assay and all video 
microscopy experiments, parasites were treated with 10 nM rapamycin or 0.005% 
(v/v) DMSO for 3 hours, before drug was removed and parasites were re-suspended in 
fresh media.  
2.3.4 Parasite multiplication rate assays 
To determine the multiplication rate of mutant parasites, ring stage DMSO and 
rapamycin-treated cultures were adjusted to a parasitaemia of 0.5% and a 2% 
haematocrit and were grown in 24 well plates in a gassed chamber at 37°C. After 24 
hours, a starting reading was taken when parasites were roughly 24-27 hours old. A 
second reading was taken 26 hours later. For dual cycle assays, a third reading was 
taken roughly 26 hours later again.  
For single cycle assays, cultures were set up in duplicate using both macaque (National 
Institute for Biological Standards and Control) and human erythrocytes, and 2 
biological replicates were performed. For the multi-cycle assays, cultures were set up 
in triplicate in human erythrocytes. A total of three biological replicates were 
performed. Parasitaemia was measured using a flow cytometry (FACS) based assay. 
Samples were fixed in 2% paraformaldehyde (Sigma) and 0.2% glutaraldehyde 
(Sigma) in PBS for 1 h at 4°C, washed 3 times in PBS, permeabilised with 0.3% Triton 
X-100, and washed 3 times in PBS again. Finally, samples were treated for 1 h at 37°C
with RNase (MP Biomedicals) before staining with SYBR Green I (Life Technologies)
and performing FACS analysis. Assays were analysed either on a Becton Dickenson
LSR-II or an Attune NxT flow cytometer using FACSDiva 6.1.3 software. Data were
analysed using FlowJo_V10.
2.3.5 Isolation of parasite material for DNA extraction 
Parasite culture was pelleted at 700 x g, washed 3 times in RPMI, and snap frozen. 
Genomic DNA was extracted from parasite pellets using a DNeasy blood and tissue kit 
(Qiagen) according to the manufacturer’s instructions.  
2.3.6 Isolation of parasite material for western blot 
Parasite culture or purified schizonts were pelleted at 700 x g and saponin lysed with 





subsequently centrifuged at 12,000 x g for 5 min and then washed 3 times in cold PBS, 
before being snap frozen in dry ice. COmplete, EDTA-free protease inhibitors (Roche) 
were included for each step.   
2.3.7 Diagnostic PCR for detection of integration and excision events 
To assess integration of constructs containing LoxP sites and tags, diagnostic PCRs 
were carried out on extracted gDNA (Section 2.3.5) using GoTaq Green master mix 
(Promega) and the following conditions: 3 min at 96°C, then 30 cycles of 25 s at 96°C, 
25 s at 52°C, and 1 min/kb at 64°C. Primers used to detect integrated and wild type 
parasites for each transfection along with the expected PCR product sizes are listed in 
Table 2.5. A positive control using primers RM75 and RM76, which amplified a 
1043bp product from the PkMTIP locus, was also included in each set of reactions.  
Likewise, to detect excision of PkNBPXa from rapamycin treated PkNBPXa cKO 
parasites, diagnostic PCRs were carried out on extracted gDNA from rapamycin and 
DMSO treated parasites, using GoTaq Green master mix (Promega). Primers CH203 
and CH206, positioned outside of each LoxP site amplified a 606 bp product indicative 
of excision using the following conditions: 3 min at 96°C, then 30 cycles of 25 s at 
96°C, 25 s at 52°C, and 1 min/kb at 64°C. Primers MH1543 and CH206 flanking the 
C-terminal LoxP site were used to detect un-excised parasites, with an expected 
product size of 404 bp for un-excised but floxed parasites, and 340 bp for the parental 
(non-tagged) control. WT products were amplified using the same conditions as above, 
except using 27 cycles, instead of 30 
 
Detecting Fwd primer Rev primer Expected product size (bp) 
RON2 tags 
WT MH890 MH909 1209 
Int mNG MH890 MH291 1338 
Int HA tag MH890 MH563 1221 
PkAMA-1 tags 
WT MH892 MH904 984 
Int mNG MH892 MH291 1113 
Int HA MH892 MH563 996 
PkNBPXa mNG 
WT MH835 MH1128 1565 (If integrated) OR (863 if WT) 




WT MH959 MH1353 1228 
Int MH959 MH1171 1250 
NBPXa LoxPint2 
WT MH959 MH1143 1261 
Int MH959 MH1172 1284 
NBPXa C-term LoxP 
WT MH1129 MH1128 1004 
Int MH1129 MH563 997 
DBPa mNG 
WT FM421 MH225 1778 (If integrated) OR 1046 (WT) 
Int mNG FM421 MH291 691 
Floxed PkDBPa 
WT CH193 MH1041 849 
Int MH562 MH1041 824 
Control locus 
PkMTIP product RM75 RM76 
 NBPXa mCherry 
WT 1129 1128 863 
Int 1129 1160 1053 
DiCre p230p 
WT FM49 FM50 969 
Int FM90 FM32 891 
 
2.4 Protein and immunohistochemistry techniques 
2.4.1 Immunoblot analysis 
Saponin released schizonts (2.1.6) were lysed in four volumes of a CoIP buffer 
containing: 10 mM Tris/Cl pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 0.5% NP-40, 1mM 
PMSF, and 2x cOmplete EDTA free protease inhibitors (Roche). Lysates were 
incubated on ice for 10 min and then centrifuged at 12,000 x g for 20 min to remove 
residual solid material. Subsequently, 1 volume of 2x LDS sample buffer (Invitrogen) 
was added to the soluble fraction. Samples were boiled for 5 minutes before being 
separated by SDS PAGE by running samples on precast 3-8% Tris-Acetate NuPAGE 
gels (Invitrogen). 
SDS-PAGE fractionated proteins were transferred to a nitrocellulose membrane using 
a semidry Trans-Blot Turbo Transfer System (Bio-rad). Membranes were blocked in 
10% (w/v) milk in 0.1 % PBS-Tween-20 (PBST) over night before incubation with 
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primary antibodies, diluted to the concentrations indicated in Table 2.5, in 1% (w/v) 
skimmed milk in PBST for at least 1 h Membranes were subsequently washed 3 times 
for 10 min/wash in PBST, and incubated for 1 h. with secondary antibodies conjugated 
to near infra-red dyes, at concentrations listed in Table 2.5. Membranes were washed 3 
times for 10 min in PBST and then dried between Whatman 3MM blotting papers. 
Finally, immunoblots were imaged using a Chemidoc imaging system (Bio-Rad).  
2.4.2 Indirect immunofluorescence assays (IFA) 
Late stage schizonts were thinly smeared on glass slides, dried, and fixed in 4% 
paraformaldehyde (PFA) in PBS for 30 minutes, followed by 0.1% Triton X-100 in 
PBS for 10 min. Slides were subsequently blocked in 3% BSA in PBS overnight at 
4°C, and then incubated with primary antibodies diluted to appropriate concentrations 
(listed in Table 2.6) in blocking solution for at least 1 h. Next, slides were washed 3x 
in PBS, for 10 min/wash and incubated with secondary antibodies (Table 2.6) for 1 h. 
After a final wash in PBS (3x 10 min), slides were mounted in ProLong Gold Antifade 
Mountant containing DAPI (Thermo Fisher Scientific). 
For in solution IFAs, merozoites were captured mid-invasion by treating egressing 
cultures with 100 nM cytochalasin D (Sigma) for 30 min and then gently spinning 
cultures down at 1500 x g for 1 minute. Parasite pellets were re-suspended in a 
4%PFA/0.0025% glutaraldehyde solution in PBS, and then loaded into a poly-L-lysine 
coated µ-Slide VI 0.4 (Ibidi). Parasites were incubated in fixative solution for 30 min 
before fixative was removed by pipetting the solution out of the channel slides. 
Channels were then washed 5x by gently pipetting PBS into the channel and then 
removing it in the same manner as the fixative. Subsequently, parasites were incubated 
with 0.1% Triton X-100 in PBS for 10 min, followed by 5 wash steps in PBS. Washed 
parasites were blocked with 3% BSA in PBS for at least 1 h and then incubated with 
primary antibodies, diluted in blocking solution at concentrations indicated in Table 
2.6, for 1 h. This was followed with 5 x wash steps in PBS, and then incubation for 1 h 
with the appropriate secondary antibody (Table 2.6), also in 3% BSA. After the final 
wash steps, parasites were incubated in PBS containing Hoechst 33342 (Cell Signaling 
Technology) for half an hour prior to imaging. All samples were imaged with a Nikon 




Flash 4.0 CMOS camera (Hamamatsu). Images were acquired, processed and 
statistically analysed using the NIS Advanced Research software package. 
Primary	antibodies	
Target	 Species	(clone)	 IFA	 Western	
Provider/manufacture
r	
α-HA	 Rat	(3F10)	 1/500	 1/5000	 Sigma	












Target	 Conjugate	 IFA	 Western	
Provider/manufacture
r	
α	-rat	IgG	(H	+L)	 Alexa	Fluor-594	 1/1000	 NA	 Invitrogen	
α	-rat	IgG	(H	+L)	 IRDye	680	RD	 1/1000	 1/5000	 LI-COR	Odyssey
α	-mouse	IgG	(H	+L)	 Alexa	Fluor-488	 1/1000	 NA	 Invitrogen	
α	-rabbit	IgG	(H	+L)	 Alexa	Fluor-488	 1/1000	 NA	 Invitrogen	
α	-rabbit	IgG	(H	+L) DyLight	800	 NA	 1/5000	 Invitrogen	
2.5 Time lapse imaging 
2.5.1 Invasion assays 
For all invasion assays (Table 2.6), purified schizonts were added to fresh erythrocytes 
to make a 10-15% parasitaemia and 2.5% haematocrit culture. The haematocrit was 
subsequently adjusted to 0.25%, and 150 µl culture was loaded into a PLL coated µ-
Slide VI 0.4 (Ibidi). For the anti-DARC assay, either 5µg/mL human anti-DARC (2C3 
clone, Absolute Antibody), or 5µg/mL anti-human IgG (Invitrogen) was first added to 
the 0.25% haematocrit culture, prior to loading samples into the channel slides. For the 
calcium flux assay, erythrocytes were first incubated with 5µM fluo-4-AM 
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Table	2.7.	Imaging	conditions	used	to	capture	P.	knowlesi	merozoites	invading	human	erythrocytes		
(Invitrogen) in RPMI for 1h at 37°C. Cells were subsequently washed three times in 
RPMI, and then allowed to rest at 37°C for a further half an hour for de-esterification 
to occur, prior to mixing with parasites. Loaded slides were subsequently transferred to 
the Nikon Ti E inverted microscope chamber, pre-warmed to 37°C. Samples were 
imaged using a 100x or 60 x oil immersion objective and an ORCA Flash 4.0 CMOS 
camera (Hamamatsu), with conditions outlined in table 2.7. Videos were acquired and 
processed using the NIS Advanced Research software package.  






NBPXa cKO DMSO Brightfield/100msec 1 
NBPXa cKO 10 nM rapamycin Brightfield/100msec 1 
α-DARC 
block 
NBPXa cKO 5µg/mL α-DARC Brightfield/100msec 1 











NBPXa-mNG None Brightfield/100msec; 488nm/100msec 1 
DBPα-mNG None Brightfield/100msec; 488nm/100msec 0.25 or 1 
AMA1-mNG None Brightfield/100msec; 488nm/100msec 0.5 
2.5.2 Gliding assays 
Synchronized late stage schizonts (PkNBPXaNtermLoxP1 line) were loaded into poly-
L-lysine-coated polymer, uncoated polymer, or glass µ-Slides 0.4/0.5 (Ibidi) and imaged
using the same microscopy set-up as described above. Parasites loaded into PLL
coated slides were treated with either 0.1µM cytochalasin D in 0.005 (v/v) DMSO
(Sigma), or with the equivalent volume of DMSO. Time-lapse brightfield images (50-
100msec exposure) were collected at a rate of 1-10 frames/second. Gliding speed was
calculated manually, using the distance measurement tools in the NIS Advanced
Research software package. The tangential speed of each merozoite was determined by
calculating the number of rotations it performed/minute and multiplying this value by
the circumference of the widest portion of the merozoite (merozoite diameter x π). The
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angle of the merozoite motor was calculated using the formula Tan(x) = R/L, where x 
= the angle of the motor, R = the average distance each merozoite rotated/per body 
length travelled forward, and L = the body length of the merozoite, from its apical tip 
to the basal end. 
2.5.3 Secretion assays 
Synchronized late stage PkNBPXa-mNG, PkDBPa-mNG, and PkAMA1-mNG 
schizonts were loaded (either plus or minus fresh erythrocytes) into PLL-coated µ-
Slides 0.4 (Ibidi) and transferred to a pre-warmed microscope, as described in the above 
sections. Time-lapse brightfield and fluorescent images were acquired at a rate of 1 
frame/sec (100 msec exposure for each channel). The fluorescence intensity around the 
periphery or down the length of each merozoite was measured using the intensity 




Chapter 3: Results I - Dissecting the morphological 
steps of invasion 
3.1 Introduction 
The very first video microscopy study describing invasion featured P. knowlesi 
merozoites (Dvorak et al., 1975). Not only did this pivotal investigation demonstrate 
how rapid invasion is, lasting less than a minute from start to finish, but it also 
visualized key mechanical steps for the first time. These included deformation of the 
host cell membrane, internalisation of the apically aligned merozoite into the 
erythrocyte, and echinocytosis of the host cell in response to invasion (Dvorak et al., 
1975). Subsequent studies imaging P. falciparum, as well as the rodent malaria 
parasite, P. yoelii, have sought to examine invasion in greater detail. Analysing 
hundreds of invading merozoites enabled them to investigate the kinetics of invasion 
and to determine if the events described for P. knowlesi are conserved across different 
species and characteristic of all invasions (Gilson and Crabb, 2009; Weiss et al., 2015; 
Yahata et al., 2012)  
The multi-step process of invasion begins when freshly egressed merozoites encounter 
erythrocytes and form reversible attachments (Dvorak et al., 1975; Gilson and Crabb, 
2009). For P. falciparum, the majority of merozoites (~ 85%, for 3D7 parasites) will 
invade the first cell that they contact, and the majority of these contacts will occur 
within 1 minute of egress (Gilson and Crabb, 2009; Weiss et al., 2015). Unlike other 
typical zoites, including Plasmodium sporozoites and T. gondii tachyzoites, 
Plasmodium merozoites are not thought to use gliding motility to encounter new host 
cells (Vanderberg, 1974; Håkansson et al., 1999; Baum et al., 2006). Rather, host cell 
contacts are proposed to arise from random interactions, as a result of merozoites 
moving by Brownian motion and tumbling across erythrocyte surfaces in the context 
of a moving blood stream (Dvorak et al., 1975; Pinder et al., 2000; Weiss et al., 2015). 
These engagements frequently, but not always, cause the merozoite to deform the host 
cell to a varying extent, ranging from a slight indentation of the erythrocyte membrane, 
to interactions so forceful that the erythrocyte appears to wrap around the merozoite 
(Dvorak et al., 1975; Gilson and Crabb, 2009; Weiss et al., 2015). Weiss et al. (2015) 
investigated merozoite-host cell interactions of both invading and non-invading 
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parasites in detail, by scoring them from 0-3 based on deformation intensity. Contacts 
that did not elicit any deformation were designated a score of 0, while contacts 
resulting in the most intense deformation were given a score of 3. Critically, a high 
scoring contact was far more likely to result in successful invasion compared to a 
lower scoring contact, highlighting the potential importance of this step (Weiss et al., 
2015).  
Prior to host cell entry, merozoites must also undergo apical re-orientation - the 
alignment of the merozoite’s apical tip with the erythrocyte surface (Ladda et al., 
1969; Aikawa et al., 1978). Interestingly, an early description of P. knowlesi 
merozoites deforming host cells postulated that deformation is the result of the 
merozoite attempting to embed its apical end into the erythrocyte, as deformation was 
observed only when the merozoite’s apical end was in contact with the host cell 
(Dvorak et al., 1975). Thus re-orientation was not described as a separate invasion step 
per se, although correct alignment was of course required for entry. However, very few 
invasion events were captured for this study, and so the matter was not definitively 
resolved. Later, after observing many more P. falciparum invasion events, Gilson and 
Crabb (2009) came to a similar conclusion: that re-orientation likely happens during 
deformation itself, because when deformation subsided, P. falciparum merozoites were 
not observed to move again, prior to internalisation. Thus, the authors concluded that 
re-orientation occurs as the parasite is rolled around the erythrocyte surface during 
deformation. However, it is worth noting that the round morphology of P. falciparum 
merozoites likely hindered efforts to address this issue, as it is often difficult to 
determine the orientation of P. falciparum merozoites. Conversely, a more recent 
study, observing P. yoelii merozoites, which are slightly larger and less spherical than 
P. falciparum, showed examples of re-orientation occurring after deformation, and by
a pivoting motion (Yahata et al., 2012). Furthermore, another study showed that
treating P. falciparum merozoites with the actin polymerization inhibitor cytochalasin
D inhibits deformation, but does not prevent the formation of the moving junction, a
step that is theorized to take place only after apical alignment (Riglar et al., 2011;
Weiss et al., 2015). Thus, in combination these later results seem to suggest that re-
orientation could indeed be a discrete invasion step not strictly reliant on forces
generated from deformation.
A further molecular milestone, which takes place just prior to internalisation, is a 
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fusion event between the merozoite’s apex and the host erythrocyte (Weiss et al., 
2015; Volz et al., 2016; Introini et al., 2018). This event can be observed when 
merozoites invade erythrocytes loaded with Fluo-4-AM, a calcium-sensitive 
fluorescent dye (Weiss et al., 2015; Introini et al., 2018). Approximately 3-4 seconds 
prior to host cell entry, a fluorescent spot appears at the apical end of the merozoite, 
which has been termed a calcium “flux”, because it may correspond with the secretion 
of calcium-rich rhoptry contents into the host cell (Weiss et al., 2015; Volz et al., 
2016; Introini et al., 2018). However, these experiments have only been performed 
using P. falciparum parasites, and it is still not entirely clear when this event occurs in 
relation to re-orientation.  
Finally, after all of these events the merozoite initiates internalisation. For all species 
investigated so far, host cell entry appears to be rapid, usually occurring within a 30 
second window (Dvorak et al., 1975; Gilson and Crabb, 2009; Yahata et al., 2012; 
Weiss et al., 2015). Within a minute of internalisation, the erythrocyte then becomes 
echinocytotic. The reasons for this phenomenon are not entirely clear; but it may be 
triggered by secretion of rhoptry components (Gilson and Crabb, 2009; Weiss et al., 
2015). Intriguingly, echinocytosis does not occur in around 10-20% of cases for P. 
falciparum, and erythrocyte swelling, rather than echinocytosis, was reported for some 
P. knowlesi invasions (Dvorak et al., 1975; Weiss et al., 2015). When echinocytosis
does occur, though, the erythrocyte returns to its biconcave shape within several
minutes, marking the very end of a successful invasion (Dvorak et al., 1975; Gilson
and Crabb, 2009).
Importantly, understanding the invasion kinetics of P. falciparum and P. yoelii 
parasites has been critical to interpreting the phenotypes of genetic mutants that cannot 
invade erythrocytes, or those which can invade, but less efficiently (Yap et al., 2014; 
Tham et al., 2015; Weiss et al., 2015; Kegawa et al., 2018). However, the molecular 
steps driving the early events of invasion, in particular those performed by the RBL 
and DBP ligands, remain largely enigmatic. One reason for this is that despite great 
efforts so far, basic questions regarding the mechanics of invasion, such as the order of 
deformation, re-orientation, and calcium flux steps, remain unanswered.  
In theory, the larger size (2-3 µm long), and clearly polarized morphology of P. 
knowlesi merozoites, as compared to P. falciparum merozoites (Lyth et al., 2018), 
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should enable these basic questions to be addressed. However, since P. knowlesi’s 
debut appearance in 1975, no further live imaging studies featuring this species have 
been published elaborating on questions which have arisen since this early work 
(Dvorak et al., 1975). Furthermore, the 1975 study described invasion of macaque 
RBCs and did not include any data regarding human RBC invasion (Dvorak et al., 
1975). Although the basic morphological steps of invasion are likely to be the same for 
both species, P. knowlesi parasites exhibit a preference for macaque RBCs over 
human, and therefore the mechanisms underlying host cell selection and the timings 
involved may differ significantly (Moon et al., 2016). Additionally, P. knowlesi 
merozoites exhibit much longer half-lives compared to P. falciparum merozoites, 
which suggests that invasion dynamics might also differ between these species (Dennis 
et al., 1975; Boyle et al., 2010; Lyth et al., 2018). 
Therefore, before characterizing transgenic P. knowlesi lines produced in this study 
(described in chapter 4), the first logical step was to thoroughly analyse the invasion 
mechanics and kinetics of the PkA1-H.1 line, to gain an understanding of how P. 
knowlesi merozoites interact with human erythrocytes, and how the early events of 
invasion unfold. Notably, a second goal was also to compare the dynamics of human 
vs. macaque invasions. However, unfortunately, due to the fact that macaque 
erythrocytes are difficult to obtain in the UK, these experiments could not be 
performed yet. Attempts will be made to explore the dynamics of macaque invasions 
in the future. It is also important to note that the results in this chapter are largely 
observational. However, in addition to providing the basis for understanding the 
phenotypes of transgenic parasites produced in Chapter 4, dissecting the early events 
of wild type P. knowlesi invasions may provide valuable insight into invasion 
mechanisms shared by all Plasmodium species. Thus, taking the time to carefully 
analyse wild type P. knowlesi invasions will likely ultimately advance current P. 
falciparum and P. vivax research.   
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3.2 From egress to first contact: going house hunting 
3.2.1 P. knowlesi merozoites exhibit incomplete dispersal post egress 
In order to examine A1-H.1 merozoites invading human erythrocytes, tightly 
synchronised late stage schizonts (~1h pre egress) were purified by nycodenz and 
mixed with fresh RBCs at a 0.2-0.3% haematocrit and 10-15% parasitaemia. This 
dilution was loaded into a poly-L-lysine (PLL) coated µ-Slide VI 0.4 (Ibidi) to create a 
loose monolayer of erythrocytes along the channel coverslip. Schizont egresses and 
subsequent invasions were imaged at a rate of 1 frame/second over a 10-minute 
window with a 60x lens in bright field. 
Prior to visualizing any invasion events, an immediate difference was observed 
between the manner in which P. falciparum and P. knowlesi merozoites are dispersed 
post egress. Unlike P. falciparum merozoites, which are released in an “explosion” 
like manner, scattering individual parasites (Gilson and Crabb, 2009), P. knowlesi 
merozoites often emerged from host erythrocytes in pairs or small groups (Figure 3.1), 
and occasionally, with all merozoites still attached to the residual body or each other. 
Parasite groups frequently remained connected throughout the recordings and strongly 
deformed nearby RBCs in unison. If individual parasites within a group attached to 
adjacent RBCs, the ensuing deformations could pull RBCs together, creating clumps 
of RBCs and parasites (Video 3.1). These multi-parasite-RBC deformation events 
often allowed parasite groups to break apart, releasing individual merozoites, which 
could be more easily tracked from this point onwards. However, RBC clumping also 
obscured the view of other interactions and in some cases prevented determining the 
end fates of these merozoites (as invaders or non-invaders).  
Dvorak et al. (1975) also noted that parasites taken from macaques could remain 
attached to the residual body post egress and that multiple P. knowlesi merozoites 
attempting to invade the same macaque erythrocyte could cause it to lyse. Therefore, 
the incomplete dispersal of PkA1-H.1 merozoites is unlikely to merely be an artefact 
of adaptation to growth in human cells. Interestingly, some successful double 
invasions into a single host cell were observed during this experiment. However, at 
least two examples of host cells lysing due to the invading merozoite remaining 
attached to either another (non-invading) merozoite or the residual body were observed 
(example in Video 3.2). Thus, incomplete dispersal could clearly be a hindrance to 
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parasite survival. It is worth noting, though, that these observations may only be 
representative of invasions happening in static cultures. It is possible that the shear 
forces parasites are exposed to under flow conditions in the bloodstream may also 
disperse parasite groups effectively in vivo. 
On a practical note, P. knowlesi’s tendency to pull RBCs together, forming clumps of 
erythrocytes, meant that often the fates of individual merozoites were unclear due to 
parasites being hidden within these clumps. So, out of all the merozoites imaged in the 
following invasion experiments (from 20 different schizonts), 47 invaded RBCs, 102 
did not invade, and at least 38 were classed as ‘unclear’. A proportion of ‘unclear’ 
merozoites likely did invade, though, as evidenced by echinocytosis events within 
RBC clumps. However, because RBC clumping obscured the view of these invasions, 
it was not clear how many merozoites invaded any one cell or whether every 
echinocytosis event was definitely caused by an invasion. Therefore, while the average 
number of invasions recorded here was around 2-3/schizont, this value is very likely 
higher and more reflective of the replication rate (3-5 invasions/schizont) measured 
under standard culturing conditions (Moon et al., 2016).  
3.2.2 Gliding motility facilitates merozoite movement across RBC and solid 
surfaces 
Another striking feature of dispersing P. knowlesi merozoites was that they appeared 
to exhibit directional movement across the coverslip and erythrocyte surfaces, 
travelling away from their site of egress (Video 3.3; Figure 3.2). This surprising 
feature was especially apparent when a merozoite appeared to travel across an 
erythrocyte, detach from its surface, and then travel across the surface of the coverslip 
before attaching to another erythrocyte several microns away from the first (Figure 3.2, 
Figure 3.1. P. knowlesi schizont exhibiting incomplete dispersal.  
In static cultures, P. knowlesi merozoites frequently emerge from 
erythrocytes and contact new host cells while remaining attached to 
each other and/or the residual body. Scale bar = 5µm. 
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white arrows). Notably, this movement occurred in one orientation, with the wide end 
of the parasite leading forward movement along the surface of attachment. So it 
appeared that P. knowlesi merozoites might be capable of active motility and not 
merely relying on Brownian motion for dispersal and initiating contacts with potential 
host cells. Therefore, to investigate this surprising feature further, we sought to verify 
that this movement was not simply Brownian motion alone and to characterize this 
new and potentially important invasion step. 
3.2.2.1 Merozoite motility is an actin dependent process 
Inhibition of actin polymerisation with cytochalasins disrupts the acto-myosin motor 
and stalls host cell invasion as well as surface gliding of Plasmodium sporozoites, T. 
gondii tachyzoites, and B. bovis merozoites (Ryning and Remington, 1978; Miller et 
al., 1979; Stewart and Vanderberg, 1988; Håkansson et al., 1999; Asada et al., 2012). 
Therefore, the first logical step in characterising potential gliding activity of P. 
knowlesi merozoites was to compare the motility of parasites treated with cytochalasin 
D (cyto D) or its carrier, DMSO.   
Treated purified schizonts (n = 20 schizonts for each group) were monitored in the 
absence of fresh RBCs for 10 minutes post rupture. Control merozoites appeared to 
stick to the poly-L-lysine coated coverslip surface, and as noted before, move in one 
orientation, with the wider end of the merozoite leading (Figure 3.3A; Video 3.4). 
Each glide ended when the merozoite in question stopped forward motion and 
detached from the coverslip, resuming random motion (Denoted with a black arrow in 
Figure 3.3A, panel 10). While half-attached parasites could occasionally appear to 
exhibit forward movement for a couple of seconds, random motion also caused them to 
wobble from side to side. As such, a ‘glide’ was defined as continuous forward motion 
Figure 3.2. P. knowlesi merozoites travel away from their site of egress. White arrows depict 
a merozoite moving across the surface of an erythrocyte, before transitioning to the poly-L-lysine 
coated coverslip and attaching to a second erythrocyte. Stills taken from video 3.3. 
Scale bars = 5µm
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across the coverslip surface, for at least 5 seconds, as this time frame easily ruled out 
forward motion due to random movement alone. Using these parameters, 69% of 
DMSO-treated merozoites in a given schizont exhibited gliding motility (Figure 3.3B). 
In stark contrast, not one gliding merozoite was identified for the cyto D-treated 
parasites (video 3.5), indicating that like other Plasmodium zoites, merozoite motility 
is also actin-dependent.   
Figure 3.3. P. knowlesi merozoites exhibit gliding motility across poly-L-lysine-coated 
coverslips. (A) Panels from Video 4. DMSO treated P. knowlesi merozoites attach to PLL 
coated surfaces and move in one orientation across the slide, with their wide ends leading 
(direction shown with red arrows in panels 1-9). Forward movement ends when the wide end of 
the merozoite detaches from the coverslip surface (depicted with a black arrow, at 32 sec). 
Scale bars = 5µm. (B) Cytochalasin D (CyD) treated merozoites do not exhibit any forward 
motion across coverslip surfaces, while for DMSO treated parasites, a median 69% of 
merozoites in a given schizont demonstrate forward motility. ****Indicates p<0.0001 (Mann-
Whitney U-test). (C) Significantly fewer cyD-treated merozoites in a given schizont are 
dispersed  (median = 10%), compared to DMSO treated parasites (median = 51%). **** 
indicates p<0.0001 (Mann-Whitney U-test). For both graphs, thick red bars indicate medians, 
and error bars indicate interquartile ranges.   
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Interestingly, almost all cyto D-treated schizonts stayed attached to each other and the 
residual body, and only occasionally would a merozoite or two disperse from the 
group. However, it is important to note that the erythrocyte membrane of cyto D-
treated samples can clearly be seen to burst, releasing the entire schizont (video 3.5), 
indicating that egress as such, was not stalled by cyto D. Also, the release of a whole 
schizont as opposed to individual, separated merozoites is also common in non-cyto D-
treated parasites. However, once merozoites within DMSO-treated schizonts settled on 
the coverslip, they could pull away from the schizont and glide away from the group 
(Video 3.6). Overall, 51% of DMSO treated parasites either egressed as individual 
merozoites or became individual merozoites by pulling apart from pairs/groups. In 
contrast, only 10% of the cyto D-treated parasites emerged as individual merozoites 
(Figure 3.3C). Thus, motility, and therefore also dispersal are impacted when parasites 
are treated with actin-polymerisation inhibitors.  
3.2.2.2 The efficiency of gliding motility is dependent on the surface substrate 
Having established that P. knowlesi merozoite movement is not due to Brownian 
motion alone, an important question is, why have gliding merozoites not been 
observed before? Are gliding merozoites only characteristic of certain Plasmodium 
species, and even if this is the case - why did the original P. knowlesi study not reveal 
that these parasites are motile? Interestingly, Dvorak and Miller (1975) did observe P. 
knowlesi merozoites demonstrating ‘pivotal motion’ and bending, once they had 
settled to the bottom of glass coverslips. This motion was predicted at the time to be 
distinct from Brownian movement, but these results were never investigated further. 
Therefore, one hypothesis as to why merozoite motility has not been readily observed 
previously is that glass coverslips, frequently used for invasion imaging, may not 
support efficient gliding. This is certainly the case for Plasmodium sporozoites, which 
require a BSA coating to glide effectively across glass surfaces (Vanderberg, 1974). In 
contrast, the poly-L-lysine (PLL) coated polymer coverslips used in this study appear 
to facilitate P. knowlesi merozoite attachment and therefore have allowed productive 
gliding to be detected for the first time. 
To test this theory, motility of parasites on uncoated polymer or glass surfaces was 
assessed using the same parameters as for the PLL conditions. While some motility 
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was observed on both uncoated surfaces, overall, fewer merozoites/schizont exhibited 
motility, with only 32% of parasites gliding on the uncoated polymer surface, and 24% 
of parasites on the glass coverslips (Video 3.7), as compared to the 69% of parasites on 
PLL surfaces (Figure 3.4A).  Furthermore, even in the absence of an inhibitor, 
parasites on uncoated surfaces also exhibited reduced dispersion. Only 14% and 32% 
of egressing merozoites were able to disperse as individuals on uncoated polymer and 
glass surfaces, respectively (Figure 3.4B). These values are greater than the 10% seen 
for cytochalasin D treatment, as would be expected, given that some Brownian motion 
is observed under these conditions. However, the reduction in dispersal, as compared 
to the dispersal rates on PLL surfaces (51%), supports the hypothesis that gliding does 
indeed contribute to this process. Therefore, while it is possible to observe motility on 
these alternative surfaces, glass surfaces, in particular, provide less than optimal 
conditions for gliding, and as such, could make motility appear far less apparent 
without scrutiny.  
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3.2.2.3 The merozoite’s apical end is wider than its basal end 
The observation that P. knowlesi merozoites glide with their wide ends leading was 
also a surprising finding. Plasmodium merozoites are normally depicted as teardrop 
like forms with the wide end forming the basal side and the thinner tip housing the 
apical complex (Figure 3.5A) (Bannister et al., 2003; Cowman and Crabb, 2006). 
Thus, at first, it appeared that P. knowlesi merozoites might be travelling in the 
opposite direction to which they would during invasion.  
Apical orientation was examined with a fluorescently labelled line (See chapter 4 for 
further details regarding the generation of tagged lines) to investigate whether the 
apical end of P. knowlesi merozoites might, in fact, be the wide end. A line expressing 
a PkNBPXa-mNeonGreen fusion protein clearly showed that this tagged micronemal 
ligand (Meyers et al., 2009) localizes to the wide end, and not the thin, pointy end of 
Figure 3.4. Efficiency of gliding motility is impacted by the surface substrate (A) poly-L-
lysine (PLL) coated polymer coverslips facilitate maximum motility (median of 69% merozoites 
in a given schizont demonstrating motility), while glass and uncoated polymer surfaces facilitate 
significantly lower levels of motility (medians of 32.5% and 24% respectively). Differences were 
assessed using one-way ANOVA, with Dunnett’s multiple comparison test. *Indicates p<0.05. 
B) Fewer merozoites/schizont disperse from each other when schizonts egress on glass (median=
14.6%) and un-coated polymer surfaces (median = 32.9%) compared to PLL (median = 51%)
coverslips. Differences were assessed using one-way ANOVA, with a Kruskal-Wallis test. ***
indicates p=0.0002. For both graphs: n = 20 schizonts for PLL, 17 schizonts for uncoated
polymer, and 8 schizonts for glass coverslip. For both graphs, thick red bars indicate medians
and error bars indicate interquartile ranges.
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free merozoites (Figure 3.5B). Tagged parasites could also clearly be seen to glide via 
their wide, fluorescently labelled ends (Figure 3.5B, Video 3.8). Thus P. knowlesi 
merozoites were not moving “backwards”, and the apical end of the zoite did indeed 
appear to be the wide end. It is also worth noting that as a merozoite glides, it appears 
to stretch, and a small, pointed tip becomes apparent towards one side of the wide end 
of the zoite (Figure 3.5C, inset). This tip likely corresponds to the apical complex, 
which is depicted in transmission electron microscopy (TEM) images of apically 
aligned merozoites just before host cell entry (Figure 3.5C). Thus, the observation of 
this small, pointy tip by TEM could explain why early studies concluded that 
merozoites were entering host cells via their thinner ends.  
Overall, although surprising, the finding that the apical end of the P. knowlesi 
merozoite is its wide end does make sense in light of previous studies. These studies 
showed that within mature P. knowlesi schizonts, the thin, pointed ends of merozoites 
attach to the residual body, while the rounded ends face outwards, fanning around the 
residual body in a flower-like configuration (Figure 3.5D) (Moon et al., 2013; Mohring 
et al., 2019). Thus the arrangement of merozoites within the P. knowlesi schizont 
means they are perfectly positioned, upon egress, to glide away from the site of egress 
(and each other) after the host erythrocyte ruptures, as seen in Video 3.3. 
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Figure 3.5. The apical end of a P. knowlesi merozoite is the wider than its basal end (A) 
Cartoon taken from Bannister et al., (2003) depicting a typical representation of a Plasmodium 
merozoite, with the apical complex displayed at the merozoite’s thin tip. (B) Stills from Video 8, 
showing gliding NBPXa-mNeonGreen tagged merozoites, with their wide, fluorescently labeled 
ends leading forward motion. (C) Electron micrograph taken from Bannister et al., (1975) 
depicting the apical complex of a P. knowlesi merozoite. Mn = micronemes. Ms = microspheres. 
Inset: brightfield image of a stretched, gliding P. knowlesi merozoite, exhibiting a pointed tip at 
its wide, apical end, which may correspond to the apical complex.  (D) NBPXa-mNeonGreen 
tagged merozoites in a mature schizont. The apical ends of merozoites, marked by green dots, 
face outwards, while the thin basal ends are attached to the residual body, as depicted in the 
cartoon below. Scale bars = 5µm
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3.2.2.4 Corkscrew-like rotation drives efficient forward motion 
When examining gliding P. knowlesi merozoites closely, it became clear that they, like 
the other apicomplexan zoites, undergo the classically described ‘corkscrew’ motion 
(Video 3.9) to drive forward movement (Håkansson et al., 1999; Asada et al., 2012). 
Attempts were made to visualize this rotation by observing parasites stained with mito-
tracker, but it produced a symmetrical staining pattern, so that rotation could not be 
followed by fluorescence. However, a dark spot to one side of the merozoite’s apical 
end could be seen by brightfield, which rotated along with the parasite (Figure 3.6A). 
Tracking this dark spot revealed that parasites completed one full rotation 
approximately every 3.7 seconds, showing a clear positive correlation between the 
number of turns completed per glide and distance travelled forward (Figure 3.6B). 
Like Plasmodium sporozoites, P. knowlesi merozoites were found to rotate in a 
clockwise (right-handed) manner 90% of the time. Taking into account the merozoite’s 
circumference (on average 3.58 µm), merozoites were found to rotate at a tangential 
speed of 61 µm/min.  Practically speaking, this means that a 3.1 µm-long merozoite 
(the average length) completes 0.78 turns/body length travelled forward, consistent 
with a linear motor running at a 42° angle along the longitudinal axis of the merozoite 
(n = 10 merozoites; Figure 3.6C).  
Gliding speed varied, depending on whether merozoites travelled in pairs/groups or 
alone. Not surprisingly, single merozoites travelled at a faster speed (1.06 µm/s) than 
merozoites in pairs/groups (0.87 µm/s) (Figure 3.6D). This faster speed is comparable 
to that recorded for B. bovis merozoites (1.2 µm/s), which are a similar size to P. 
knowlesi merozoites, but slower than speeds recorded for larger zoites, such as 
Plasmodium sporozoites and T. gondii tachyzoites (~1-2 µm/s). However, when 
considering the smaller size of P. knowlesi merozoites compared to larger zoites (2-3 
µm in length, as opposed to Plasmodium sporozoites, which are 8-14 µm in length), P. 
knowlesi merozoites demonstrate remarkable efficiency despite possessing 
presumably, a shorter motor (Håkansson et al., 1999; Siden-Kiamos et al., 2006; Asada 
et al., 2012). Interestingly, speed decreased over subsequent glides. Figure 3.6E 
compares the first and final glide speeds of individual merozoites (on PLL coverslip) 
and shows that on average, initial glide speeds were faster (1.09 µm/s) than the final 
glides recorded for the same merozoites (0.90 µm/s). This difference could possibly be 
due to a slower rate of adhesin secretion as micronemal stores diminish over time,  or 
potentially cleavage of surface adhesins already in place. 
Figure 3.6. Corkscrew like rotation drives efficient motility (A) Gliding merozoites exhibit 
corkscrew-like rotation as they travel forwards. Rotation is evident when tracking a dark patch at the 
merozoite’s apical end (indicated by a red arrow in each frame), which turns around the merozoite’s 
circumference as the zoite travels forwards. Scale bar = 5µm. (B) By determining the length of the 
merozoite (L) and calculating the average distance it rotates for every body length it moves forward (R, 
or the number of turns/body length travelled forward x merozoite circumference), it is possible to 
calculate the length of the motor (M), and the angle at which it runs (m) using the formula Tan(m) = R/
L.  (C) The number of rotations a merozoite completes is positively correlated with the distance it 
travels forward (D) Gliding merozoites travel at an average speed of 1.1µm/s, and up to a maximum 
of 1.9 µm/s (n= 57 merozoites) when they are detached from other merozoites or the residual body 
(‘single merozoites’). Gliding speed is significantly slower (0.9µm/s; n = 59 merozoites) when 
merozoites travel in pairs or groups. *** Indicates P = 0.0001 (determined by a two-tailed, un-paired 
T-test).    84	
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3.2.2.5 Gliding duration corresponds with invasive capacity 
After egress, merozoites required a settling period of around 30-60 seconds to allow 
them to sink to the coverslip and make contact necessary to glide on a solid 
surface. Following this, merozoites spent a median 15 seconds and up to a maximum 
of 315.5 seconds gliding before any further movement continued as random 
motion (Figure 3.7A). Gliding was often discontinuous, with merozoites gliding 
for short periods before detaching from the coverslip, and then re-starting after a brief 
interval. As such, the longest continuous glide time was 207.5 seconds, with a 
median length of 14.2 seconds (Figure 3.7B).  
Figure 3.7. legend next page	
(E) A small, but significant difference was observed between the average speeds of a merozoite’s first 
glide (1.1µm/sec) vs its last glide (0.9 µm/sec). ** Indicates P= 0.0032, as determined by a two-tailed, 
paired T-test (n= 29 merozoites). For all graphs, red error bars indicate means and standard deviations.   
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The majority of gliding occurred within the first 5 minutes post egress (Figure 3.7C), 
with less than 5% of parasites continuing to glide beyond this point. Interestingly, this 
time frame appeared to correlate with the invasive capacity of P. knowlesi merozoites 
observed under these same conditions. The majority of merozoite-RBC contacts that 
lead to an invasion were also initiated within the first 3-4 minutes post egress (Figure 
3.7D). Thus, when merozoites lose the capacity to glide on extra-cellular surfaces, they 
may also lose their ability to invade erythrocytes.  
3.2.2.6 Gliding facilitates multiple RBC contacts 
Each merozoite travelled a median total distance of 14µm, and up to a maximum of 
198.6µm (Figure 3.8A). This distance, in theory, could allow parasites to glide 
over and contact multiple adjacent cells before committing to invasion. By 
examining gliding in the presence of RBCs, this hypothesis was found to hold true. 
On average, gliding merozoites contacted three RBCs, while non-gliding merozoites 
contacted only two cells (Figure 3.8B).  
This feature becomes especially relevant when considering the percentage of 
merozoite-RBC contacts that lead to successful invasions. Out of 284 merozoite-RBC 
interactions considered (from 20 schizont ruptures), all lasting at least 2 seconds and 
occurring during the window of time ranging from egress to the final invasion 
recorded (208 seconds), only 15% lead to invasion. Many of these interactions were 
made by merozoites that ultimately never invaded. Interestingly, though, when 
considering only those merozoites that did invade, only 40% invaded the first cell they 
contacted. 
Figure 3.7. Period of peak gliding corresponds with the invasive window of P. knowlesi 
merozoites (A) Each merozoite spent a median length of 15 seconds and up to 315.5 seconds gliding 
in total post egress (n= 109 merozoites). (B) The median length of each individual glide was 10 
seconds (and up to a maximum of 207 seconds; n= 204 glides). (C) The majority of gliding 
occurred within 4 min of egress. Peak gliding occurred 1-2 min after egress (window 
highlighted in red) with all the merozoites in a given schizont travelling a median, cumulative 
distance of 28µm during this window. A comparison of the median values across each window of 
time with the peak median value was performed using one-way ANOVA, with Dunnett’s 
multiple comparison test (**, **** indicates p< 0.05; ns indicates p > 0.05). No merozoites 
demonstrated motility beyond 9 minutes post egress. (D) Merozoites took a median length of 53 
seconds and up to 208 seconds after egress, to contact the cell they would invade. For all graphs, 
thicker red/black bars indicate medians and error bars indicate interquartile ranges.    
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Conversely, the remaining invasive merozoites made a median of 3 RBC contacts 
(including the cell they invaded), with some merozoites forming up to 7 intermediate 
contacts prior to the cell they invaded (Figure 3.8C). Furthermore, 87% of these 
intermediate contacts were also unique events, meaning that each invading 
merozoite rarely contacted the same RBC more than once.  
While these results contrast with what is seen for P. falciparum, with ~85% of Pf3D7 
invasive merozoites entering the first RBC they contact (Weiss et al., 2015), they are 
not altogether too surprising, given that human RBCs are not the natural host cells for 
P. knowlesi, as they are for P. falciparum. Thus, P. knowlesi merozoites may require a 
much more extensive human RBC selection process than P. falciparum merozoites do - 
a hypothesis that could be investigated by comparing the number of contacts P. 
knowlesi merozoites make when interacting with macaque vs. human erythrocytes.
Finally, an additional observation worth noting is that as merozoites stop and then re-
start productive gliding motility, they were frequently observed to rise up on their 
basal ends, with their wide apical ends waving above the coverslip surface. Without 
erythrocytes present, the merozoite’s basal end would also quickly detach from the 
coverslip surface, resulting in the merozoite floating or bobbling above the coverslip 
surface temporarily, before it re-attached and began rotational movement along the 
coverslip again (See Video 3.4 for examples). However, in the presence of 
erythrocytes, the merozoite’s basal end could remain attached to an erythrocyte 
surface, and the merozoite could briefly “twirl” on its basal end (Video 3.10), akin to 
what has been described for T. gondii tachyzoites (Håkansson et al., 1999). While this 
feature did not seem particularly helpful in the context of static monolayer cultures, as 
used for video microscopy, it is possible that merozoites may use twirling motions in 
vivo to access cells flowing above the cell they are attached to. Thus, twirling may be 
another mechanism P. knowlesi merozoites use to contact multiple erythrocytes and a 
potential mechanism to “actively” leave a cell. 
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Figure 3.8. Gliding facilitates multiple RBC contacts (A) Individual merozoites 
travelled a median cumulative distance of 14µm and up to a maximum of 198.6µm. (B) 
Gliding merozoites contacted a median of 3 and up to 10 erythrocytes throughout 
filming, while non-gliding merozoites contacted significantly fewer erythrocytes overall 
(median of 2 and a maximum of 3 erythrocytes). * Indicates P=0.0361 as determined using a 
Mann-Whitney U-test. (C) 16/42 merozoites invaded the first cell they contacted, while the 
remaining merozoites made at least 1 additional, and up to 7 additional contacts prior to their last 
host cell contact, culminating with an invasion. For all graphs, red thick red bars indicate 
medians and error bars indicate interquartile ranges.  
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3.3 Deformation and apical re-orientation: selecting the perfect 
new home 
3.3.1 Gliding leads into erythrocyte deformation 
A close examination of P. knowlesi merozoite-RBC interactions showed that 35% 
(98/277 clear interactions; see Figure 3.9A) eventually resulted in deformation of the 
host cell within 2-36 seconds (Figure 3.9B) of the merozoite contacting the host cell. 
While Dvorak and Miller (1975) originally described this event as the apically aligned 
merozoite attempting to drive its apical end into the erythrocyte, Gilson and Crabb 
(2009) proposed that deformation occurs when any part of the merozoite comes into 
contact with the erythrocyte. In partial agreement with Dvorak et al. (1975), 
observations of P. knowlesi merozoite-RBC interactions showed that deformation did 
frequently begin when a merozoite glided into the side of an erythrocyte, bending it 
around itself (Figure 3.10A, bottom panels; also see Video 3.11, frames 1-2). 
However, deformation was also often observed when merozoites were running parallel 
to the erythrocyte surface. In this instance, the erythrocyte membrane appeared to 
pinch or wrap around the length of the merozoite (Fig 3.10A, top panels; also see 
Video 3.11, frames 3-7). Interestingly, though, imaging parasite-RBC interactions with 
a faster frame-rate (10 frames/sec vs. 1 frame/sec for other videos) revealed that as 
merozoites glide forwards on erythrocyte surfaces, ‘ripples’ of deformation, starting 
towards their apical ends, would travel down the lengths of their bodies (Video 3.12). 
Thus, although deformation did not appear to result from an apically aligned merozoite 
trying to drive itself into the host cell, deformation might still originate from the 
merozoite’s apex, rather than any random point on the zoite.  
Importantly, in almost all cases, deformation coincided with gliding. At least 92% of 
deformation events (82/89 clear interactions) began simultaneously with, or within 1 
(minimum) – 24 (maximum) seconds of merozoites beginning to glide on erythrocyte 
surfaces (Figure 3.9C). As per the definition of a “glide” used in section 3.2.2.1, only 
events where the merozoite exhibited continuous forward motion across the RBC 
surface (or a combination of the RBC surface + coverslip) for at least 5 seconds were 
included as gliding events. However, it is worth noting that this strict cut-off excluded 
7/89 events from the gliding + deformation group. Of these interactions, 6 did display 
short (<5 sec) glides, below the cut-off, and only 1 deformation interaction was  
90	
Figure 3.9. Host cell deformation correlates with gliding. (A) Flowchart depicting 
classification of merozoite-RBC interactions, starting with 277 (out of a total of 284) 
interactions, which could confidently be divided into interactions resulting in deformation, or 
no deformation. (B) Merozoites typically began deforming host erythrocytes a median of 1 
second, and up to 24 seconds after gliding commenced (n= 79 interactions). (C) There was no 
significant difference (ns) between the length of time merozoites spent gliding on erythrocytes 
when they deformed them (median = 5.5 sec) vs. when they did not cause deformation (median 
= 5 sec). P=0.8236 (Mann-Whitney U-test). For both graphs, thick red bars indicate medians 
and error bars, interquartile ranges. 
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observed without any apparent sign of gliding. Thus, the percentage of deformation 
interactions coupled to gliding calculated with the 5-second cut-off (92%), is likely an 
under-estimate. So, overall there is a strong link between gliding and deformation, and 
it may even be that gliding is required for this process to occur.  
Conversely, not every gliding interaction progressed into deformation. For 35% of 
gliding interactions (44/126 gliding events), merozoites would travel over erythrocytes 
without ever indenting them, or causing any wrapping motions (See examples in Video 
3.3). Interestingly, there was no significant difference between the lengths of time 
merozoites spent gliding on erythrocytes they did not deform, vs. those they did (Fig 
3.9C). Therefore, merozoites did not appear to “try harder” to initiate deformation by 
gliding on a given cell for longer durations, when deformation did not occur.  
3.3.2 Strong host cell deformation is associated with P. knowlesi invasion of 
human RBCs  
Previous analysis of P. falciparum invasions determined that almost all invasions, 
across three different strains (3D7, D10, and W2mef), were preceded by deformation. 
Furthermore, there was a strong association between the extent of that deformation and 
the likelihood of invasion (Weiss et al., 2015). To determine the importance of 
deformation for P. knowlesi invasion and to investigate whether the level of 
deformation could be used to predict the likelihood of invasion, parasite-host cell 
interactions were scored similarly to those described in Weiss et al. (2015), from 0-3. 
Figure 3.10A shows example top and side views for each deformation score. A score 
of 0 indicated no deformation, and a score of 1 indicated a slight indentation to the 
RBC. Score 2 deformations were seen as deeper indentations from the side, with the 
merozoite appearing to be partially embedded into the RBC. From the top view, this 
score produced a slight ‘pinching’ of the RBC membrane down the length of the 
merozoite. The strongest interactions score 3 deformations, resulted in the entire RBC 
‘folding’ down the length of the merozoite, almost entirely enveloping it so that only a 
small portion of the merozoite could be seen.  
A breakdown of the maximum deformation scores for each interaction is summarised 
in Figure 3.10B. When considering interactions of parasites that did not invade at any 
point, score 0 interactions contributed to the majority (76.9%) of these, with the next 
biggest contributors being score 1 and 2 interactions (10.4% and 11.5% respectively). 
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Figure 3.10. Strong deformation correlates with invasion. (A) Host cell deformation scoring 
based on indentation level and the extent of merozoite wrapping. Score 0 = no deformation; 
score 1 = shallow indentations/shallow membrane pinching; score 2 = deeper indentations to the 
side of the erythrocyte/host cell membrane pinching around the middle of the zoite; score 3 = 
full host cell bending/wrapping around the merozoite. Scale bars = 5µm. (B) A breakdown of 
deformation scores for 1) every merozoite-RBC interaction (all interactions), 2) interactions 
leading directly to invasion (invaders), 3) interactions from merozoites which never invade 
(non-invaders), and finally, 4) interactions happening prior to the final interaction resulting in 
invasion (intermediates). 
The strongest score 3 interactions accounted for just 1.2% of non-invader interactions. 
In stark contrast, all invasions were preceded by deformation. A breakdown of these 
scores shows that over 95% of these interactions were composed of score 2 (43.9%) 
and score 3 (51.2%) interactions, with the remaining scores being weak, score 1 
interactions. Therefore, as is the case for P. falciparum, strong deformation correlates 
with successful P. knowlesi invasion events.  
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To investigate why this could be the case, each scored subgroup was analysed to 
determine the relative likelihood of invasion success.  Overall, 91.3% of all score 3 
interactions culminated in invasion, while only 40.9% of score 2, and a mere 6.5% of 
score 1 interactions led to invasion. Thus, while merozoites performed double the 
number of score 2 vs. score 3 events (44 events vs. 23), score 3 events had more than 
double the chances of leading to invasion than score 2 events did. Therefore, as for P. 
falciparum, it is likely that it is the extent of the wrapping motions themselves that 
contributes to this success, perhaps by increasing the surface area of the RBC that the 
merozoite is exposed to, or vice versa, so that the molecular interactions required for 
subsequent steps can be formed.   
3.3.3 Weak deformation scores characterize intermediate contacts 
As already explored in previous sections, additional RBC contacts precede around 
60% of invasion events. This subset of contacts, the ‘intermediate’ interactions, was of 
great interest, as they are initiated by parasites that are proven to be viable, but yet 
require several attempts to invade. Furthermore, the majority of these intermediate 
contacts (86%) were unique, suggesting that cell sampling, especially enabled by 
gliding motility, contributed to the ultimate ability of the parasite to invade eventually. 
Yet, why are intermediate cells deemed inadequate for invasion?  
In order to begin to address this complex question, the deformation scores of 
intermediate contacts were assessed to see whether they were more reflective of 
interactions from parasites that never invaded, or could perhaps be predictors of their 
eventual ability to invade. Interestingly, the scoring for this group (Figure 3.10B) was 
almost identical to the scoring of the non-invaders, with over half of interactions given 
a score of 0 (73%), and the rest composed of score 1 and 2 interactions. No score 3 
interactions were observed for this group.    
However, 58% (n= 37/64 interactions) of intermediate interactions were also gliding 
interactions. Thus, the reason for this overall lack of deformation did not appear to be 
linked to parasite motility, per se. Perhaps instead it is due to another parasite related 
factor, such as delayed secretion of a particular ligand necessary for deformation, or 
due to a host cell factor, such as variations in RBC deformability or surface receptor 
densities (Koch et al., 2017; Sisquella et al., 2017). Again, an ideal way to assess these 
theories would be to compare P. knowlesi invasion of human RBCs with invasion of 
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macaque RBCs. In theory, if intermediate contacts are rejected primarily due to host 
cell factors, P. knowlesi’s preference for macaque erythrocytes (Moon et al., 2016) 
may mean that fewer intermediate macaque RBC contacts would be observed overall.  
3.3.4 Merozoites cease forward motion and deformation prior to re-orientation 
Confusingly, apical re-orientation is frequently described in the literature as the 
merozoite “[orientating] its apical end onto the erythrocyte surface” (Weiss et al., 
2015). On one level, this is true; the merozoite’s apical end does need to come into 
contact with the erythrocyte membrane prior to internalization. However, the 
merozoite apex contacts the erythrocyte multiple times throughout the pre-
internalization steps. Gliding merozoites almost always contact erythrocytes apical end 
first, because they glide with the apical end leading. Yet, is the act of simply landing in 
the right position synonymous with achieving “re-orientation”?  
A careful analysis of the steps leading up to internalization showed that for P. 
knowlesi, re-orientation occurred in two phases. Firstly, towards the end of 
deformation, which lasted from 3-45 seconds (a median of 9 seconds, Figure 3.11A), 
the merozoite appeared to attach itself to the erythrocyte surface firmly, and forward 
gliding motion ceased (Seen at around 13 sec in Video 3.12, and at 53 s in Video 
3.13). It was difficult to determine the exact timing of this event for all invasions, as 
strong deformation frequently obscured the view of the merozoite. However, by 
looking at invasions preceded only by score 1 and 2 deformation events (such as video 
3.13), on average merozoites paused forward gliding movement 4 seconds before 
deformation had subsided and the erythrocyte had returned to its original shape (Figure 
3.11B). Notably, as the erythrocyte recovered from deformation, the stationary 
merozoite could be seen to lie lengthwise across the surface of the erythrocyte (Figure 
3.11C panels 1 and 2; videos 3.12-3.14). Intriguingly, sometimes if the merozoite was 
attached to the side of the erythrocyte, the apical end appeared to cling to the 
erythrocyte membrane as it returned from a deformed to a relaxed state (Figure 3.11C, 
panel 2, and video 3.14, at 9 sec). This indicated that the apical end, in particular, is 
firmly attached to the erythrocyte at this point in time. Subsequently, phase two of re-
orientation ensued. This involved the release of the basal end of the merozoite from the 
erythrocyte surface, while the apical end simultaneously pivoted on the spot, as 
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previously described by Yahata et al.  (2012) until it was perpendicular to the 
erythrocyte membrane (Videos 3.12-3.14, Figure 3.11B panels 3-7). The median 
length of time a merozoite took to pivot from a flat to perpendicular orientation was 3 
seconds, although this process ranged from 2-8 seconds (Figure 3.11D). 
Strikingly, for all invasions (n = 26 clear examples), merozoite pivoting 
Figure 3.11. Re-orientation occurs after deformation. (A) Merozoites deform host cells for a 
median of 9 seconds and up to 45 seconds, prior to beginning to pivot on their apical ends. (B) 
Merozoites pause forward movement a median 4 seconds (and up to 7 seconds) before deformation 
ends and the host cell recovers to a relaxed, biconcave shape. (C) Stills from video 3.14. Panel 1 
shows the erythrocyte recovering from deformation. Panels 1 and 2 show the merozoite’s apical end 
firmly attached to, and holding the erythrocyte membrane inwards. Panels 3-7 show the merozoite 
pivoting on its apical end, until re-orientation is complete. Scale bars = 5µm. (D) Apical 
pivoting was completed within a median of 3 seconds (and up to 8 seconds). For all graphs, red 
error bars indicate medians and interquartile ranges.  
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consistently began immediately after the last wave of deformation had ceased, and the 
RBC had returned or had very nearly returned to its original morphology (Videos 3.12-
3.14). Therefore, these findings confirmed that the mechanical act of deformation itself 
does not merely tilt the merozoite into the correct angle for entry. Clearly, re-
orientation is a carefully orchestrated process, governed potentially by several 
molecular steps, which are yet to be fully understood. Importantly, in line with this, no 
parasites were observed to re-orientate and then detach from the erythrocyte. Thus, 
commitment to invasion likely occurs in the steps leading up to re-orientation.	
3.3.5 A calcium flux between merozoite and host cell occurs prior to re-
orientation 
Having established that P. knowlesi merozoites exhibit a very clear “paused” phase 
just before re-orientation, where the apical end of the zoite is pinned to the erythrocyte 
surface, the next question to address was whether or not a calcium flux also occurs 
within this window. To address this question, P. knowlesi merozoites were observed 
while invading Fluo-4-AM loaded erythrocytes. For 11/14 invasions observed, a bright 
fluorescent dot appeared at the apical end of merozoites after they had paused on the 
erythrocyte surface, but on average 2.5 seconds prior to the beginning of re-orientation 
(Figure 3.12A and 3.12B, Video 3.15). Thus, for the majority of invasions, the order of 
events could be seen to be: 1) deformation and gliding begin, 2) the merozoite ceases 
forward gliding motility, 3) a calcium signal appears at the merozoite’s apex, 4) 
deformation ceases, and finally, 5) re-orientation begins. Notably, for 3/14 invasions, 
the calcium flux was observed at a later point, either during re-orientation, or as entry 
progressed. While the findings for these three invasions could be significant, it is 
important to note that in these instances, the merozoite’s apical end may simply have 
been out of focus; thus, if the calcium flux did begin prior to re-orientation, it may not 
have been apparent. Still, a much greater sample size will be needed to validate this 
theory. Finally, and in contrast to what has been observed for P. falciparum, no 
examples of the dot-like signal spreading to the rest of the host cell, causing it to turn 
green, were observed (Weiss et al., 2015; Introini et al., 2018). Instead, 8/15 apical 
signals ceased during or within several seconds of internalization, and 7/15 signals 
continued for a time beyond this point (Figure 12A, Panel 7 and Video 15), even up to 
156 seconds post internalization (Figure 3.12C).  
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3.4 Internalisation: moving on in 
3.4.1 Re-orientation seamlessly leads to internalization 
A previous study reported that after re-orientation, P. falciparum merozoites appeared 
to pause briefly on the surface of the erythrocyte, a step which was hypothesized to 
allow merozoites time to secrete rhoptry contents needed for moving junction 
formation (Gilson and Crabb, 2009). In contrast to these findings, our data indicates 
that the calcium flux begins prior to re-orientation, and that subsequently, re-
orientation seamlessly leads into internalization, without a noticeable break between 
the two events. This was especially apparent when observing merozoites invading 
from the side of the erythrocyte, rather than top down (Video 3.16).  
Figure 3.12. A calcium flux between merozoite and host cell begins prior to re-orientation. 
(A) P. knowlesi merozoites display a calcium flux between their apical ends and host cell cytosol 
of Fluo-4-AM loaded erythrocytes. Panels taken from Video 3.15. The fluorescence signal 
appears to originate at the merozoite’s apex (Panel 2) and remain localised to a single dot from 
start to finish. It begins when the merozoite has ceased forward gliding movement and (B) a 
median of 2.5 sec (and up to 4 sec) prior to the beginning of re-orientation. (C) The calcium 
signal remained at the apical end of the merozoite for a median of 64 seconds post internalisation 
for 7/15 invasions. Green dots represent where no end point was observed (e.g. the end of 
filming prevented determining the true end point). For both graphs, thick red bars indicate 
medians and thinner error bars, interquartile ranges. Scale bars = 5µm.
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Figure 3.13. Merozoites rapidly re-orientate and drive themselves into host cells. (A) P. 
knowlesi merozoites are internalized within 18 sec (mean) and up to 27 sec post re-orientation.  
Thick red bar indicates mean, and error bars indicate standard deviation. (B) Electron 
micrograph of an invading P. knowlesi merozoite (taken from Bannister et al., 1975), which 
depicts the apical end of the zoite being compressed as it travels through the junction. (C) Panels 
from Video 3.16 showing that the basal end of the merozoite expands during entry. Scale bar = 5µm.
However, similarly to what has been observed for both P. falciparum and P. yoelii 
(Gilson and Crabb, 2009; Yahata et al., 2012) once internalisation began, P. knowlesi 
merozoites rapidly entered host cells, completing this step within 11-27 seconds (Fig 
3.13A).    
3.4.2 Merozoite morphology changes during internalisation 
As discussed in previous sections, P. knowlesi merozoites invade wide end first. To 
begin with, this seemed particularly baffling, as many electron micrographs, depicting 
invading P. knowlesi merozoites show what looks to be entry from the thin end of the 
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zoite (Figure 3.13B) (Bannister et al., 1975). However, it became apparent during this 
study that as merozoite entry into the host cell progresses, the basal end of the 
merozoite appears to expand, rounding out (Figure 3.13C and Video 3.16, at 25-30 
sec) presumably as a result of the physical pressure placed around the merozoite-RBC 
junction, as the merozoite attempts to squeeze through. Therefore, static electron 
microscopy images likely depict this phenomenon, hence why it frequently appears 
that merozoites are invading via their thin ends. Additionally, it is worth noting that 
most examples of early EM images were taken from very thin sections of merozoites. 
Thus, only a single plane was ever visualized at once, making it even more challenging 
to determine the full morphology of the cell. 
3.5 Post invasion: getting settled 
3.5.1 Host cell recovery: when moving house is successful 
The final phase of invasion, reported to occur within 30-60 seconds after 
internalisation is completed, is echinocytosis, the formation of spicules over the entire 
erythrocyte surface. These spicules remain for several minutes, but eventually, the 
erythrocyte returns to its biconcave shape (Dvorak et al., 1975; Gilson and Crabb, 
2009; Weiss et al., 2015). Interestingly, whilst 70-90% (depending on the specific 
strain) of P. falciparum invasions reportedly culminate in echinocytosis (Weiss et al., 
2015), a small proportion does not, for reasons that are not entirely clear.  
In good agreement with these studies, whilst the majority of successful P. knowlesi 
invasions lead to echinocytosis (35/38 clear events), 3 invasions did not culminate in 
echinocytosis. Interestingly, echinocytosis progressed in a variety of ways. In most 
instances (79% of events), the RBC membrane appeared to twist around the site of 
merozoite entry, causing the cell to buckle, and fold at that site (Figure 3.14A; Video 
3.13 at 75-86 sec, and Video 3.17, at 161-167 sec). This then led to the formation of 
spicules over the RBC membrane, as the RBC shrivelled into an echinocyte. In 74% of 
these cases, membrane shrivelling and spiking appeared to spread from the site of 
buckling across the entire RBC (Video 3.13). However, for the remaining events, 
membrane spiking remained localized to the half of the RBC inhabited by the newly 
invaded merozoite (As in Figure 3.14A and Video 3.17). Some echinocytosis events, 
however, were not preceded by membrane twisting or buckling. For these events, 
membrane spiking began evenly across the surface of the RBC, and no half-cell 
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echinocytes were observed (e.g. Video 3.16 at 59 sec onwards).  This last group may 
represent invasions where host cell re-sealing and the pinching away of the 
parasitophorous vacuole occurred more efficiently.  
Overall, the median time at which maximal echinocytosis occurred was 46 seconds 
post internalisation (Figure 3.14B; n = 29 clear events), which is similar to what has 
previously been observed for P. falciparum. Full recovery, marked not only by the 
absence of membrane spicules, but also a return of the RBC to its original biconcave 
shape occurred slowly over the next 3-12 minutes for 26/35 echinocytosis events 
(Figure 3.14C). However, for the remaining echinocytosis events (9/35 events) the 
recovery phase was not observed at any point over the duration of the video, either due 
to erythrocyte clumping, or the end of filming occurring first. Therefore, to investigate 
the recovery phase more fully, further imaging for a longer duration is needed. 
However, what has been observed here is consistent with past work for P. knowlesi 
(echinocytosis lasting 10-15 min, from Dvorak et al., 1975), which is a little longer 
than has been observed for P. falciparum (5-10 min; from Gilson and Crabb, 2009).  
Figure 3.14. Most P. knowlesi invasions culminate with echinocytosis. (A) Stills taken from 
Video 17. Immediately after entry is completed (panel 1), the erythrocyte membrane begins to twist 
and fold (Panels 2-5). Membrane spikes, indicative of echinocytosis, then form, sometimes 
remaining localized to one side of the erythrocyte (Panel 6). Finally, the erythrocyte recovers, and 
the invaded parasite can be seen as a lump under the erythrocyte membrane (Panel 7). Scale bars 
= 5µm. (B) Peak m	embrane spiking occurs around 46 sec (median) post entry, but can be observed as 
late as 254 s post entry.  Thick red bar indicates median and errors bars show interquartile range. 
(C) Erythrocyte recovery occurs 3-12 min (mean = 7.7 min) after onset of echinocytosis. Thick red 
bar indicates mean, while error bars indicate standard deviation.
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3.5.2 Host cell lysis: when merozoites are evicted from the property 
Three failed invasion events were also observed during this study, marked by 
erythrocyte lysis rather than recovery from echinocytosis. Two of these events 
appeared to be because a second merozoite or the residual body remained attached to 
the invading merozoite and prevented it from fully invading and the host cell from re-
sealing (Video 3.2). However, a third event was noted, where after a normal invasion 
and the onset of echinocytosis, a group of additional merozoites bound to, and strongly 
deformed the echinocyte, which then immediately lysed (Video 3.18). Therefore, it 
appears that cells undergoing echinocytosis are also particularly sensitive to additional 
deformation from outside sources. Given that overall 3/47 (total) invasion events 
ended in lysis, this presents an impairment that likely does affect the replication rate of 
P. knowlesi parasites, unless having more RBCs available at a higher haematocrit and
the shear forces merozoites are exposed to in vivo, prevents these problems from
arising. However, since lysis events were also observed by Dvorak et al. (1975) for
similar reasons when merozoites were invading macaque erythrocytes, these failures
do not appear to be host-cell specific. Thus, so far, there is no indication that post-
invasion lysis events prevent P. knowlesi parasites from expanding in human cells any
more than they would in macaque cells.
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3.6 Summary and discussion of the mechanics of invasion 
Overall, our results have demonstrated a very clear order to the morphological steps of 
invasion, clarifying several pertinent questions. Figure 3.15 summarizes these results, 
outlining the steps that P. knowlesi merozoites take to invade human erythrocytes. 
These steps include initial contact, which may occur by the merozoite gliding to the 
host cell upon egress or by Brownian motion causing a random merozoite-RBC 
contact. Regardless, next, the merozoite initiates gliding motility to progress into 
erythrocyte deformation. Towards the end of deformation, the merozoite stops forward 
movement, pausing on the erythrocyte surface with its apical end in contact with the 
erythrocyte surface. This leads to a calcium flux between merozoite and host cell and 
finally to the merozoite pivoting on its apical end so that it is correctly orientated to 
drive itself into the erythrocyte.  
Roughly 31 seconds pass from the onset of host cell deformation to the completion of 
internalisation, although this can range significantly, from 22-73 seconds. Overall, this 
value is longer than what has been recorded for P. falciparum parasites (26 seconds; 
data from Gilson and Crabb, 2009). Interestingly, both species were internalised in a 
Figure 3.15. An overview of the morphological steps leading to invasion. Black arrows indicate 
individual steps of invasion. From left to right: Egress à first contact; first contact à beginning of 
deformation; beginning of deformation à recovery of deformation; beginning of apical pivoting 
à completion of re-orientation; and finally completion of host cell entry à peak echinocytosis.
Red arrows indicate lengths of phases outlined by Gilson and Crabb (2009): “Pre-invasion phase”
(the window of time covering the beginning of deformation à immediately prior to
internalisation) “Internalisation”, and “Post-invasion (window of time covering echinocytosis and
recovery to the erythrocyte’s original shape). Black text indicates timings for P. knowlesi invasion
steps. Blue text outlines P. falciparum timings reported by Gilson and Crabb, (2009).
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similar time (mean time of 18 seconds for P. knowlesi, and 17 seconds for P. 
falciparum), despite P. knowlesi merozoites being almost double the length of P. 
falciparum. The most significant differences in timings, then, lay between pre-
internalisation steps (or “pre-invasion steps”, as referred to by Gilson and Crabb, 2009; 
also see figure 3.15). In particular, while P. knowlesi merozoites spent a median length 
of 9 seconds and up to a maximum of 45 seconds deforming host cells, P. falciparum 
merozoites spent considerably less time doing so (median of 6 seconds and up to a 
maximum of 8 seconds; data from Gilson and Crabb, 2009). This perhaps indicates 
that P. knowlesi merozoites are generally less efficient at forming the interactions with 
human RBCs required for subsequent steps. P. knowlesi merozoites do exhibit a 
preference to invade macaque erythrocytes over human (Dankwa et al., 2016; Moon et 
al., 2016). One reason for this preference could be that specific pre-invasion steps are 
carried out more efficiently during macaque vs. human invasions, leading to higher 
invasion success rates overall. One practical reason for the difference in the duration of 
host cell deformation between P. falciparum and P. knowlesi could be the difference in 
densities between species-specific receptors. For instance, while each human 
erythrocyte contains roughly 1 million copies of the PfEBA-175 receptor, Glycophorin 
A, on its surface, far fewer copies (only 6000-13,000) of the PkDBPα receptor, DARC, 
are present (Salinas and Tolia, 2016). Thus P. falciparum invasions facilitated by 
EBA-175 binding to GPA may be more efficient than P. knowlesi invasions mediated 
by PkDBPα-DARC binding if a critical threshold of these respective DBP interactions 
is required for invasion to progress beyond deformation. Therefore, an interesting 
experiment in the future will be to compare the invasion dynamics of P. knowlesi 
merozoites invading human vs. macaque erythrocytes to see, for instance, whether or 
not P. knowlesi merozoites deform macaque erythrocytes for a shorter duration before 
internalisation. Given a chance to invade erythrocytes from its natural host, P. 
knowlesi may exhibit the same propensity observed for P. falciparum, to commit to 
invasion rapidly.  
Excitingly, our work has identified gliding motility as a new pre-internalisation step. 
Despite the long-held theory that merozoites only exhibit gliding motility during host 
cell entry (Baum et al., 2006; Tardieux and Baum, 2016), imaging P. knowlesi 
merozoites has clearly shown that they are also capable of gliding along host cell 
surfaces prior to internalization. This feature may allow P. knowlesi merozoites to 
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sample several different host cells before committing to host cell entry. Another reason 
for P. knowlesi’s preference for macaque erythrocytes (Dankwa et al., 2016; Moon et 
al., 2016) could be that a much smaller subset of human erythrocytes, compared to 
macaque erythrocytes, are deemed suitable for invasion. P. knowlesi parasites exhibit 
higher growth rates in reticulocyte enriched human blood vs. human normocytes 
(Moon et al., 2016). Furthermore, PkA1-H.1 parasites can ultimately achieve much 
higher parasitaemias in macaque erythrocytes than they can in human cells (Moon et 
al., 2013). Therefore, these results suggest that older macaque erythrocytes might be 
more amenable to invasion than human normocytes are.  Thus the ability to glide and 
contact multiple erythrocytes may be a huge benefit for this species, enabling it to 
proliferate in not just macaques, but also humans (Singh and Daneshvar, 2013). Again, 
future work examining P. knowlesi merozoites invading macaque erythrocytes will be 
required to address this question. However, in theory, if a greater proportion of 
macaque vs. human erythrocytes is suitable for invasion, merozoites should contact 
fewer macaque erythrocytes overall, before committing to invasion.  
Yet, an important question, which remains outstanding, is how might cell sampling 
work in vivo? Can merozoites transfer from cell to cell, even under flow conditions? In 
this study, merozoites frequently contacted erythrocytes by travelling across the 
coverslip, attaching to erythrocytes, and then gliding on to them. If multiple 
erythrocytes were positioned adjacent to each other, the merozoite could glide across 
several of them, with intermediate erythrocytes essentially forming a bridge to the 
merozoite’s final destination. While these conditions are indeed artificial, in the 3D 
environment of the vasculature, erythrocytes may still form bridges, as such. For 
instance, live in vivo imaging of erythrocytes flowing through capillaries shows that 
they are frequently attached to each other for prolonged periods of time, travelling 
together at roughly the same rate (McKay et al., 2020). Thus, in theory, this could 
potentially facilitate the transfer of merozoites from cell to cell. Furthermore, P. 
knowlesi merozoites also possess the ability to rise up on their tails and twirl, akin to 
what has been observed to other invasive zoites (Håkansson et al., 1999; Siden-Kiamos 
et al., 2006). This phenomenon could potentially allow merozoites to reach above and 
adhere to erythrocytes flowing above them.  
Gliding may also facilitate host cell invasion within extravascular environments, such 
as within the bone marrow or the liver.  Recent evidence has shown that significant 
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proportions of schizonts from the closely related species, P. vivax, sequester to the 
bone marrow, liver, and lungs of infected Aotus monkeys (Obaldia et al., 2018). 
Additionally, significantly higher proportions of ring-stage P. vivax parasites have 
been identified in bone marrow aspirates vs. the peripheral blood of human patients 
(Baro et al., 2017) in line with evidence that suggests key target cells for P. vivax are 
very young, CD71+ reticulocytes, also found in bone marrow parenchyma (Malleret et 
al., 2014). One explanation for this phenomenon could be that infected cells are 
leaving the blood vessels and entering tissue compartments by extravasation (Malleret 
et al., 2014; Venugopal et al., 2020). However, another exciting possibility is that 
gliding motility may be providing merozoites with a mechanism to leave the bone 
marrow vasculature, cross through sinusoidal capillary linings, and enter the red bone 
marrow compartment. Additionally, once within the bone marrow, gliding could also 
enable merozoites (either those coming from the bloodstream or rupturing within 
tissue compartments) to sample the diverse cell types present within this tissue to 
identify cells susceptible to invasion. Recent evidence also suggests that both P. 
falciparum and P. berghei gametocytes can sequester to extra-vascular spaces within 
the bone marrow (De Niz et al., 2018; Joice et al., 2014). Again, while extravasation 
may be responsible for these findings, gliding may also play a role in granting sexually 
committed merozoites access to young reticulocytes (Venugopal et al., 2020). Thus, 
gliding may be a highly important but under-appreciated capability of merozoites of 
multiple Plasmodium species.   
Importantly, our work has also shown that gliding and host cell deformation are 
inextricably linked, a finding that suggests that gliding is not just a mechanism 
merozoites use to move from cell to cell, but also an integral step of invasion. 
Excitingly, these findings have also been observed for P. falciparum, in a recent study 
performed in parallel to our work (Yahata and Hart et al., 2020). Disruption of P. 
falciparum motor complex components, including PfACT1 and PfGAP45, inhibited 
extra-cellular motility, as well as the ability of merozoites to deform host erythrocytes 
(Das et al., 2017; Perrin et al., 2018; Yahata and Hart et al., 2020). However, 
disrupting the merozoite’s molecular motor does not prevent echinocytosis from 
occurring (Weiss et al., 2015; Das et al., 2017; Perrin et al., 2018) or the nascent 
moving junction from forming (Miller et al., 1979; Riglar et al., 2011). Thus, while the 
acto-myosin motor is clearly required for internalisation, pre-internalisation gliding 
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and deformation may not be absolutely essential steps. However, live microscopy of 
cytochalasin-D treated P. falciparum merozoites shows that they need to contact 
almost triple the number of erythrocytes before forming attachments leading to 
echinocytosis (Weiss et al., 2015). Therefore, both gliding and erythrocyte deformation 
likely increase the chances of a merozoite forming the interactions it needs to progress 
on to the next steps of invasion, and thus overall increase the efficiency of host cell 
selection.    
After deformation subsides, P. knowlesi merozoites then re-orientate, so that the widest 
part of the zoite is vertically aligned with the erythrocyte, ready for entry to begin. 
Critically, the results from our work show that re-orientation is a distinct mechanical 
step to deformation, just as it also appears to be for P. yoelii (Yahata et al., 2012). 
Furthermore, we show that re-orientation is preceded firstly by a pause to gliding 
motility, and secondly by a calcium flux between merozoite and host cell. This is in 
contrast to the order of events described for P. falciparum, with both deformation and 
re-orientation predicted to occur simultaneously, and the calcium flux hypothesized to 
occur after re-orientation (Gilson and Crabb, 2009; Weiss et al., 2015; Volz et al., 
2016; Introini et al., 2018). The possibility that these two species might be behaving in 
such a vastly different manner was intriguing. However, a closer examination of the P. 
falciparum videos published by Gilson and Crabb (2009) revealed that this might not 
be the case. The most obvious reason is the lower time resolution of that study, in 
which invasions were imaged at a rate of 1 frame every 2-5 seconds. Our P. knowlesi 
data, imaged at a rate of 1 frame/sec, showed that merozoites typically complete re-
orientation within 3-4 seconds, suggesting that most P. falciparum re-orientation 
events may have been missed due to the slower frame rate. However, one video from 
Gilson and Crabb (2009), did manage to capture a re-orientation event, reminiscent of 
P. knowlesi invasions, with the merozoite pivoting after deformation had ceased (See
attached Video 3.19 at 36-38 sec, taken from Gilson and Crabb, 2009). Importantly,
this video also clearly shows the P. falciparum merozoite re-orientating on to its wider
end, in good agreement with data from Yahata and Hart et al. (2020), which
demonstrated that like P. knowlesi, P. falciparum merozoites also glide (and therefore
invade) with their wide ends leading. Thus, although re-orientation appears to be a
much more subtle event for P. falciparum, on the whole, it is likely that both species
perform these steps in the same order.
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Naturally, after considering all of this new information, questions arise regarding the 
molecular steps underpinning each morphological phase. For instance, if deformation 
and re-orientation are mechanically distinct steps, do separate molecular pathways 
underpin them? Or is deformation simply the by-product of the molecular interactions, 
which are necessary for re-orientation? For P. falciparum, members of the DBP and 
RBL families, aside from PfRh5, are hypothesized to perform overlapping roles, 
facilitating both deformation and re-orientation (Weiss et al., 2015; Tham et al., 2015). 
However, the complexity of the P. falciparum RBL and DBP families has meant that 
determining the individual roles for each family member has been difficult. In contrast, 
P. knowlesi relies on one DBP (PkDBPα) and one RBL (PkNBPXa) to invade human 
erythrocytes (Moon et al., 2016; Singh et al., 2005). Therefore, chapter 4 explores the 
roles of PkNBPXa and PkDBPα and attempts to address the question of which step, or 
















Chapter 4: Exploring the roles of PkDBPα and 
PkNBPXa during invasion 
4.1 Introduction 
A cascade of molecular interactions governs the mechanical steps of invasion 
examined in chapter 3. For P. falciparum, some of these interactions have been well 
characterised, such as the binding of PfAMA-1 to its parasite-derived receptor, 
PfRON2, to form the moving junction (Lamarque et al., 2011; Srinivasan et al., 2011). 
However, the interpretation of molecular steps facilitating earlier events quickly 
becomes more complex.  A particular subject of intense debate has been whether all of 
the P. falciparum RBL and DBP family members perform entirely synonymous roles 
(erythrocyte deformation and potentially apical re-orientation), or whether a subset of 
ligands performs unique functions (Gunalan et al., 2011, 2013, & 2020; Singh et al., 
2010). The apparent redundancy between specific P. falciparum RBL and DBP family 
members, such as PfEBA-175 and PfRh4, has complicated phenotypic studies 
considerably (Duraisingh et al., 2003b; Stubbs et al., 2005; Gaur et al., 2006; Weiss et 
al., 2015). Immunofluorescence data has shown that the P. falciparum RBL and DBP 
members both localize to the apical surface of free merozoites pre internalisation 
(Taylor et al., 2002; Treeck et al., 2006; Triglia et al., 2009; Gunalan et al., 2011). 
Thus both families are suitably located to mediate apical attachment and re-
orientation. However, the ectodomains of both families undergo multiple processing 
steps during invasion, which may lead to the release of different erythrocyte binding 
domains, which could, in theory, allow these ligands to perform secondary roles 
downstream of their initial functions (Triglia et al., 2009; Gunalan et al., 2011 & 
2020).  
Another source of debate, which has confused the issue further, is the question of 
whether the RBL ligands are secreted before the DBP ligands, or vice versa (Singh et 
al., 2010; Gao et al., 2013). P. falciparum’s separation of invasion ligands between 
different organelles – primarily the rhoptries and micronemes - is presumed to play an 
important role in moderating the order of their release during invasion, and therefore, 
the sequence of molecular events leading to its completion (Harvey et al., 2012; 
Cowman et al., 2017). While the PfRBL ligands are localized to the rhoptry necks, the 
PfDBPs are localized to the micronemes (Lee Sim et al., 1992; Rayner et al., 2001; 
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Thompson et al., 2001; Triglia et al., 2001; Duraisingh et al., 2003b; Gilberger et al., 
2003). Thus, if one family is secreted before the other, this could indicate that some 
DBP and RBL ligands perform sequential functions. However, the order of RBL/DBP 
secretion has never been systematically explored using fluorescently labelled lines and 
live microscopy techniques. Instead, protein localization has relied upon 
immunofluorescence data of fixed cells, which has lead to conflicting results regarding 
the order of their secretion. For instance, Singh et al. (2010) proposed that the PfEBA-
175 secretion is triggered upon egress and that when it binds to its receptor, 
glycophorin A, the PfRBL ligands are released from the rhoptries. Conversely, Gao et 
al. (2013) came to the very opposite conclusion: that PfEBA-175 is secreted just before 
the formation of the moving junction, but after PfRh1 interacts with its host cell 
receptor. Therefore a conclusive answer to the question of whether one family is 
secreted before the other remains elusive. Furthermore, it is also not known whether all 
micronemal secretion precedes rhoptry secretion, or whether subsets of micronemes 
exist, which carry our distinct roles. Intriguingly, in contrast to P. falciparum, the P. 
knowlesi and P. vivax RBL and DBP families are both localized to the micronemes 
(Meyer et al., 2009; Han et al., 2016). Thus, there may be no hierarchy to RBL/DBP 
secretion for these species. Alternatively, if the P. vivax and P. knowlesi RBL and DBP 
families are secreted separately, this would support the hypothesis that micronemal 
subsets exist, and could provide a way for these species to release key invasion ligands 
temporally. 
The relative simplicity of the P. knowlesi RBL and DBP families means that studying 
the order of their secretion and determining the roles of individual ligands is likely to 
be a much more straightforward process than studying their P. falciparum 
counterparts. Only one PkRBL and one PkDBP protein, PkNBPXa and PkDBPα, 
respectively, are critical for human erythrocyte invasion (Singh et al., 2005; Moon et 
al., 2016). Given the essential nature of each ligand, this suggests that PkDBPα and 
PkNBPXa may be facilitating separate steps of invasion. However, the precise role(s) 
of these two proteins remain largely unknown.  
An early study investigating P. knowlesi merozoite interactions with Duffy negative 
erythrocytes reported that P. knowlesi merozoites were capable of deforming Duffy 
negative cells, even though they could not invade them (Miller et al., 1975). However, 
this study did not describe to what extent merozoites could deform Duffy negative 
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cells, or whether they could apically re-orientate. A later study examining PkDBPα 
KO parasites by EM depicted seemingly apically aligned merozoites attached to 
human erythrocytes but without evidence of a junction having formed between each 
parasite and host cell. Therefore, this study concluded that PkDBPα KO parasites are 
capable of performing all invasion steps up to, and including re-orientation, but that 
PkDBPα is instead required for junction formation (Singh et al., 2005). Arguably, 
though, it is possible that the apically aligned merozoites, as seen by EM could simply 
have been the result of random merozoite-RBC interactions, rather than the merozoite 
specifically pivoting on to its apical end after deformation. Therefore, further 
examination of these events by live microscopy will be necessary to understand 
whether PkDBPα is required for re-orientation, or not. Even less is known about the 
role of PkNBPXa, other than the fact that while PkNBPXa null parasites can stick to 
the outside of human erythrocytes, they cannot invade them (Moon et al., 2016).  
I, therefore, adopted two distinct strategies to address the hypothesis that PkDBPα and 
PkNBPXa may be performing distinct roles during the early steps of invasion and to 
understand better how their storage, order of secretion, and localization before and 
during invasion relates to these roles. Firstly, I aimed to label both PkNBPXa and 
PkDBPα, as well as known moving junction markers PkAMA-1 and PkRON2, with 
fluorescent and epitope tags, using our newly developed CRISPR-Cas9 system 
(Mohring et al., 2019). This system relies on one plasmid that contains both the Cas9 
and sgRNA cassettes, as well as two selectable markers: one for positive selection and 
one for negative selection. The positive selectable maker, the hdhfr gene, gives 
resistance to the drug pyrimethamine and selects for parasites that have taken up the 
Cas9 plasmid, immediately after transfection. The negative selectable marker, encoded 
by the yfcu gene, causes cell death upon addition of the drug, 5-fluorocytosine. Once 
integration of the donor DNA (provided as a separate construct, without any selectable 
marker) has occurred, parasites are treated with 5-fluorocytosine, killing all parasites 
still carrying the Cas9 plasmid, and resulting in marker-free cultures, ready for further 
modifications. An additional benefit of this system is that efficient homologous repair 
of Cas9 induced double-stranded DNA breaks can be achieved using donor DNA 
introduced as a PCR product, containing homology arms with ≥200 base pairs - thus 
eliminating the need for plasmid delivery and conventional cloning strategies. 
Importantly, the optimization of this strategy, which I contributed to throughout the 
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early stages of this project, paved the way for me to generate multi-tagged lines 
rapidly. These lines allowed me to investigate the dynamics of secretion and invasion 
directly, using live microscopy, on top of indirect, immunofluorescence methods to 
explore the localizations of each ligand relative to each other.    
Our CRISPR-Cas9 system also enabled me to work towards strategy number two: the 
generation of PkNBPXa and PkDBPα conditional KO (cKO) lines, using the 
Dimerisable Cre-recombinase (DiCre) system (Andenmatten et al., 2013; Collins et al., 
2013). This system relies upon parasites expressing the Cre-recombinase enzyme in 
two halves, each fused to a different rapamycin binding protein: either FKBP12 or 
FRB. Addition of rapamycin to culture media induces both binding partners to form a 
heterodimer, and in doing so brings each enzyme half together, resulting in an active 
form of the recombinase. Active Cre-recombinase can then recognize short 34bp 
sequences, called LoxP sites, and perform site-specific excision of DNA sequences 
within the parasite’s genome, which are artificially flanked by LoxP sites, or ‘floxed’ 
(Andenmatten et al., 2013; Collins et al., 2013). In recent years, the DiCre system has 
been optimized particularly for P. falciparum to create inducible knockout lines, which 
have allowed robust analysis of multiple essential invasion genes, otherwise refractory 
to deletion (Yap et al., 2014; Volz et al., 2016; Das et al., 2017; Perrin et al., 2018). 
However, at the beginning of this study, no DiCre expressing background lines existed 
for P. knowlesi. Maintenance of previously generated PkNBPXa and PkDBPα KO 
lines relies upon a continuous supply of macaque RBCs (Singh et al., 2005; Moon et 
al., 2016). However, since macaque cells are a limited resource in the UK, relying on 
their availability was not a practical approach. Therefore, I worked to generate P. 
knowlesi DiCre background lines and iteratively modifying them to produce cKO 
lines, so that I could image these lines using live microscopy, to determine which steps 
of invasion are impeded when either PkNBPXa or PkDBPα is absent.  
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4.2 An overview of strategies used to generate transgenic P. 
knowlesi parasites 
4.2.1 Using CRISPR-Cas9 to target P. knowlesi invasion ligands 
The GC-rich (37.5%, as compared to P. falciparum - 19.4%) genome of P. knowlesi 
provides distinct advantages to genome editing, particularly for Cas9 mediated double-
stranded breaks and their subsequent repair (Pain et al., 2008; Mohring et al., 2019). 
Cas9 activity requires recognition of a 20 bp guide sequence within the desired locus, 
that is immediately followed by an ‘NGG’ site. Disruption of either the target sequence 
or the NGG site prevents further DNA cleavage (Mojica et al., 2009; Jinek et al., 2012). 
Within the P. knowlesi genome, ‘NGG’ sites are relatively abundant, even within non-
coding regions. Therefore, where possible, cut sites were chosen so that insertion of a 
new sequence, such as a tag, or LoxP sequence, would split the 20 bp guide sequence 
from its corresponding NGG site and ablate further Cas9 activity. This strategy worked 
particularly well for tagging PkNBPXa, PkRON2, and PkAMA-1, with c-terminal tags 
(see section 4.3), as all of these genes have NGG sites almost immediately following 
their stop codons (Figure 4.1A).
PkDBPα also contains NGG sites downstream of the stop codon; however as has 
previously been reported, all three PkDBPs share a high degree of sequence similarity 
(Adams et al., 1990, 1992) at both protein and DNA level (~94% similarity for 
PkDBPα vs. PkDBPγ), and in their 3’UTR regions. This feature means that designing 
constructs to target each PkDBP individually by CRISPR-Cas9 is challenging. Figure 
4.1B shows the alignment of the c-terminal sequences of all three genes, with potential 
NGG target sites. No target sites unique to wild type PkDBPα are available within 
40bp either side of the PkDBPα stop codon. Therefore, to overcome this problem, c-
terminal modifications to PkDBPα were performed using a parasite line in which the 
entire DBPa ORF has been replaced with a recodonised PkDBPα (RecDBPα) 
sequence, which also lacks PkDBPβ (Mohring et al., 2019). The PkDBPα coding 
sequence of this line is unique enough to allow specific homology region and guide 
RNA design that allows PkDBPα to be modified, via a cut site just before the stop 
codon without off-target cutting of PkDBPγ. (Figure 4.1B). When targeting the C-
terminus of PkDBPα, a silent mutation was introduced to the same site within repair 
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templates (TGG —> TTG) in order to prevent subsequent Cas9 cleavage at the 
modified locus. 
Figure 4.1. Choosing guide sequences to target P. knowlesi invasion genes. A) PkNBPXa, 
PkDBPα, PkRON2, and PkAMA-1 all have ‘NGG’ Cas9 cut sites several base pairs after their respective 
stop codons. Addition of a tag immediately prior to the stop codon splits the guide sequence from 
the NGG site. B) Sequence alignment of the last 40bp of the coding sequence + the first 40 bp of the 
3’UTR for all three WT PkDBP sequences and the RecDBPα sequence. The cut site used to target 
RecDBPα is indicated by a red rectangle, and the guide sequence is underlined in green. Asterisks 
indicate differences between RecDBPα and PkDBPγ, which enable specific targeting of RecDBPα. 
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4.2.2 A modified three Step PCR method enables quick and efficient Donor DNA 
generation 
The cloning steps necessary to create donor DNA plasmid constructs can be time 
consuming and labour-intensive, and so we sought to develop methods to improve the 
efficiency of donor DNA construct synthesis (Mohring et al., 2019; Mohring et al., 
2020). Mohring et al. demonstrated that efficient homologous repair of Cas9 induced 
double-stranded DNA breaks can be achieved using donor DNA introduced as a PCR 
product, containing homology arms with ≥200 base pairs, and thus eliminating the 
need for plasmid delivery and conventional cloning strategies. In order to quickly 
synthesize constructs containing a fluorescent tag, a previously established protocol 
(Ecker et al., 2006) was used as a starting point. This protocol consists of two 
amplification steps: the first to synthesize both homology regions (HR1 and HR2) 
from parasite gDNA, with overhangs to the tag of choice; and the second using both 
homology region PCR products and the plasmid template carrying tagging sequence, 
to amplify the full construct. As this approach varied in final product purity and yield, 
I attempted to improve reproducibility with a modified approach. By amplifying the 
tagging sequence (T3) separately, and using gel extracted PCR products as templates 
in a three-step nested PCR protocol (Figure 4.2A), it was possible to generate 
transfection-ready constructs within a day with both reliable final product purity and 
high yields (~100ng/µl for the PkNBPXa and PkDBPα constructs in Figure 4.2B).  
These high yields meant that 6-8 final (50 µl) reactions generated enough DNA for two 
transfections. Likewise, to generate constructs with a smaller insert, such as an epitope 
tag, a similar approach was applied. However, only two PCR steps were required: one 
to amplify both homology regions with overhangs to the tag and the second to fuse 
both homology regions and intervening tag together.   
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Figure 4.2. A Three-step PCR method for generating transfection constructs 
(A) Schematic showing each PCR step. 1) Amplification of each homology region and tag separately:
homology region 1 (HR1), the tag  (T3), and homology region 2 (HR2). The tag (amplified from plasmid
DNA) is amplified with an overhang to the plasmid it came from, which is removed in subsequent steps.
Primers used to amplify HR1 and HR2 contain sequences to add on overhangs to T3. 2) Fusion of HR1
and T3 using a forward primer amplifying from the start of HR1, and a nested reverse primer inside of
T3. 3) Fusion of the HR1/T3 template with HR2 to generate the full construct using nested primers placed
inside of HR1 and HR2. (B) Example gel images of each of the three step PCR results for mNeonGreen
(mNG) tagged PkNBPXa and PkDBPα constructs. Expected sizes: Homology regions left to right – 524
bp, 464 bp, 514 bp, 524 bp, 836 bp; HR1/3 – 1176bp, 1173 bp; Full constructs: 1617 bp, 1580 bp.
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4.2.3 An overview of transgenic lines used and produced in this study 
Being able to produce marker-less transgenic lines has opened up opportunities to 
make serial modifications to single parasite lines (Knuepfer et al., 2017; Zhang et al., 
2017; Mohring et al., 2019). This has especially revolutionised P. knowlesi work, as 
prior to developing a marker-less Cas9 system, only one marker (hDHFR) had been 
reliably integrated into target loci to select for transgenic P. knowlesi parasites after 
transfection (Singh et al., 2005; Moon et al., 2013; Moon et al., 2016). Therefore, with 
these new developments, a key objective of this study has been not just to tag, or flox 
(flank with LoxP sites) single genes, but to begin to build libraries of multi-tagged and 
floxed lines, so that dynamic invasion processes can be dissected. For instance, a line 
produced by tagging PkDBPα with a fluorescent label, on top of an inducible 
PkNBPXa KO line, could be used to address the question of whether or not PkDBPα 
can be secreted in the absence of PkNBPXa. 
Figure 4.3 shows a flowchart of the transgenic lines produced in this study, which are 
described in much greater detail in the following sections.  At the beginning of this 
study, Dr Franziska Mohring (LSHTM) generated the PkRecDBPα line (line 2 from 
Figure 4.3, and described in Mohring et al., 2019), which I used as a background for 
lines in which I targeted (or later intended to target) PkDBPa with a c-terminal tag. 
Additionally, it is also important to note that before beginning this study, no P. 
knowlesi DiCre expressing background line had been published, as had been for P. 
falciparum (Collins et al., 2013; Knuepfer et al., 2017). Thus early project work 
included the production of these lines. Dr Franziska Mohring and Dr Avnish Patel 
(LSHTM), synthesized the donor DNA and Cas9 plasmids for these transfections 
(described in section 4.5), and Dr Mohring transfected them into the WT PkA1-H.1 
background, producing the WT DiCre line (line 3). I then transfected both plasmids 
into RecDBPa background lines (lines 2&5) to produce two additional DiCre lines 
(lines 7&11). One final note is that a second WT DiCre background line (line 4), 
kindly donated by Dr Ellen Knuepfer (Francis Crick Institute/RVC), was produced 
concurrently from a separate study, and was used to generate a PkDBPα cKO line (line 
9) when we experienced difficulty producing this line from our WT A1-H.1 DiCre
background (See section 4.7). Overall, 18 new transgenic lines were generated from
this study. Due to time constraints, not all of them have been phenotyped (indicated by
white boxes in the flow chart). However, they demonstrate the robustness of the
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CRISPR-Cas9 system for use in P. knowlesi and will be a valuable resource for taking 
the findings of this study forwards.  
4.3 Successful tagging of P. knowlesi invasion ligands 
4.3.1 PkNBPXa, PkDBPα, PkAMA-1, and PkRON2 can all be modified to 
introduce C-terminal fluorescent protein tags 
In order to investigate when the P. knowlesi RBL/DBP ligands are being secreted, and 
to determine their localizations throughout invasion, I attempted to tag the C-terminus 
of PkNBPXa and PkDBPα with mNeonGreen (mNG), an exceptionally bright 
fluorescent protein (Shaner et al., 2013). This would allow these ligands to be 
visualized using live microscopy, and enable dynamic processes such as secretion, and 
potential changes to localization, to be mapped to the distinct morphological steps of 
invasion. I also attempted to tag the micronemal protein PkAMA-1 (Healer et al., 
2002) and the rhoptry neck protein, PkRON2 (Zuccala et al., 2012; Lyth et al., 2018) 
with mNG, so that the localization and secretion patterns of PkNBPXa and PkDBPα 
could be compared to these known moving junction markers (Lamarque et al., 2011; 
Srinivasan et al., 2011).  
Figure 4.3. An overview of transgenic P. knowlesi lines produced in this study. 
Parasite lines marked with asterisks were generated outside of this study, but have 
subsequently been iteratively modified within this study. (*Mohring et al., 2019, and Moon lab, 
unpublished). (**Knuepfer et al., 2019).  
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PkAMA-1, PkDBPα, and PkRON2 guide sequences were all cloned into plasmid 
pCas9/sg (described in Mohring et al., 2019). However, due to difficulty cloning the 
PkNBPXa guide sequence into pCas9/sg, this guide was instead inserted into an 
alternative Cas9 Plasmid, Pl_11 (Appendix figure 4B), which contains all of the 
components of pCas9/sg, but carries a smaller backbone and a high fidelity (HF) Cas9 
sequence instead of the wild type version. Donor DNA constructs were synthesized to 
include the mNG tag inserted directly in front of the stop codon and flanked by 400 bp 
homology arms to the 3’end of the gene, as well as the 3’UTR (Figure 4.4A). 
PkNBPXa, PkAMA-1, and PkRON2 donor constructs were all produced by overlapping 
PCR, and transfected as PCR products, along with their corresponding Cas9 guide 
plasmids. However, due to the similarity of the PkDBPα and PkDBPγ 3’UTR regions, 
the PkDBPα-mNG donor construct was synthesized by PCR, but cloned into a plasmid 
backbone to be sequenced prior to transfection.  
PkDBPα-mNG and PkNBPXa-mNG constructs were transfected into the RecDBPα line 
(line 2, from Figure 4.3), before the development of DiCre expressing background 
lines, leading to the production of lines 5 and 6, respectively. Later, the PkDBPα-mNG 
construct was also transfected into a DiCre expressing background line (line 15, from 
Figure 4.3), as were the PkAMA-1-mNG and PkRON2-mNG constructs, generating 
lines 18, 19, and 20, respectively (Figure 4.3). Following transfection, cultures were 
screened by PCR for the presence of WT and transgenic parasites using primers listed 
in Table 2.5 and depicted in Figure 4.4B. Transgenic parasites in which the tags were 
correctly integrated into the genome were detected by PCR for all variants (Figure 
4.4B).  
All four fusion proteins could be visualised by live microscopy, localising to the apical 
ends of merozoites in schizonts, consistent with their proposed micronemal and 
rhoptry localisations (Figure 4.4C). Very interestingly, in some cases, PkAMA-1mNG 
staining was also evident on the merozoite surface, prior to rupture (Figure 4.4C), as 
has previously been noted for P. falciparum AMA-1 (Treeck et al., 2009; Riglar et al., 
2011). However, no obvious early secretion of PkNBPXa or PkDBPα was observed, 
which could indicate that these ligands may be stored in different micronemal subsets 
to PkAMA-1, so that they can be secreted at a later point in time.  
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Figure 4.4. Generation of mNG tagged lines. (A) Schematic showing the insertion of an 
mNeonGreen (mNG) tag prior to the stop codon (red circle) of P. knowlesi invasion genes. Blue lines 
indicate the position of the Cas9 guide sequence used to target PkNBPXa, PkRON2, and PkAMA-1. 
Yellow dot indicates PAM sequence. Green arrows indicate positions of diagnostic primers used to 
detect WT and integrated parasites. (B) Diagnostic PCRs showing integration of the mNG tag to the 
PkNBPXa, PkRON2, and PkAMA-1, and PkDBPα loci. All primers are listed in Table 2.5 and 
positions outlined in above schematic. Expected PCR product sizes: PkDBPα WT (primer positions A/
C): 1046 bp (or 1778 bp if tag present); PkDBPα integrated (primers A/D): 691bp; PkNBPXa WT 
(primers A/B): 863bp (or 1565 if tag present); PkNBPXa Integrated (primers A/D): 973bp; 
PkAMA-1 WT (primers A/B): 984bp; PkAMA-1 Integrated (Primers A/D): 1113 bp; PkRON2 WT 
(primers A/B): 1209bp; PkRON2 Integrated (primers A/D): 1338bp. (C) Cartoon (left) depicts how 
P. knowlesi merozoites are arranged in schizonts, with their wide, apical ends fanning around the
haemozoin crystal. Live imaging of tagged parasites (panels, right) shows evidence of mNG fusion
proteins, localized to the apical ends of merozoites.  Scale bars = 5µm.
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Almost all parasites in the PkAMA-1mNG line appeared to be transgenic, as seen by 
live microscopy, and PCR. However, the remaining lines exhibited a mixture of 
transgenic and WT parasites, and so the PkDBPα and PkNBPXa mNG lines were 
subsequently cloned by limiting dilution (Figure 4.4B). However, attempts to clone out 
the PkRON2-mNG line were unsuccessful, and WT parasites quickly outgrew 
transgenic parasites in the bulk culture, indicating that the mNG tag is likely 
detrimental to PkRON2 function, and thereby parasite growth. Therefore, further work 
using the PkRON2-mNG line was not pursued, and the AMA-1 mNG line was relied 
upon instead as a marker for the moving junction, for live microscopy work (See 
section 4.4).   
4.3.2 Dual- tagging of apical markers demonstrates overlapping localisations of 
micronemal proteins  
Having established that PkDBPα, PkNBPXa, and PkAMA-1 proteins can tolerate even 
a bulky fluorescent label, the next step was to produce multi-tagged lines for co-
localisation studies. Firstly, further modifications were made to a clonal PkDBPα-
mNG line (line 5, from Figure 4.3), targeting PkAMA-1, and PkRON2 with a HA tag 
(Figure 4.5A), and PkNBPXa with a mCherry (mCh) tag. At the same time, a DiCre 
expression cassette was also introduced into the DBPα-mNG line (described in detail 
in 4.5.1). On top of this resulting line (line 11, from Figure 4.3), PkNBPXa was 
targeted with a construct to add both a HA tag before its stop codon and also a 34bp 
LoxP sequence directly after its stop codon (Figure 4.5A, box), so that this line could 
be modified again at a later point, to generate a floxed PkNBPXa cKO line (described 
in 4.5.2). All constructs were synthesized using the same overlapping PCR methods as 
described above and transfected with the same cas9 guide plasmids used to generate 
mNG tagged lines. Transgenic parasites (lines 10-14 from Figure 4.3) were 
successfully generated from all of the above constructs as confirmed by PCR (Figure 
4.5B), IFA (Figure 4.5C), and live microscopy (Figure 4.5D). 
Dual labelled IFAs showed that PkDBPα appears to mostly, but not entirely, co-
localise with PkNBPXa and un-secreted PkAMA-1 within schizonts (Figure 4.5C; 
average Pearson R values = 0.94 and 0.96, calculated from 50 and 47 individual 
schizonts, respectively), as opposed to PkRON2, which clearly resides in separate 
organelles (average Pearson R value = 0.84, calculated from 50 schizonts). Likewise, 
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live images taken from parasites expressing both PkDBPα-mNG and PkNBPXa-
mCherry show that these two fusion proteins exhibit very similar localisations (Figure 
4.5D; average Pearson R value = 0.92, from 6 different schizonts). These slight 
differences observed between the micronemal proteins may be indicative of 
micronemal subsets. Ultimately, though, since the resolution of epi-fluorescence 
imaging is unlikely to be sufficient enough to distinguish between micronemal subsets 
anyway, at least super-resolution techniques will be needed to address this question at 
a later date. However, overall, these results are consistent with PkDBPα, PkNBPXa, 
and PkAMA-1 all residing, as predicted, in the micronemes (Healer et al., 2002; Meyer 
et al., 2009). 
Unfortunately, in comparison to the PkNBPXa-mNG fusion protein, the PkNBPXa-
mCh signal was very weak and bleached very quickly, when continuously imaged. 
Thus further live imaging was not carried out with this line. Instead, observations of 





4.4 From storage to invasion: investigating the fates of P. 
knowlesi micronemal ligands 
4.4.1 PkNBPXa and PkDBPα are secreted simultaneously but show distinct 
distribution patterns from each other and PkAMA-1 once secreted. 
If the P. knowlesi RBL and DBP ligands perform discrete functions, one expectation is 
that they may be released at different times. Previous research has suggested that 
secretion of the RBL ligands may be dependent on the DBP ligands binding to their 
respective host cell receptors, or vice versa (Singh et al., 2010; Gao et al., 2013). 
Nevertheless, for either scenario to be true, the P. knowlesi RBL and DBL ligands 
would need to be stored within different micronemal subsets. Therefore, in order to 
investigate when the P. knowlesi RBL and DBL homologs may be secreted, and 
whether the release of one family may trigger the release of the other, freshly egressed 
transgenic parasites, expressing fluorescently labelled PkNBPXa, PkDBPα, and 
PkAMA-1, for comparison, were examined by live microscopy to observe these events 
directly.  
AMA-1 secretion has been visualized by live microscopy previously, for P. falciparum 
(Treeck et al., 2009). This study demonstrated that PfAMA-1 secretion begins before 
egress, but continues gradually, after egress, until PfAMA-1 is eventually evenly 
distributed along the merozoite’s surface (Treeck et al., 2009). In contrast to these 

















the majority remained at the apical end of the zoite throughout 3-4 minutes of filming 
(Figure 4.6; Video 4.1). Measuring the fluorescence intensity at three points around the 
periphery of the merozoite (Fig 4.6, cartoon) demonstrated that PkAMA-1 formed a 
gradient from its apical end to its basal end (Figure 4.6, graphs). Gradually, the ratio 
between the peak fluorescence intensity of the merozoite’s apical: middle: basal parts 
did begin to equalize somewhat, over time (Figure 4.6), indicating that after egress, 
some PkAMA-1 re-distribution continued, albeit slowly. However, as Video 4.1 and 
Figure 4.6 shows, at 203 seconds post egress, a time point by which five other 
merozoites in this video had invaded host cells, the non-invasive merozoite’s apical 
end still retained a visible concentration of PkAMA-1, almost double the fluorescence 
intensity of its basal end. Furthermore, invading merozoites also clearly exhibited 
strong apical concentrations of PkAMA-1-mNG (e.g. see invasion at 57 sec in Video 
4.1). Thus an even distribution of PkAMA-1 along the merozoite surface is clearly not 
required for invasion. 
It was unclear, though, whether apically concentrated PkAMA-1 had been secreted and 
simply remained at the apical tip of the merozoite, or whether this pattern represented 
un-secreted micronemal stores. Given AMA-1’s role in junction formation, it does 
make sense that the majority of secreted protein would remain at the merozoite’s apex, 
ready to interact with RON2 (Lamarque et al., 2011; Srinivasan et al., 2011). While the 
merozoites captured here were viable, with several within this video going on to 
invade erythrocytes, Treeck et al., (2009) did not demonstrate whether or not P. 
falciparum merozoites with evenly distributed PfAMA-1 were capable of invading 
erythrocytes. Therefore, these merozoites may have actually been rendered incapable 
of invading once micronemal stores were spent, and an apical concentration of AMA-1 
may even be a requirement for invasion.  
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Figure 4.6. Secretion of PkAMA-1 post egress. Top panels follow the secretion of an 
example merozoite secreting PkAMA1-mNG from immediately after egress (time 0) to 200 
sec post egress. Measuring the fluorescence intensity around the periphery of the merozoite 
(cartoon) shows that an apical gradient of PkAMA1-mNG remains throughout filming, 
rather than distributing evenly around the entire merozoite surface.  Intensity values 
normalized to peak basal fluorescence intensity shown in red for apical end, blue for 
middle of the merozoite, and orange for the basal end. Scale bars = 2µm.
In contrast to PkAMA1, secretion of both PkNBPXa and PkDBPα began immediately 
after egress, even in the absence of merozoite-erythrocyte interactions (Videos 4.2 and 
4.3). Critically, this provided strong evidence that receptor engagement of either 
RBL/DBP is not required for secretion of the other. Instead, both families appear to be 
secreted simultaneously, in contrast to what has been proposed for the P. falciparum 
RBL/DBP homologs (Singh et al., 2010; Gao et al., 2013). However, these results will 
need to be confirmed with fluorescently labelled ligands on top of KO backgrounds 
(e.g. PkDBPα-mNG + PkNBPXa cKO), as we cannot rule out the possibility yet that 
merozoites may be engaging with receptors on the erythrocyte membrane of the host 
cell they egressed from. What did become immediately apparent, though, was that 
once secreted, PkNBPXa and PkDBPα exhibited very distinct distribution patterns 
from each other, as well as PkAMA-1 (Figures 4.7 and 4.8). 
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As PkNBPXa is released from the micronemes, it spreads evenly down the length of 
the merozoite (Figure 4.7A, video 4.2), but does not appear to associate with the 
merozoite’s periphery. One explanation for this could be that the ectodomain of 
PkNBPXa is being cleaved from the merozoite’s surface after it is secreted to the 
apical surface and that its cytoplasmic tail domain  (plus mNG tag) is simultaneously 
being released into the merozoite’s cytosol. The P. falciparum RBL and DBL 
members are likely cleaved at sites within their transmembrane domains by the 
rhomboid like protease, PfROM4, at some point during invasion (Baker et al., 2006; 
O’Donnell et al., 2006). PkNBPXa also contains a putative ROM4 cleavage site within 
its TM domain (figure 4.7B). Thus ROM4 cleavage may be what is being observed in 
these videos. However, it will be necessary to perform western blot analysis of culture 
supernatants to investigate PkNBPXa shedding, as well as to label free merozoites 
with an antibody targeting the PkNBPXa ectodomain to see whether any of the 
ectodomain remains associated with the merozoite surface.  
Notably, secretion appeared to be a continuous process from the point of egress 
onwards, both for merozoites that do eventually invade and for those that do not 
(Videos 4.2 and 4.4). Secretion could be monitored by determining the fluorescence 
ratio (FR) between the peak fluorescence intensity of the merozoite’s apical end to the 
peak intensity of its body (Fig 4.7A, cartoon) every 10 seconds following egress. 
Where possible, two FR-values were calculated within a given 10-second window and 
averaged. Within the first 20 seconds after egress, FR-values were high, ranging from 
7-41 times that of the body (n = 9 merozoites from 5 different schizonts). Over time,
though, this ratio gradually decreased (Fig 4.7A and 4.7C), as the peak intensity of the
merozoite’s body increased relative to its peak apical intensity. Merozoites incubated
with erythrocytes, which did not invade, eventually became uniformly green (FR=1),
marking the end of secretion (Fig 4.7A, panel 6). It was difficult to pinpoint precisely
when this occurred for every merozoite observed, as, after 2-3 minutes, most
merozoites stopped gliding, detached from the coverslip surface, and moved out of
focus. However, for those merozoites for which endpoints could be accurately
determined (n = 8/12 merozoites, from 6 different schizonts), secretion was on average
completed within 124 seconds, and up to 156 seconds post egress. Of the remaining
four merozoites, for which an accurate endpoint time could not be determined, two had
FR-values >1 at 156 seconds post egress. Thus, while the majority of merozoites
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appear to fully secrete PkNBPXa within 2-3 minutes, a small proportion may take 
longer to secrete this ligand. Going forwards, this newly developed assay will allow us 
to analyse a much greater number of merozoites, in order to determine the full range of 
time it takes for merozoites to secrete micronemal contents.  
Very interestingly, preliminary data also suggested that merozoites might be secreting 
their contents more quickly in the presence of erythrocytes, as opposed to without 
them. Analysis of 8 merozoites (from 7 different schizonts), which were not incubated 
with fresh erythrocytes, showed that only 3/8 merozoites had finished secreting their 
contents by the maximum end-point time (156 s) observed for the +RBCs group. 
Furthermore, at 156 sec post egress (+/- 15 s), the median FR value for the –RBCs 
group (median =1.75; n = 8 merozoites) was found to be significantly greater than the 
median value for the +RBCs group (median = 1; n=12 merozoites) (Fig 4.7D). Thus, 
while PkNBPXa secretion can occur without merozoites contacting fresh erythrocytes, 
secretion speed may be increased by merozoites interacting with host cells. However, 
again, much larger samples sizes will be needed to confirm these findings.  
The distribution of PkDBPα post secretion (Video 4.3) was also intriguing. PfEBA-
175 has been localised to the apical tips of free merozoites, with the aid of both a C-
terminal epitope tag and antibodies targeting the N-terminus of this protein (Triglia et 
al., 2009). PkDBPα, however, accumulated primarily in three patches over the 
merozoite: the apical end, the widest portion of the merozoite, and at the tip of the 
basal end, resulting in three noticeable peaks when measuring the fluorescence 
intensity along the length of the merozoite (Fig 4.8A). Additionally, all three patches 
appeared to be connected by a fluorescent strip, running down the length of one side of 
the merozoite (See cartoon in Fig 4.8A). When PkDBPα-mNG tagged merozoites 
glide, this strip can be seen to rotate in and out of focus (Video 4.5). 
Interestingly, this odd distribution pattern occurs regardless of whether merozoites 
interact with erythrocytes or not, and can be seen to form within ~30-60 seconds of 
egress (Videos 4.2 and 4.5, and Fig 4.8B) (n = 16 merozoites, from 6 different 
schizonts). However, the patchy PkDBPα pattern made monitoring the rate of secretion 
using the same methods applied to PkNBPXa secretion, difficult. Faster, 3D imaging 
techniques, such as spinning disk confocal microscopy, will be needed to determine  
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Figure 4.7. PkNBPXa is secreted gradually and continuously post egress. (A) Live microscopy stills 
show PkNBPXa secretion is completed within 2-3 minutes. Secretion can be measured by comparing the 
fluorescence intensity of the merozoite’s apical end, to the peak intensity of its body (cartoon, and 
graphs). (B) Clustal alignment of predicted transmembrane domains of several RBL and DBP ligands. 
All contain a conserved alanine residue (red box), followed by potential helix destabilising motifs 
(underlined in green, and taken from Baker et al., 2006 & O’Donnell et al., 2006), making up putative 
ROM4 cleavage sites. The experimentally determined PfEBA-175 ROM4 recognition site is underlined 
in purple (O’Donnell et al., 2006). (C) Graph showing PkNBPXa secretion over time when merozoites 
are incubated with fresh erythrocytes. FR-values were calculated, where possible, every 10 seconds 
post egress for 15 merozoites, and plotted against time. Each data point represents an FR value from an 
individual merozoite at specified time point. Blue line shows a non-linear fit of FR values/time for all 
merozoites. Red dotted lines indicate 95% confidence interval (D) At 156 sec post egress, merozoites 
which have not been incubated with fresh erythrocytes exhibit a higher median FR-value (median=1.75) 
than those, which are incubated with fresh erythrocytes (median= 1). N = 12 merozoites for +RBCs 
group, and 8 merozoites for –RBCs group. Medians were found to be significantly different when 
compared by a Mann-Whitney U-test (p= 0.0305).  Scale bars = 2µm.
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how quickly PkDBPα is secreted after egress, and whether the speed of PkDBPα 
secretion is impacted by erythrocyte contact or not. Also, again, as for PkNBPXa, it is 
difficult to discern whether secreted PkDBPα is localized to the merozoite surface, or 
not, without probing free merozoites with an antibody targeting the N-terminus of this 
protein. Thus overall, what is clear from these initial results is that PkAMA-1 is 
secreted prior to both PkDBPα and PkNBPXa. Furthermore, despite PkDBPα and 
PkNBPXa exhibiting similar secretion dynamics, they appear to occupy distinct 
regions of the merozoite. Therefore, perhaps different localisations, and not secretion 
timings, may prepare them to perform their roles in discrete steps of invasion.  
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4.4.2 Apical micronemal stores correlate with erythrocyte deformation and 
invasion  
Next, since PkNBPXa-mNG parasites provided the clearest example of secretion, I 
used this line to investigate whether continuous micronemal secretion might be a 
requirement for early invasion events. Results from chapter 3 demonstrated that 
gliding and deformation are both linked, a finding in good agreement with Weiss and 
colleagues (2015), who showed that deformation is a motor dependent process. Since 
Figure 4.8. PkDBPα exhibits a striped distribution post secretion. (A) Stills from live 
microscopy (Video 4.3) showing PkDBPα secretion over time. PkDBPα-mNG concentrates 
around the widest portion of the merozoite, as well as the basal tip. Both of these 
concentrations are connected by a strip of PkDBPα running down one side of the merozoite 
(Cartoon, and particularly panels 3 and 5). (B) The striped PkDBPα pattern can be visualized 
within 60 seconds (and a mean of 40 seconds; n = 15 merozoites) after egress.  Scale bars = 2µm.
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gliding might also depend on continuous micronemal secretion (Gras et al., 2019), it 
follows that merozoites which have fully secreted their micronemal contents will not 
be able to deform their host cells, and thus will be far less likely to invade.   
In order to explore the potential link between micronemal stores, host cell deformation, 
and invasion, the RBC interactions of 27 merozoites (from 12 different schizonts) 
expressing PkNBPXa-mNG were examined to see whether deformation occurs in the 
absence of apical stores. A breakdown of all deformation scores, according to 
merozoites with clear apical staining (FR > 1) vs. merozoites without prominent apical 
staining (FR =1), is shown in Figure 4.9A. Strikingly, almost all score 1-interactions 
(92%; n = 24 interactions) and all scale 2 and 3 interactions (n= 28) were performed by 
merozoites with prominent apical staining (FR>1).  Furthermore, while the median 
FR-value for score 0 interactions was 2.5 (n=73 interactions), the median FR-value for 
scale 1-3 interactions was significantly higher (median FR-value = 4; n= 52 
interactions), as determined by a Mann-Whitney u-test (Figure 4.9B; p < 0.0001). 
Importantly, all invasions observed (n=9) were initiated by merozoites with apical 
fluorescence intensities at least double (FR≥2) and ranging up to 21 times that of the 
merozoite body. Therefore, merozoites do seem to exhibit a much greater chance of 
deforming host erythrocytes, and thus invading them prior to having fully secreted 
PkNBPXa. So, a merozoite’s invasive half-life may be dependent on the rate at which 
it secretes micronemal proteins.   
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Figure 4.9. P. knowlesi merozoites cannot deform erythrocytes without apical PkNBPXa stores. 
(A) The proportions of score 1-3 deformation events are significantly higher when merozoites 
possess apical stores of PkNBPXa (FR>1) as opposed to when secretion is 
complete (FR=1). (P<0.0001, determined by Chi squared test; n = 35 events where FR=1, and 90 
events where FR>1). (B) The median F R-value (4) associated with score 1-3 deformation events 
is significantly greater than the median FR-value (2.5) associated with merozoite-RBC contacts which 
do not result in deformation (score 0 events). ****Indicates p<0.0001, when comparing the means by 
Mann-Whitney u-test; n = 52 score 1-3 events, and 73 score 0 events. Red bars indicate medians and 
interquartile ranges.
4.4.3 PkDBPα, but not PkNBPXa, associates with the moving junction during 
invasion 
Several P. falciparum RBL and DBP members, including PfRh1, PfRh2a, and PfEBA-
175 have been localised to or found to be in close proximity to the moving junction of 
merozoites captured mid invasion. These results have been obtained both with 
antibodies targeting tagged cytoplasmic domains, as well as with antibodies targeting 
the N-terminal ectodomains of these ligands (Triglia et al., 2009; Gunalan et al., 2011; 
Gao et al., 2013; Gunalan et al., 2020). Therefore, to investigate whether PkNBPXa 
and PkDBPα might also exhibit similar properties during invasion, mNG-tagged lines 
were examined using live microscopy, to visualise how the localisations of these 
ligands might change during host cell entry, in comparison to the moving junction 
marker, PkAMA-1.  
Live imaging of PkAMA-1 mNG tagged parasites demonstrated junction formation 
and progression very clearly (Video 4.6, and corresponding Figure 4.10A, top panels). 
As parasites entered the host cell, some, likely un-secreted, PkAMA-1 remained at the 
tip of the merozoite (Fig 4.10A, top panels, 3 and 4). However, surface-bound  
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Figure 4.10. Legend on next page. 
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PkAMA1-mNG was translocated from the apical end of the merozoite to its basal end, 
appearing as two foci at the merozoite-RBC interface as internalisation progressed (Fig 
4.10A, top panel 3). Strikingly, a close examination of the un-secreted apical stores 
showed that merozoites rotate in a corkscrew-like manner while entering host cells. 
Video 4.6, at 147-161 sec demonstrates this action, as apically stored PkAMA-1 comes 
in and out of focus, when the zoite glides into the erythrocyte, rotating its apical end in 
a clockwise manner. Additionally, at around 161 sec, after the junction closes, the 
merozoite continues to rotate, in a manner reminiscent of that described for T. gondii 
tachyzoites after host cell entry (Pavlou et al., 2018). This rotation continued for 20-30 
seconds, possibly allowing the parasite to seal itself within the newly formed PVM and 
detach from the host cell membrane. 
Next PkDBPα-mNG parasites were examined. Attempts were made to determine if 
prior to re-orientation, the merozoite is orientated so that the side of the merozoite 
containing a continuous line of PkDBPα (as in figure 4.8A, and Video 4.5) is attached 
to the erythrocyte surface. However, it was unclear, even after watching multiple 
videos, which side of the merozoite was pinned to the erythrocyte surface before entry. 
Faster, 3D imaging methods may reveal the answer to this question at a later date.  
Interestingly, whilst not as clear as for PkAMA-1, PkDBPα did appear to form a ring-
like structure during entry (Videos 4.7&4. 8, and corresponding Fig 4.10A, middle 
panels 2-4). Double tagged PkDBPα-mNG/PkAMA-1-HA parasites were subsequently 
fixed mid-invasion and probed in solution with α-mNG and α-HA antibodies to 
directly compare the localization of PkDBPα with PkAMA-1 during host cell entry. 
Images taken from z-stacks of an invasion stalled by cytochalasin D show that 
PkDBPα appears to trail behind PkAMA-1 at the moving junction, partially co-
localising with this structure (Fig 4.10B). These exciting findings suggest that 
PkDBPα might play a role during internalisation. Alternatively, though, it is also 
Figure 4.10. Capturing the localization of P. knowlesi invasion ligands during invasion (A) 
Live stills of PkAMA1-mNG (top; taken from video 4.6), PkDBPα-mNG (middle; taken from 
Video 4.7) and PkNBPXa-mNG (bottom; taken from video 4.9) tagged parasites invading 
erythrocytes. S c a l e  b a r s  =  5 µ m . (B) Two slices from a z-stack, of an IFA of a P. knowlesi 
merozoite stalled mid-invasion with the addition of cytochalasin D. PkDBPα-mNG (green 
channel) and PkAMA1-HA (red channel) fusion proteins were detected using anti-mNG 
(32F6, Chromotek) and anti-HA (3F10, Sigma) antibodies, respectively. The graph below depicts 
the fluorescence intensity for each channel along a line drawn through one side of the moving 
junction.  Scale bars = 2µm.
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possible that PkDBPα might be being shed from the merozoite surface as the junction 
moves back across the basal end of the zoite. Going forward, using super-resolution 
microscopy techniques may help to determine whether PkDBPα truly overlaps with 
the moving junction, or exists within a different structure facilitating host cell entry.  
Finally, in contrast to both PkAMA-1, and PkDBPα, the localization of PkNBPXa did 
not change during invasion (Videos 4.4 and 4.9; Fig 4.10A, bottom panels). Like 
PkAMA-1, apically stored PkNBPXa was carried into the erythrocyte. However, 
PkNBPXa did not appear to be trans-located down the merozoite body, as entry 
progressed, and overall no evidence of a role for PkNBPXa during host cell entry was 
apparent. Since PkNBPXa secretion may correlate with cleavage from its C-terminal 
domain, though, going forward, it will be necessary to label invading parasites with 
antibodies targeting the PkNBPXa ectodomain, to determine whether or not processed 
PkNBPXa fragments contribute to host cell entry.  
4.5 Exploring RBL/DBP function through a conditional KO 
approach 
4.5.1 Establishment of P. knowlesi DiCre background lines 
Since previously established PkDBPα and PkNBPXa KO lines can only be maintained 
in macaque erythrocytes, (Singh et al., 2005; Moon et al., 2016) it was necessary to 
establish conditional KO (cKO) lines for both of these ligands. The first step towards 
generating cKO lines was to generate stable, DiCre-expressing background lines, by 
integrating a DiCre cassette into the parasite’s genome using CRISPR-Cas9, as has 
been successfully done for P. falciparum (Collins et al., 2013; Knuepfer et al., 2017). 
Following this, parasites could be iteratively modified using CRISPR-Cas9 to generate 
floxed PkNBPXa and PkDBPα lines. 
Since the Pkp230p locus is redundant in the blood stages and has previously been used 
as a site for the integration of GFP expression cassettes (Moon et al., 2013; Mohring et 
al. 2019), a DiCre expression cassette was introduced into this locus by double 
homologous recombination (Figure 4.11A), using CRISPR-Cas9. Dr Franziska 
Mohring kindly provided both the Cas9 plasmid pCas9sg_p230p, targeting Pkp230p 
(Mohring et al., 2019), as well as the donor DNA plasmid, pDonor_DiCrePkp230p 
carrying the DiCre expression cassette, flanked by 500 bp homology arms to the 
Pkp230p target site (Figure 4.11A). 
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Figure 4.11. Generation and genotyping of P. knowlesi DiCre expressing background 
lines. (A) Schematic showing the integration of a DiCre expression cassette into the Pkp230p 
locus. Primers used to screen for WT parasites indicated with green arrows, and those used to 
screen for transgenic parasites indicated with red arrows). (B) Diagnostic PCRs showing the 
integration of the DiCre cassette into the RecDBPα and RecDBPα/DBPa-mNG 
backgrounds. All primers listed in Table 2.5. Expected PCR product sizes: Non-modified 
parasites: 969bp; Integrated parasites: 891bp. WT = wild type control parasites; B = bulk, 
uncloned parasites; C1 & C2 = clones 1&2. 
Both plasmids were transfected into the PkDBPα-mNG and PkRecDBPα backgrounds 
(lines 5 and 2, respectively, from Figure 4.3). Additionally, Dr Mohring (LSHTM) 
introduced the DiCre cassette into the wild type PkA1-H.1 line (line 1, from figure 
4.3). Integration of the DiCre cassette into Pkp230p was shown to be successful by 
PCR for all background lines, and the RecDBPα and wild type DiCre lines (lines 7 
and 3 from Figure 4.3) were subsequently cloned by limited dilution prior to further 
modifications (Figure 4.11B).  
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4.5.2 Generation of PkNBPXa cKO lines 
PkNBPXa is an 8.5 kbp gene located on chromosome 14. Due to its large size, LoxP 
sites were integrated into the gene in two separate steps (Figure 4.12A). As PkNBPXa 
contains a 186bp endogenous intron towards the 5' end of the gene, constructs were 
designed to take advantage of this feature and insert a LoxP site within this sequence. 
This new intron (PkLoxPint) would not only serve the purpose of this study but could 
also be introduced into other genes, for subsequent conditional knockout designs - a 
strategy that has been widely used for P. falciparum work (Jones et al., 2016; 
Knuepfer et al., 2017; Sherling et al., 2017; Boonyalai et al., 2018). The P. falciparum 
synthetic LoxP intron (PfLoxPint) was designed by placing a LoxP sequence into the 
PfSERA2 intron after its predicted branch point, so to avoid disrupting this sequence 
and impede correct splicing of the gene (Jones et al., 2016). This branch point was 
predicted using a consensus sequence (YWHWW) derived from a previous study of P. 
falciparum intron structure (Zhang et al., 2011). The PkNBPXa intron was screened 
for possible branch point sites using this same consensus sequence. However, this 
search yielded many possible branch sites throughout the entire intron (Figure 4.12B). 
Therefore, two different insertion sites (LoxPint1 and LoxPint2) were chosen within 
the second half of the intron, to identify one that avoided branch point disruption. As 
introns cannot be 'recodonised', these positions were also chosen on the basis of 
available nearby Cas9 'NGG' cut sites so that insertion of the LoxP sequence would 
disrupt the Cas9 guide sequence from its corresponding NGG site, and therefore ablate 
subsequent Cas9 targeting. 
Guide sequences targeting each potential insertion site, along with donor PCR products 
designed to replace the endogenous PkNBPXa intron with a LoxPint version, were 
transfected into the PkDBPα-mNG/PkNBPXaHA-LoxP background (line 14, from 
Figure 4.3). This line also contains a copy of PkNBPXa that is HA-tagged and flanked 
at its C-terminus by a LoxP sequence (section 4.3.2). Thus, if successful, this 
transfection would generate a floxed, and HA-tagged PkNBPXa line, also expressing a 
PkDBPα-mNG fusion protein. However, a rather frustrating finding was that the 
PkDBPα-mNG/NBPXaHA-LoxP line (line 14) was resistant to pyrimethamine 
treatment, even after being pre-treated with ancotil to remove the Cas9 plasmid from 
the previous transfection. Therefore, unfortunately, no further modifications could be 
made to this line. The reasons for this were puzzling, as no other transfection in this 
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study thus far had yielded irreversibly pyrimethamine resistant parasites. However, 
since the PkNBPXa guide sequence targeting the PkNBPXa C-terminus, was the only 
one to be cloned into the PL11HF Cas9 plasmid (Appendix Figure 4), instead of 
pCas9/sg (Mohring et al., 2019), we reasoned that this might be where the problem lay. 
In the meantime, a second attempt was made to transfect the LoxPint constructs, this 
time into the RecDBPα/DiCre background, without any fluorescent tags (line 7, from 
Figure 4.3). Post transfection, parasites were screened for the presence of integrated or 
wild type parasites using primers depicted in Figure 4.12A and listed in Table 2.5. 
Diagnostic PCRs showed that the endogenous PkNBPXa intron was successfully 
substituted for PkLoxPint1, but not PkLoxPint2 (Figure 4.12C). Therefore, the 
PkNBPXa_LoxPint1 line (line 15) was cloned out by limiting dilution and used as the 
background line for iterative modifications. These included the addition of an mNG 
tag to PkAMA-1, PkRON2, and PkDBPα, generating lines NBPXaLP1/DBPα-mNG 
(line 18), NBPXaLP1/AMA-1mNG (line 19) and NBPXaLP1/RON2mNG (line 20), as 
already described in section 4.3.1 (also see figure 4.3). Finally, the PkDBPα-mNG, 
PkAMA1-mNG, and non-fluorescent PkLoxPint1 variants were modified to introduce 
both a HA tag and a LoxP site to the C-terminus of PkNBPXa (Fig 4.7A, step 2), using 
the same pL11_NBPXaCterm guide and accompanying donor DNA plasmids, as in 
section 4.3.2. This resulted in three PkNBPXa cKO variants: NBPXa_cKO/PkDBPα-
mNG, NBPXa_cKO/AMA1-mNG, and NBPXa_cKO_A lines (lines 21, 22, and 17, 
respectively from Figure 4.3). Integrated parasites were detected by PCR (Figure 
4.12C) using primers depicted in Figure 4.12A and listed in Table 2.5. Furthermore, 
HA-tagged PkNBPXa was also detected by western blot (Fig 4.12D), and IFA (Figure 
4.12E) for the PkNBPXa_cKO_A line, which was subsequently cloned by limiting 
dilution. Notably, though, all three of these cKO lines were also permanently resistant 
to pyrimethamine treatment, just as line 14, strongly indicating a specific issue relating 
to the guide plasmid used. 
Therefore, one last PkNBPXa cKO line was produced, by introducing the same donor 
DNA plasmid as above into the LoxPint1 background (line 13, Figure 4.3), but using 
the newly cloned pCas9/PkNBPXa_Cterm_sg plasmid, instead of the PL11HF Cas9 
plasmid to target the PkNBPXa C-terminus. This time the resulting line, PkNBPXa 
cKO_B (line 16, Figure 4.3), responded to ancotil treatment after transfection, yielding 




4.5.3 Efficient conditional deletion of PkNBPXa 
To investigate whether treating the PkNBPXa_cKO_A line with rapamycin results in 
efficient excision of the floxed gene, tightly synchronized ring-stage parasites (0-3 
hours), were treated with 10nM rapamycin or its carrier, DMSO (0.005%) for 3 hours. 
Samples were taken at the end of the first cycle, when parasites were roughly 27-28 
hours old, for PCR, western blot, and IFA analysis. Deletion of the 8.4kbp fragment 
between both LoxP sites should not only remove all of PkNBPXa, apart from its signal 
peptide, but also the C-terminal HA tag (Fig 4.13A).  
PCR analysis, using primers depicted in Figure 4.13A, showed excision of the 8.4kbp 
PkNBPXa fragment for rapamycin-treated parasites (Fig 4.13B). Interestingly, a much 
fainter band of the same size (606bp) was also detected for the DMSO control. 
Therefore, some leaky excision appeared to occur even without rapamycin induction. 
As expected, no excision band was detected for the parental line control. Additionally, 
primers specific for the wild type sequence amplified a 404bp product specific to un-
excised parasites (Fig 4.13B). Strong WT bands were detected for the parental line, 
and DMSO treated KO line, while a much fainter band was detected for the rap treated 
KO line.  
Figure 4.12. Generation and genotyping PkNBPXa cKO lines. (A) Schematic depicting the 
two-step modification process, to insert a LoxP site into 1) the endogenous PkNBPXa intron, 
towards the N-terminus of the gene, and 2) immediately after the stop codon. Positions of 
primers used to screen for WT and integrated parasites for step 1 indicated with red arrows, and for 
step 2 with green arrows. (B) Positions of guides (indicated in green) used to target cut sites 
(indicated in purple) within the PkNBPXa intron. Yellow highlighted sequences indicate potential 
branch points within the PkNBPXa intron, found when searching for the P. falciparum branch 
point consensus sequence (YWHWW), from Zhang et al., 2011. (C) (Top, step 1) Diagnostic PCRs 
showing integration of the PkLoxPint1, but not the PkLoxPint2 construct, into the PkNBPXa 
locus. (Bottom, step 2) Diagnostic PCRs showing integration of the c-terminal LoxP site + HA 
tag into the PkNBPXa locus, into various PkLoxPint1 backgrounds +/- fluorescently labelled 
parasites. All diagnostic primers can be found in Table 2.5. Expected band sizes = PkLoxPint1 
WT: 1228bp, Int: 1250bp; PkLoxPint2 WT: 1261bp, Int: 1284bp; CtermLoxP WT: 1004bp, Int: 
997bp. For all PCR sets, WT = wild type control gDNA; B = bulk, un-cloned transgenic gDNA; C = 
clonal line gDNA. (D) Western blot showing anti-HA tagged PkNBPXa in the NBPXa_cKO_A 
line, but not the WT control. HA tagged protein detected using an anti-HA antibody (3F10, Sigma). 
Expected size of full length PkNBPXa = 325 kDa. (E) Detection of HA tagged PkNBPXa and 
PkMSP1 in the NBPXa_cKO_A line, by probing late stage schizonts with anti-HA (3F10, Sigma) and 




Furthermore, full-length HA-tagged PkNBPXa (around 325 kDa) could be detected by 
western blot for DMSO treated samples, but 3-hour incubation with 10nM rapamycin 
resulted in no detectable protein expression (Fig 4.13C), consistent with results for 
similar treatment regimes for P. falciparum (Knuepfer et al., 2017). Analysis of the 
same samples by IFA revealed that HA-tagged parasites were detectable for mock-
treated parasites, but very infrequently for rap treated parasites (Fig 4.13D), allowing 
calculation of an overall excision rate of 93.4% (± 1% calculated from 4 individual 
experiments). One concern at the beginning of the study was that the horse serum P. 
knowlesi parasites are grown in could shift the working concentration of rapamycin, as 
has been the case for various other drugs (Lyth et al., 2018; van Schalkwyk et al., 
2017). To address this potential problem, parasites were treated with increasing 
concentrations of rapamycin (up to 200 nM), and for an entire cycle, as opposed to 3 
hours. However, neither increasing the concentration of rapamycin beyond 10nM nor 
leaving the drug in culture for the full cycle length, increased excision efficiency, 
indicating that the horse serum did not increase the concentration required.  
Furthermore, in agreement with the above PCR results, around 5% of DMSO treated 
parasites showed no HA staining in mature, segmented schizonts (circled in Figure 
4.13D). This is in contrast to non-floxed tagged lines, which show PkNBPXa staining 
for every segmented parasite. While this result does not present a problem to this 
Figure 4.13. Efficient rapamycin induced excision of floxed PkNBPXa. (A) A schematic 
depicting excision of an 8.5kbp fragment of PkNBPXa upon rapamycin treatment of the 
PkNBPXa cKO parasites. After treatment, only a short sequence, encoding a signal peptide remains. 
Positions of primers used to screen for wild type, un-excised parasites depicted with green arrows. 
Positions of primers used to screen for excised parasites depicted with red arrows. (B) Diagnostic 
PCRs showing excision of rap treated (Floxed +) PkNBPXa cKO parasites, using primers CH203/
CH206, positioned outside of LoxP sites (expected band size = 606bp). A faint excision band is also 
detected in the DMSO control (Floxed -). Primers MH1543, located 156bp upstream of the 
PkNBPXa stop codon, and CH206, within the PkNBPXa 3’UTR amplify an 340bp band in the 
WT control (lacking a HA tag and LoxP sequence), and a slightly larger 404bp band from un-
excised, floxed parasites in both DMSO and rapamycin treated samples. (C) Western blot 
showing loss of ~325 kDa HA tagged PkNBPXa, from rapamycin treated (floxed +) PkNBPXa 
cKO parasites.  HA-tagged PkNBPXa detected using rat anti-HA antibody (3F10, Sigma). Anti-
PkDBPα antibody (Muh et al., 2018) used as a loading control (expected processed product size = 
~60kDa) (D) IFAs showing that expression of HA-tagged PkNBPXa is ablated when the 
PkNBPXa cKO line is treated with rapamycin. A white circle indicates a PkNBPXa null parasite 
in the DMSO control, resulting from un-induced, leaky excision. Parasites labelled with a rat anti-
HA antibody (3F10, Sigma) and rabbit anti-MSP119 antibody (Ellen knuepfer, Crick) to detect 
HA tagged PkNBPXa (un-excised) and mature, segmented schizonts.  Scale bars = 5µm.
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study, it is worth noting that leaky DiCre mediated excision may be a problem when 
attempting to interpret non-lethal conditional modifications. Deletion of PkNBPXa 
results in parasite death (Moon et al., 2016); however, deletion of a non-essential gene 
may eventually result in a mixed population of excised and non-excised parasites. 
Therefore a modified strategy would be needed when considering non-essential genes. 
4.6 Investigating the role of PkNBPXa 
4.6.1 PkNBPXa null parasites exhibit a severe growth defect in human but not 
macaque erythrocytes 
Previous work has shown that disrupting PkNBPXa severely inhibits P. knowlesi 
replication in human erythrocytes, but does not impede growth in macaque 
erythrocytes (Moon et al., 2016). To investigate whether PkNBPXa cKO parasites 
exhibit this phenotype, DMSO and rapamycin-treated parasites were grown in both 
human and macaque erythrocytes, for a single cycle. This assay, performed with two 
biological replicates, clearly showed that rapamycin-treated PkNBPXa cKO parasites 
retain their ability to replicate in macaque erythrocytes, but exhibit very poor growth in 
human erythrocytes (Fig 4.14A).  
It is worth noting, that for these experiments, the non-clonal PkNBPXa cKO/A line 
was used, as a clonal line had not yet been obtained prior to macaque erythrocytes 
becoming available (a very rare occurrence throughout this study!). Thus, it is probable 
that at least a small proportion of rapamycin-treated parasites, which successfully 
managed to invade human erythrocytes, did so because they were wild type parasites. 
Ideally, I will need to wait for more macaque erythrocytes to become available, and 
repeat this experiment in triplicate with the clonal line, for robust statistical analysis. 
Additionally, because PkNBPXa expression is not ablated for roughly 7% of floxed 
parasites, some residual invasions into human erythrocytes were to be expected. 
However, a third potential source of residual invasions was the possibility that some 
PkNBPXa null parasites really do manage to invade human erythrocytes, despite not 
expressing this ligand.  
To investigate this third possibility, growth assays (three biological replicates) were 
performed over two cycles using the clonal PkNBPXa cKO/A line. While mock-
treated parasites grew 3-4 fold over cycle 1 (Figure 4.14B), excised parasites did not 
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Figure	 4.14.	 PkNBPXa	 is	 required	 for	 invasion	 of	 human,	 but	 not	 macaque	
erythrocytes.	 (A)	 Growth	 of	 the	 parental	 (PkLoxPint1)	 and	 non-clonal	 NBPXa_cKO/A	
lines	measured	24	hours	after	treatment	with	either	rapamycin	or	DMSO.	Data	shown	are	
the	 mean	 of	 two	 independent	 experiments	 ±	 1	 SD.	 (B)	 Growth	 of	 the	 parental	
(PkLoxPint1)	 and	 clonal	 NBPXa_cKO/A	 lines	 measured	 at	 24	 and	 48	 hours	 after	
treatment	 with	 either	 rapamycin	 or	 DMSO.	 Data	 shown	 are	 the	 mean	 of	 three	
independent	 experiments	 ±	 1	 SD.	 (C)	 Diagnostic	 PCRs	 screening	 for	 excised	 and	 non-
excised	parasites	 using	 gDNA	 taken	 from	NBPXa	cKO/A	 parasites	 continuously	 treated	
with	rapamcyin	(n+)	or	DMSO	(n-).	Also	included	is	a	positive	control	for	excision	–	gDNA	




exhibit multiplicative growth, and the parasitaemia decreased again over the following 
cycle. Still, a few rapamycin-treated parasites managed to re-invade over both cycles, 
forming rings discernable by Giemsa smear. These parasites were maintained in 
culture and grown continuously in the presence of rapamycin for 4-5 weeks, until they 
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eventually expanded, reaching a parasitaemia above 1%. Subsequent PCR analysis 
showed only the presence of wild type, un-excised parasites in the rapamycin-treated 
sample (Fig 4.14C). No band was detected using primers specific for excision, which 
is seen even for control floxed parasites maintained in DMSO (Fig 4.14C). These 
results confirmed that a small subset of parasites is resistant to rapamycin treatment 
and is eventually able to expand in culture if grown continuously. However, as no 
excised parasites were detected, this suggests that even if some PkNBPXa null 
parasites do manage to invade human erythrocytes, they suffer the same level of 
growth attrition in subsequent cycles, similar to that observed previously (Moon et al., 
2016). Thus it is likely that PkNBPXa null parasites, which do manage to invade, do 
so by chance rather than because they possess any specific attributes, which would 
enable them to expand in culture. 
4.6.2 Video microscopy shows that PkNBPXa null parasites are motile, but fail to 
deform host erythrocytes 
A previous study using an immunofluorescence assay (IFA) to differentiate between 
newly formed rings and extracellular merozoites, showed that PkNBPXa KO parasites 
stick to the outer surface of human erythrocytes, rather than invading them (Moon et 
al., 2016). However, the precise reasons why PkNBPXa null parasites cannot invade 
human erythrocytes have never been explored. Therefore, a thorough analysis of how 
PkNBPXa KO parasites interact with human erythrocytes was undertaken using live 
microscopy.  
An immediately noticeable feature of PkNBPXa KO merozoites is that they are still 
motile (Video 4.10). The median percentage of gliding merozoites/schizont was 85% 
for both mock-treated and rap treated parasites (Figure 4.15A; n = 17 schizonts for 
DMSO, and 15 schizonts for rapamycin-treated samples), demonstrating that 
PkNBPXa KO parasites are perfectly capable of attaching to erythrocytes and forming 
the initial parasite-host cell interactions required for motility (p= 0.5281, determined 
by performing a Mann-Whitney u-test). 
However, while observing PkNBPXa KO parasites gliding across erythrocyte surfaces, 
it quickly became evident that they were unable to progress into, or beyond, the next 
step of erythrocyte invasion: host cell deformation. A hallmark of invasive merozoites, 
as discussed in chapter 3, is their ability to deform host erythrocytes strongly. Indeed, 
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Figure 4.15. PkNBPXa null parasites are motile, but cannot deform host erythrocytes. 
(A) There is no significant difference between the median percentage of gliding merozoites/
schizont of DMSO (85%) and rapamycin (85%) treated
NBPXa_cKO/A parasites, as determined by a Mann-Whitney u-test (p=0.53; n = 17 DMSO
treated schizonts, and 15 Rap treated). (B) The proportion of merozoite-RBC contacts leading
to erythrocyte deformation (scores 1-3) is significantly less for rapamycin vs DMSO treated
NBPXa_cKO/A parasites (measured by chi-squared test; p= 0.0005; n= 483 interactions for
DMSO control, and 466 interactions for rap treated parasites). (C) The median length of time
Rapamcyin treated NBPXa_cKO/A parasites spend gliding on erythrocytes is slightly, but
significantly longer than the length of time DMSO control parasites spend gliding on
erythrocyte surfaces (8 sec vs 6 sec), when compared using a Mann-Whitney u-test.
(****p<0.0005; n = 122 gliding interactions for DMSO, and 99 interactions for rap treated
parasites). For both graphs, thick red bars indicate the medians and thinner red bars indicate
interquartile ranges.
high scoring score 2 and 3 interactions, characterized by pinching, or wrapping of the 
host cell membrane (Video 4.11) down the length of the merozoite, made up 17.6% of 
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all interactions between DMSO treated parasites and erythrocytes (n= 85/483 
interactions). However, a breakdown of the interactions between rapamycin treated 
parasites and erythrocytes (n = 466 interactions), revealed that KO parasites initiated 
very few score 2 deformation events (<2% of all interactions) and no score 3 events at 
all (Fig 4.15B). Furthermore, the proportion of lower scoring, scale 1 interactions, 
which include very minor indentations, caused by collisions between merozoites and 
RBCs, was significantly, although not as drastically, reduced (14.6% vs 22.2% in 
comparison to the DMSO control; p= 0.0126, measured by a chi-squared test). Thus 
overall, PkNBPXa appears to be critical for strong host cell deformation, particularly 
score 2 and 3 interactions.  
Importantly, the overall lack of deformation correlated with a considerably lower 
invasion efficiency for rapamycin treated parasites, in comparison to the DMSO 
control. While 58 DMSO treated merozoites invaded host erythrocytes (from 20 
schizonts), only two clear invasions (from 2/20 schizonts) were observed for 
rapamycin treated parasites. Both of these invasions were preceded by score 2 
deformations, and since the excision efficiency of the PkNBPXa cKO/A line ranges 
from 92-94%, it is reasonable to conclude that these two invasions (and scale 2 
interactions) could be explained by non-excised parasites. However, a loss/gain of a 
fluorescent marker upon excision would be necessary to absolutely confirm this. 
Interestingly, no score 1 interactions lead to rap treated parasites invading 
erythrocytes. Under the imaging conditions used for this study, an invasion preceded 
by a score 1 interaction is a rare event and accounted for only 1/58 DMSO invasions. 
However, given that Rap treated parasites are still capable of performing scale 1 
interactions, albeit fewer of them, an invasion or two, mediated by scale 1 interactions 
might have been expected to be observed, and could have offered an explanation 
towards why some PkNBPXa null parasites may still invade. One possibility is that 
strong deformation, mediated by PkNBPXa, is not essential for invasion, per se, but 
rather it just significantly increases the chances of an invasion occurring. Thus 
PkNBPXa null parasites might still be able to invade, albeit rarely, by chance, if 
PkNBPXa mediates only deformation and not an additional, essential role also. 
However, analysis of a much larger sample size, with fluorescently labelled parasites 
to confirm the KO status of individual merozoites, will clearly be required to address 
this outstanding question. 
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A final question was whether PkNBPXa KO parasites might spend a more extended 
period of time gliding on erythrocyte surfaces while attempting to establish the 
interactions required for deformation. Interestingly, overall KO parasites spent a 
median length of 8 seconds actively circling erythrocyte surfaces (n= 99 interactions), 
which is significantly longer than what was observed for DMSO treated parasites 
(median length of 6 seconds, n= 123 interactions; p=0.0001, determined by a Mann-
Whitney u-test; Figure 4.15C). However, it is important to note that strong 
deformations tend to obscure the view of parasite motility, and the squeezing of the 
erythrocyte membrane around the merozoite may even immobilize it, holding it in 
place, in preparation for apical attachment and the calcium flux between zoite and host 
cell. Thus it may be that PkNBPXa null parasites simply glide on erythrocyte surfaces 
for a longer duration because forward motility is not impeded by strong deformations.  
4.7 Investigating the role of PkDBPα 
4.7.1 Towards generating a PkDBPα cKO line
PkDBPα is a considerably smaller (3.8kbp) gene than PkNBPXa, and therefore it is 
possible to replace the entire endogenous gene with a synthetic copy in a single 
transfection step, a strategy used to generate the RecDBPα line (Mohring et al., 2019). 
Therefore, in order to produce a floxed PkDBPα line, the donor DNA plasmid 
containing the entire RecDBPα sequence (pDonor_DBPα, from Mohring et al., 2019) 
was modified to introduce LoxP sites into the synthetic gene. This was achieved by 
inserting the PkLoxPint1 module after the RecDBPα signal peptide and inserting a 
HA/stop codon/LoxP sequence at the C-terminal end of the gene. 
The final product, pDonor_floxedDBPα (Appendix Figure 3), was transfected into the 
WT DiCre line (line 3, from Figure 4.3), along with pCas9sg_DBPα, which targets a 
cut site in the middle of PkDBPa, specific to this gene (Figure 16A; Mohring et al., 
2019). Modified parasites were subsequently detected by diagnostic PCR (Figure 
4.16B), using primers shown in Figure 4.16A. Unfortunately, it appeared that a 
substantial proportion of wild type parasites remained after drug selection, based on 
the fact that limiting dilution produced only wild type clones. Dr Franziska Mohring 
(Moon lab, LSHTM) kindly performed a second transfection and cloned the resulting 
line as soon as parasites recovered from drug selection. At the same time, due to 
evidence that the RecDBPα DiCre line exhibits some leaky excision activity, even 
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without rapamycin induction (see section 4.5.3), this transfection was repeated, but 
into a second WT DiCre line, generated from a separate study (Knuepfer et al., 2019) 
and kindly provided by Dr Ellen Knuepfer (Francis Crick Institute). In this line, the 
DiCre cassette is under the control of a different promoter (PkHSP86) and has been 
integrated into an alternative locus (Pk47), and thus, in theory, might exhibit different 
properties. After transfection, transgenic parasites were detected via diagnostic PCR, 
and a single clone, EK_DBPα cKO, was isolated by limiting dilution (Fig 4.16C).  
Figure 4.16. Generation and genotyping of an inducible PkDBPa KO line. (A) 
Schematic depicting the replacement of WT PkDBPa, with a recodonised, floxed copy. Green 
arrows depict primers used to screen lines for WT (positions 1 and 2) and transgenic 
(positions 3 and 2) parasites. (B) Diagnostic PCRs showing integration of the floxed RecDBPα 
construct into the WT PkDBPα locus, in the Moon lab (ML) DiCre background. Integration 
events detected with primers in positions 2 and 3 (Primers MH1041/CH193 from table 2.5) from 
schematic above. Expected band size = 824bp. Wild type parasites detected using primers 
in positions 1 and 2 from above schematic (Primers MH1041/MH562 from Table 2.5). 
Expected band size = 849bp. WT = wild type control parasites; B = bulk, uncloned 
transfection. (C) Diagnostic PCRs showing integration of the floxed RecDBPα construct 
into the WT PkDBPα locus, in Ellen Knuepfer’s (EK) DiCre background. The same primers 
used in (B) detected wild type parasites in the wild type control (WT), bulk culture (B), 
and clones 1 and 2 (Cl1 & Cl2). Integrated parasites were detected for clone 3 (cl3) only.  
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4.7.2 Inefficient excision of PkDBPα 
In contrast to the promising results seen with the PkNBPXa cKO line, treatment of the 
EK_DBPα cKO and ML_DBPα cKO clones did not yield high proportions of PkDBPα 
null parasites. Two independent experiments showed no loss of HA-tagged PkDBPα 
whatsoever for the ML_DBPa cKO line, upon rapamycin treatment. This line has since 
been sent off for sequencing, and we are awaiting results to see whether any mutations 
to either the integrated DiCre cassette or the floxed DBPα might be present, which 
could be preventing excision from taking place. A better outcome was observed for the 
EK_DBPα cKO clone. However, two independent experiments showed that only 
~30% of parasites lacked HA-tagged PkDBPα indicating low levels of excision (Fig 
4.17A &B). Going forward, one way to obtain PkDBPα null parasites could be to 
clone the rapamycin-treated EK_DBPα cKO line by limiting dilution in macaque 
Figure 4.17. Inefficient excision of HA tagged PkDBPα. (A) A schematic depicting excision of 
an 8.5kbp fragment of PkDBPα upon rapamycin treatment of the EK_DBPα_cKO clonal line, also 
leading to a loss of the HA tag. (B) IFA showing ablation of PkDBPa-HA expression for only 
some (~30%), but not all rapamycin treated EK_DBPα_cKO parasites. Fixed parasites probed 
with anti-HA (3F10, Sigma), and anti-PkMSP119 (Ellen Knuepfer, Francis Crick Institute) 
antibodies. Scale bars = 2µm.
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erythrocytes. Although not ideal, this could at least allow us to isolate a PkDBPα null 
clone, which could then be transferred into human erythrocytes for phenotyping, as has 
been done for the conventional PkDBPα KO line (Singh et al., 2005).  
4.7.3 P. knowlesi merozoites are capable of strongly deforming host cells without 
DBPα-DARC interactions. 
As an alternative to using a cKO approach, I instead opted to target the PkDBPα 
erythrocyte receptor, DARC (Miller et al., 1975) using an antibody, which binds to its 
Fy6 epitope. Several studies have shown that targeting this epitope inhibits both 
PkDBPα and PvDBP from binding to DARC, and thus prevents merozoites from 
invading host erythrocytes ( Smolarek et al., 2010; Russell et al., 2011; Muh et al., 
2018; Rawlinson et al., 2019). 
Live microscopy showed that treating parasites with 5µg/ml human anti-DARC (2C3 
clone, Absolute Antibody) completely inhibited invasion (n= 0 invasions, from 20 
egresses). In contrast, control parasites incubated with 5µg/ml anti-human IgG, 
exhibited normal levels of invasion, with an average of 2.8 invasions/egress observed 
(n= 56 invasions from 20 egresses; See video 4.12). Despite the block to invasion, it 
was immediately apparent that anti-DARC inhibited merozoites were entirely capable 
of gliding across and strongly deforming host cells (Video 4.13). This was not 
surprising, as P. knowlesi merozoites have been reported to be able to deform Duffy 
negative RBCs, despite not being able to invade them (Miller et al., 1975). Still, the 
extent to which they can deform Duffy negative host cells compared to Duffy positive 
cells has never been established. If PkDBPα does contribute to deformation, possible 
outcomes could be that blocking PkDBPα-DARC interactions causes the overall 
proportion of stronger deformations to decrease, or that merozoites might deform 
erythrocytes for shorter durations, even if deformation is not entirely ablated. 
Therefore, a thorough analysis of all merozoite-RBC interactions was undertaken in 
order to investigate if blocking PkDBPα-DARC interactions reduces the strength or the 
duration of erythrocyte deformation. 
Figure 4.18A depicts the relative proportions of scored (0-3) deformation events for 
both anti-DARC treated (n = 396 interactions from 73 merozoites) and control 
parasites (n= 370 interactions from 89 merozoites) and shows that overall, there are no 
significant differences between the two groups (measured by a chi-squared test; p= 
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0.1882). Next, when considering the duration of deformation interactions, no 
significant difference was found between the lengths of score 2 interactions of anti-
DARC (median = 6 s; n = 55 interactions) vs. control parasites (median = 9 s; n = 36 
interactions). Furthermore, the duration of scale 3 deformations made by anti-DARC 
treated parasites was significantly longer (median = 18.5 s; n = 16 interactions) than 
those performed by control parasites (median = 12 s; n = 17 interactions) (Figure 
4.18B). Thus, overall, deformation is not inhibited at all when the PkDBPα-DARC 
interaction pathway is blocked, and merozoites spend even longer performing the 
strongest interactions when downstream steps are inhibited. Therefore, PkDBPα does 
not appear to be required for deformation, in contrast to what is proposed for the P. 
falciparum DBP homologs (Weiss et al., 2015). 
For control parasites, there was a very close association between score 3 deformation 
events and invasions, with 15/17 score 3 interactions leading directly to invasion. As a 
result, only one control merozoite performed more than a single score 3 deformation 
event.  However, a surprising finding was that despite being unable to invade anti-
DARC treated erythrocytes, merozoites did not perform many more score 3 
interactions overall (0.25 vs. 0.20 score 3 events/merozoite, for anti-DARC vs. 
control), even though they performed almost double the number of score 2 interactions 
per merozoite compared to control parasites (0.78 vs. 0.46 score 2 
interactions/merozoite for anti-DARC vs. control). Only 4/14 scale 3 events lead on to 
an additional score 3 interaction (for a total of 18 score 3 events) suggesting that 
parasites are limited in their ability to make multiple strong interaction events.  
So, why was this the case? One possible reason could be that anti-DARC treated 
parasites spent a longer time performing score 3 (median = 18.5 sec; n = 16) vs. score 
2 interactions (median = 6 sec; n = 55 interactions; Figure 4.18C). This was in contrast 
to control parasites, for which there was no significant difference between the lengths 
of score 2 and 3 interactions (Figure 4.18D). Whilst score 3 interactions quickly 
culminated in invasion of untreated erythrocytes, anti-DARC inhibited parasites 
continued deformation far longer, thus potentially expending greater resources 
associated with this intense activity - for example, secretion of PkNBPXa. Therefore, it 
could be that after longer score 3 interactions are completed; the merozoite has 
potentially run out of PkNBPXa. Thus, whilst score 3 interactions are not a 
commitment step per se, they may require more resource investment than lower  
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Figure 4.18. Anti-DARC blocked merozoites are capable of strongly deforming host 
erythrocytes. (A) There is no significant difference between the proportions of interactions 
leading to strong host cell deformation for control vs. anti-DARC treated parasites, measured by a 
Chi-squared test (p=0.19). For control parasites n = 264 score 0, 48 score 1, 40 score 2, and 18 
score 3 interactions (from 89 merozoites, from 20 different schizonts); for anti-DARC treated 
parasites, n= 287 score 0, 35 score 1, 56 score 2, and 18 score 3 interactions (from 73 merozoites, 
from 20 different schizonts). (B) Score 3 deformation interactions persist for a longer duration for 
DARC treated (n= 16 interactions; median length = 18.5 sec) vs. control parasites (n = 17 
interactions; median length = 12 sec). ** Indicates p = 0.003, as determined using a Mann-
Whitney U-test. There is no significant difference (ns) between the median lengths of scale 2 
interactions of control (median length = 9 sec; n = 36 interactions) vs. anti-DARC treated parasites 
(median length = 6 seconds; n= 55 interactions), as determined by a Mann-Whitney U-test (p= 
0.12). (C) The median lengths of score 2 (6 sec) vs. score 3 (18.5 sec) merozoite-RBC 
interactions are significantly different for anti-DARC treated parasites, as determined by a 
Mann-Whitney u-test (****denotes p<0.0001; n= 55 score 2 interactions, and 18 score 3). 
However, there is no significant difference (ns) between the median lengths of score 2 (median = 
9 sec; n = 36 interactions) vs. score 3 (median = 12 sec; n = 17 interactions) interactions 
for control parasites, as determined by a Mann-Whitney U-test (p = 0.09). For both graphs, 
thick red bars indicate medians and thinner red bars indicate interquartile ranges. 
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intensity deformations.  Going forward, this theory could be tested by analysing 
interaction lengths of anti-DARC treated PkNBPXa-mNG parasites. Alternatively, 
another explanation could simply be that only a certain proportion of erythrocytes are 
amenable to the strongest deformation in the first instance. Thus, regardless of whether 
PkDBPα-DARC interactions are blocked or not, the number of scale 3 interactions 
overall would be relatively stable between control and anti-DARC treated groups. 
4.7.4 P. knowlesi merozoites cannot re-orientate on the erythrocyte surface 
without PkDBPα-DARC interactions 
Importantly, despite being able to deform host erythrocytes, not one anti-DARC 
blocked-merozoite (n= 73 merozoites and 396 merozoite-RBC interactions) initiated 
re-orientation (Figure 4.19). While control parasites clearly paused towards the end of 
deformation in preparation for re-orientation and invasion (n = 42 merozoites and 
42/372 merozoite-RBC interactions), anti-DARC treated merozoites continued to glide 
throughout deformation (e.g. 45-65 s in video 13). Eventually, they either transitioned 
to gliding along another surface, or they ceased gliding altogether, switched to 
Brownian motion, and floated away from the erythrocyte. Thus it appears that 
PkDBPα plays a key role directly before re-orientation, likely during the period 
between the very end of deformation and the commencement of apical pivoting. 
However, further experiments are needed to narrow this window down even more and 
to determine, for instance, whether anti-DARC blocked merozoites can establish a 
calcium flux between parasite and host cell, or not.  
Figure 4.19. Blocking PkDBPα-
DARC interactions prevents 
merozoites from re-orientating. 
Analysis of 372 (clear) merozoite-
RBC interactions made by control 
parasites (n= 89 merozoites) shows 
that 11.3% (42/372 interactions) 
lead to re-orientation and invasion. 
In contrast, none of the 396 
merozoite-RBC interactions 
performed by anti-DARC treated 
parasites (n= 73 merozoites) lead 
to re-orientation, or invasion. A 
Chi-squared test shows that these 




4.8 Summary and discussion 
The combination of P. knowlesi’s genetic amenability, the development of new genetic 
tools, and the large size of P. knowlesi merozoites have enabled us to use live 
microscopy to gain insight into molecular processes underlying invasion. We have 
demonstrated for the first time that although the P. knowlesi RBL and DBP ligands 
may be secreted simultaneously, once secreted, and during invasion itself, 
fluorescently labelled PkNBPXa and PkDBPα display different distribution patterns 
across the merozoite. While secreted PkNBPXa takes on a cytosolic appearance, 
PkDBPα forms an asymmetric surface pattern on free merozoites and a ring-like 
structure, trailing PkAMA-1 and the moving junction during host cell entry. We have 
also captured the formation and progression of the moving junction by live 
microscopy, for the first time using Plasmodium parasites, using parasites expressing 
fluorescently labelled PkAMA-1. Excitingly, these videos also demonstrated that the 
merozoite exhibits helical rotation to drive itself into the host cell, just as it does to 
transport itself across extracellular surfaces.  
Additionally, we have now unequivocally shown that loss of PkNBPXa prevents 
merozoites from initiating strong deformation. However, blocking the interactions of 
PkDBPα with its host cell receptor DARC, does not hinder deformation but prevents 
merozoites from re-orientating on the surface of erythrocytes. Thus both the 
fluorescence and conditional KO data point to PkNBPXa and PkDBPα performing 
distinct roles, with PkDBPα functioning downstream of PkNBPXa. Still, many 
questions remain. How might PkNBPXa mediate deformation? What is the precise role 
of PkDBPα? Could PkNBPXa and PkDBPα perform any additional roles to those 
outlined in this study? Finally, might the remaining RBL/DBPs also contribute to the 
invasion of human erythrocytes? These questions highlight the need to carry this work 
forward so that the mechanisms by which these ligands act can be understood.  
4.8.1 PkNBPXa mediates erythrocyte deformation – but how? 
Video microscopy has shown that PkNBPXa is continuously secreted from the 
micronemes, for several minutes after egress. Intriguingly, once secreted, PkNBPXa 
does not appear to remain at the apical tip, unlike what has been previously reported 
for the P. falciparum RBLs (Taylor et al., 2002; Triglia et al., 2009) or localise to the 
periphery of the merozoite, as is seen to a certain extent for PkAMA-1. Instead, the 
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mNG signal appears to move from an apical to a cytosolic localisation. One possibility 
is that as PkNBPXa is being secreted from the micronemes, its ectodomain is being 
continuously cleaved from its transmembrane domain and that the mNG-tagged 
cytoplasmic tail is being released into the merozoite’s cytosol.  
The P. falciparum RBL and DBP ligands undergo several proteolytic steps both before 
and after egress. For instance, the PfRh1 ectodomain is cleaved by plasmepsin X 
(PMX) and at least one other protease likely just before egress (Favuzza et al., 2020; 
Gunalan et al., 2020). Additional proteolytically cleaved PfRh1 fragments can be 
found in free merozoites and culture supernatants, and the processing steps responsible 
for these fragments may take place during invasion itself. Processed regions of the 
PfRh1 ectodomain have been found to associate with the moving junction, and so 
some cleavage steps may be responsible for exposing new functional domains, and re-
purposing this ligand for functions beyond its initial role in mediating pre-
internalization steps (Triglia et al., 2009; Gunalan et al., 2020). One final processing 
step, though, is thought to occur as merozoite entry into the erythrocyte progresses: 
this is the action of the rhomboid-like protease, ROM4, which cleaves secreted RBL 
and DBP ligands at a site within their transmembrane domains, effectively shedding 
whatever is left of the membrane-bound ectodomain, into the supernatant (Baker et al., 
2006; O’Donnell et al., 2006; Triglia et al., 2009; Favuzza et al., 2020). In the end, 
only short, cytoplasmic stubs are taken into the erythrocyte, and all ectodomain 
remnants are left behind.   
While this final shedding step is theorized to take place during host cell entry, 
PfROM4 cleavage of RBL and DBP invasion ligands is seen regardless of whether 
merozoites are given the opportunity to re-invade, or not (Gunalan et al., 2020; 
Favuzza et al., 2020). We have identified a putative ROM4 cleavage site within the 
PkNBPXa transmembrane domain. Thus, it is entirely possible that PkNBPXa could 
be being cleaved after secretion, but prior to erythrocyte entry, in a PkROM4 
dependent manner. Going forward, it will be important to investigate PkNBPXa 
processing, perhaps by mutagenesis of the putative ROM4 cleavage site, and to 
determine if any components of the PkNBPXa ectodomain remain associated with the 
merozoite surface, contributing to downstream invasion steps. Meyer et al. (2009) 
probed P. knowlesi supernatants with an anti-PkNBPXa antibody, targeting the middle 
of the PkNBPXa ectodomain. Two bands were observed, indicative of at least one 
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additional processing step, to the putative ROM4 cleavage event. Further experiments, 
using the tagged lines produced in this study, in combination with an antibody towards 
the N-terminus of PkNBPXa may reveal more processing events, which could be 
relevant for downstream invasion steps. Ideally, the best way to address this question 
would be to generate a dual fluorescently labelled PkNBPXa line, with one fluorescent 
protein tagging its C-terminus and another, its N-terminus. This would allow the fates 
of both the PkNBPXa N-terminus and C-terminus to be monitored concurrently with 
live microscopy, and allow us to see when processing occurs relative to each step of 
invasion. Our attempts to visualise PkNBPXa secretion using a mCherry tag were not 
successful, since this fluorescent protein (FP) is not particularly bright, and bleaches 
very quickly, relative to mNG. However, an array of brighter, more photostable red 
FPs has been engineered over the last several years (Cranfill et al., 2016). So one of 
these alternatives, such as mScarlet-I, which is reported to be 3-fold brighter than 
mCherry (Bindels et al., 2016), could potentially be used to tag the N-terminus of 
PkNBPXa at the same time its C-terminus is tagged with mNG.  
Intriguingly, merozoites cannot deform host erythrocytes when PkNBPXa is not 
expressed, or when apical PkNBPXa stores are spent. Erythrocyte deformation, 
however, has also been shown to be a motor-dependent process (Weiss et al., 2015), 
and, as chapter 3 demonstrated, relies upon merozoites gliding across erythrocyte 
surfaces. Yet how are PkNBPXa secretion, gliding motility, and erythrocyte 
deformation all linked? PkNBPXa could be coupled to the merozoite’s acto-myosin 
motor, as has been suggested, but not confirmed for the P. falciparum RBL/DBPs 
(Diaz et al., 2016; Pal-Bhowmick et al., 2012). However, another possible scenario is 
that when PkNBPXa is secreted to the merozoite’s apical tip, it binds to its, as of yet, 
unknown host cell receptor, tightly connecting the merozoite’s apex to the host cell. 
Receptor binding may induce structural changes to the host cell cytoskeleton, causing 
it to become more amenable to deformation, as has been observed when EBA-175 
binds to its host cell receptor, glycophorin A (Koch et al., 2017; Sisquella et al., 2017). 
Then, as the merozoite glides forward on the erythrocyte surface, rotating as it does so, 
the tightly bound merozoite may pull the erythrocyte membrane around itself, resulting 
in the host cell “wrapping” around the merozoite. Finally, enzymatic cleavage of 
PkNBPXa, potentially by PkROM4 releasing the PkNBPXa ectodomain from the 
merozoite’s apical tip, could sever merozoite-RBC contacts, allowing it to continue its 
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forward trajectory. Thus, PkNBPXa, and the RBLs in general, may not need to be 
directly connected to the merozoite’s motor in order to mediate deformation, but could 
instead act to increase the “stickiness” or torque of the parasite surface to create torsion 
driven wrapping. 
4.8.2 Towards determining a role for PkDBPα 
Anti-DARC blocked merozoites are very clearly capable of deforming host 
erythrocytes. Although these results have not yet been validated with a conditional 
PkDBPα KO line, they do reflect the description of P. knowlesi merozoites attempting 
to invade Duffy negative erythrocytes (Miller et al., 1975). However, it is worth noting 
that these results only confirm that PkDBPα-DARC interactions are not responsible for 
deformation. Ideally, an investigation of how PkDBPα null parasites interact with 
human erythrocytes will need to be undertaken in order to rule out additional, DARC 
independent roles for PkDBPα during the early steps of invasion. However, analysis of 
the conditional PkDBPα KO line generated in this study showed very inefficient 
PkDBPα excision upon induction with rapamycin. Therefore, going forward, attempts 
will be made to clone out rapamycin-treated parasites using macaque erythrocytes, in 
order to isolate a clonal line of PkDBPα null parasites. Subsequently, these parasites 
could be purified, and added to human erythrocytes, in order to analyse the PkDBPα 
null phenotype and compare what is observed to the anti-DARC data.  
Importantly, inhibiting PkDBPα engagement with DARC did show that without this 
crucial interaction, P. knowlesi merozoites are unable to pivot on their apical ends and 
align themselves into a position ready for host cell entry. This is in contrast to a 
previous study, which used electron microscopy to show a correctly aligned PkDBPα 
KO parasite in contact with a human erythrocyte (Singh et al., 2005).  However, as no 
moving junction was observed between merozoite and host cell, likely, what was 
captured here was simply a merozoite randomly fixed in this orientation, rather than a 
merozoite which had undergone apical pivoting. Therefore, while valuable information 
was gleaned from this study, it does illustrate the importance of using video 
microscopy along-side EM techniques to capture both the dynamics of invasion, in 
addition to the high-resolution details (such as junction formation) provided by EM.   
As chapter 3 illustrated, additional steps lie between the end of deformation and the 
moment the merozoite begins to pivot, including a calcium flux between the 
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merozoite’s apical end and the host cell. Going forward, imaging anti-DARC blocked 
merozoites attempting to invade Fluo-4-AM loaded erythrocytes could demonstrate 
whether PkDBPα engagement with DARC precedes this step. Importantly, if no 
calcium flux is observed in the presence of anti-DARC, then this could indicate that 
PkDBPα may not mediate apical pivoting, but rather a step bridging deformation and 
re-orientation, such as rhoptry neck secretion. This would be in good agreement with 
work by Singh et al. (2010), showing that PfEBA-175 binding to soluble Glycophorin 
A results in free merozoites secreting rhoptry bulb contents. Evidence of rhoptry bulb 
secretion is also very clearly seen when P. falciparum merozoites are incubated with 
the R1 peptide, blocking PfAMA1-RON2 interactions, and when invasion is inhibited 
by cytochalasin D treatment (Riglar et al., 2011; Srinivasan et al., 2011). Thus it is 
plausible that once PfEBA-175, or an alternative appropriate DBP ligand, binds to its 
host cell receptor that rhoptry secretion is triggered, and maintained, regardless of 
whether junction formation is subsequently inhibited or not. An interesting experiment 
going forwards might be to generate a P. knowlesi line expressing a fluorescently 
labelled rhoptry bulb protein, such as PkRAP1, and incubating this line with soluble 
DARC. In theory, if PkDBPα-DARC interactions do activate a signalling cascade that 
leads to rhoptry secretion, then PkRAP1 secretion should not be observed when 
parasites are incubated with anti-DARC antibodies plus erythrocytes but should occur 
when parasites are incubated with the soluble receptor. 
Another important consideration is that if blocking PkDBPα-DARC interactions does 
prevent the calcium flux/rhoptry secretion from occurring, then this phenotype would 
mimic that of disrupting the PfRh5 complex. P. falciparum merozoites can deform 
host cells, but cannot initiate a calcium flux when PfRh5-Basigin interactions are 
inhibited with either anti-PfRh5 or anti-basigin antibodies (Weiss et al., 2015). 
Likewise, conditional deletion of PfCyRPA and PfRipr, two essential P. falciparum 
proteins that exist in a complex with PfRh5, also produces the same results (Chen et 
al., 2011; Reddy et al., 2015; Volz et al., 2015). However, like all non-laveranian 
malaria parasites, P. knowlesi does not have a PfRh5 ortholog. Nevertheless, P. 
knowlesi does possess orthologs to PfCyRPA and PfRipr (Knuepfer et al., 2019). Like 
their P. falciparum counterparts, both PkRipr and PkCyRPA are also essential for P. 
knowlesi proliferation (Knuepfer et al., 2019). In P. knowlesi these two proteins are not 
found in a complex together, but instead, PkRipr forms a complex with two alternative 
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proteins, PkCSS and PkPTRAMP, which are also essential for parasite growth. 
Therefore, the PkRipr complex may be performing a similar role to the PfRh5-
CyRPA-RIPR complex, through PkTRAMP binding to an as of yet unknown receptor 
on the RBC surface (Knuepfer et al., 2019). If the PkRipr complex is functionally 
equivalent to the PfRh5 complex, then PkRipr may be inserted into, and form a pore 
within the erythrocyte membrane, as has been suggested for P. falciparum (Wong et 
al., 2019). If this is the case, it is possible that another outcome of PkDBPα-DARC 
interactions may be to hold the merozoite firmly in place or signal to the merozoite to 
temporarily stop gliding so that PkRipr can be deposited into the erythrocyte 
membrane, and pore formation can ensue. Therefore, going forwards, it will be 
important to explore the phenotype of PkRipr complex mutants using live microscopy 
techniques, to 1) determine whether this complex does act in a functionally equivalent 
manner to the PfRh5 complex, and 2) to ascertain when this complex acts with respect 
to PkDBPα.  
4.8.3 A role for the remaining P. knowlesi RBL and DBP ligands? 
A final consideration that needs to be addressed is whether the remaining P. knowlesi 
DBP and RBL ligands contribute to the invasion of human erythrocytes. Recent work 
has shown that the growth rate of P. knowlesi parasites actually increases, when either 
PkDBPβ, or PkDBPγ is deleted (Mohring et al., 2019). Therefore, it does not seem 
likely that either of these ligands contributes positively in the context of human 
erythrocyte invasion. Rather, they might even hinder invasion efforts, perhaps by 
competing with potential cytosolic PkDBPα interaction partners, especially since the 
cytoplasmic domains of these ligands are remarkably similar.  
A similar effect might be seen for a PkNBPXb KO parasite line, as this ligand has 
been shown to bind to macaque erythrocytes, and ultimately cannot compensate for a 
lack of PkNBPXa when parasites are grown solely in human erythrocytes (Meyer et 
al., 2009; Semenya et al., 2012; Moon et al., 2016). However, it has never been 
definitively proven that PkNBPXb does not contribute in any way to the invasion of 
human erythrocytes. Furthermore, conventional PkNBPXb KO line has recently been 
generated but has proved difficult to clone out (Dr Mohring, personal communication), 
suggesting that PkNBPXb might play a minor role during human erythrocyte invasion.  
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Now that we have developed a PkNBPXa cKO line, it may be possible to test this 
theory, by knocking out PkNBPXb on top of this line. Comparing the growth rate of a 
double KO line with the single PkNBPXa KO line in human erythrocytes may shed 
some light on the issue of whether or not residual invasions are a result of PkNBPXb 
aiding and abetting PkNBPXa null parasites. Alternatively, if a slight redundancy 
between these two ligands does not account for the rare invasion events seen, then it 
may be the invasion step (deformation) rather than the proteins, which is partially 
redundant. Deformation may greatly aid invasion events, with wrapping perhaps 
increasing the speed at which downstream ligand-receptor interactions are formed, and 
even the likelihood of them occurring in the first instance (Weiss et al., 2015). 
However, if the only role of the RBL ligands is to act as enhancers for downstream 
steps, then it is feasible that a small proportion of merozoite-RBC interactions will lead 
to invasion, even in the absence of PkNBPXa and PkNBPXb interactions. 
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Chapter 5 – Discussion and future directions 
5.1 Towards re-assessing the early molecular steps of invasion 
This work has led to the discovery of gliding as a new pre-internalisation step and 
revealed that the order of events leading up to internalisation is gliding and 
deformation, followed by a pause to gliding, putative rhoptry secretion, and finally, re-
orientation (Figure 5.1). With these findings comes the need to re-assess the molecular 
steps facilitating pre-internalisation events. Firstly, which merozoite ligands mediate 
extra-cellular gliding? Plasmodium ookinetes and sporozoites and T. gondii 
tachyzoites secrete members of the thrombospondin-related anonymous protein 
(TRAP) family from their micronemes, which connect the parasite’s motor with the 
substrate it is gliding on (Sultan et al., 1997; Dessens et al., 1999; Frenal et al., 2017). 
Two TRAP family members are expressed during the Plasmodium blood stages, and 
are localized to the apical organelles of merozoites; these are merozoite TRAP 
(MTRAP) and Plasmodium thrombospondin-related apical merozoite protein, or 
PTRAMP (Thompson et al., 2004; Baum et al., 2006). Interestingly, PbMTRAP is 
dispensable for invasion, which suggests that it may not play a key role in gliding 
motility, or that if it is responsible for motility during this stage, that surface gliding 
itself is not an essential pre-internalisation step for P. berghei (Bargieri et al., 2016).  
PTRAMP, on the other hand, is essential for invasion (Zhang et al., 2018; Knuepfer et 
al., 2019) for both P. falciparum and P. knowlesi, and thus is potentially a promising 
candidate.  
However, recent evidence has also shown that PkPTRAMP forms a complex with both 
PkCSS and PkRipr and that this complex might act in a way that is functionally 
equivalent to the PfRh5-CyRPA-Ripr complex (Knuepfer et al., 2019). The PfRh5 
complex is predicted to act just prior to the calcium flux, and interaction of PfRh5 with 
its host cell receptor, Basigin, may result in PfRh5 and PfRipr being inserted into the 
erythrocyte membrane (Crosnier et al., 2011; Volz et al., 2016; Wong et al., 2019). 
Once embedded in the erythrocyte membrane, this ligand could potentially enable the 
formation of a pore between parasite and host cell, although a mechanism for this is 
yet to be elucidated (Weiss et al., 2015; Volz et al., 2016; Wong et al., 2019). Thus, the 
PkPTRAMP-CSS-Ripr complex may be acting to achieve a similar goal. Still, this 
hypothesis has never been investigated using live microscopy. Analysis of conditional 
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PkPTRAMP null parasites will be required to determine if 1) PkPTRAMP is required 
for gliding motility, and if this is not the case, then 2) which invasion steps are 
impeded when this ligand is absent.  
Secondly, which ligand, or combination of ligands, is responsible for re-orientation? 
Furthermore, is re-orientation driven solely by a gradient of apical ligands, increasing 
in concentration towards the merozoite’s apical tip, as proposed by Weiss et al. 
(2015)? We have definitively shown, in line with work carried out by Yahata et al., 
(2012), that deformation does not physically align the merozoite for host cell entry. On 
one level, these findings do support the results presented by Weiss and colleagues. 
Furthermore, although previous mathematical studies theorized that both deformation 
and apical gradients of invasion ligands are required for re-orientation, these models 
Figure 5.1. A comparison of the current P. falciparum model of invasion (top) vs. the new P. 
knowlesi model (bottom). For P. falciparum, deformation and re-orientation are thought to occur 
simultaneously, and be facilitated by both the RBL and DBL ligands. After re-orientation is 
completed, merozoites rest for several seconds, during with the calcium flux occurs. Internalisation 
follows. In contrast, our work shows (bottom) that gliding motility + NBPXa-receptor interactions 
facilitate deformation. PkDBPα acts downstream of this event, possibly mediating the pause between 
apical attachment and re-orientation. Re-orientation begins after the calcium flux and the host cell 
has recovered from deformation. No pause occurs between completion of re-orientation, and the 
beginning of internalisation.   
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were based on the assumption that the apical end of the merozoite is its thin, pointy 
end (Dasgupta et al., 2014; Hillringhaus et al., 2020, 2019). Thus, modifying these 
studies to take into account the merozoite’s apical end being wider than its basal end 
may change the outcome of their findings to side with Weiss et al. (2015). In theory, 
aligning the merozoite’s wider, rounder end with the erythrocyte surface should be an 
easier feat than pivoting it on to its thinner, pointy end.   
However, an additional, important point worth making is that none of the above 
studies made their hypotheses taking into account the fact that merozoites can glide 
across erythrocyte surfaces. Yet, what if gliding mediates not just the steps leading up 
to, and directly after re-orientation, but also this crucial pivoting step itself? Our work 
has shown that directly before re-orientation, merozoites pause forward movement as 
the whole zoite, and in particular, its asymmetrically placed apical end becomes firmly 
attached to the erythrocyte surface. When host RBCs are loaded with the Ca2+ dye 
fluo-4, a calcium signal at the apical tip of the parasite can be seen to follow this pause 
– a sign assumed to be indicative of rhoptry secretion (Weiss et al., 2015). This, along
with the fact that there is no subsequent pause between reorientation and
internalization, would suggest that the moving junction forms before or even during re-
orientation. Given the continuous nature of re-orientation and internalisation, then, is it
possible that they are really one event?
We propose that this may be the case, and outline a potential “catapult model” in 
figure 5.2, which merozoites may use to spring themselves into apical alignment.  How 
might this happen? Firstly, taking into account the fact that gliding events “sandwich” 
re-orientation, we hypothesize that the pause to extra-cellular motility observed 
towards the end of deformation may not really be a pause to motor-power, as such, but 
rather, that the merozoite is simply pinned in place on the erythrocyte surface by 
adhesive ligands. Thus the motor could still be generating force at this point in time, 
even though forward motion is curtailed. Nevertheless, this pause gives the merozoite 
time to fuse its apical end with the erythrocyte surface, and potentially establish the 
moving junction, both events which might ensure that the merozoite’s apical end 
remains firmly attached to the erythrocyte surface. Next, after the calcium flux occurs, 
the merozoite begins to cleave molecular attachments to the host cell along the length 
of the merozoite, whilst maintaining the bonds at its apex (Figure 5.2, insets). As this 
process occurs, tension builds up at the merozoite’s apical end, which is still firmly 
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attached to the host cell, possibly by the nascent tight junction. Eventually, cleavage of 
enough adhesive ligands along the merozoite’s basal end releases it from the 
erythrocyte surface and allows the merozoite to spring forwards, pivoting on its 
anchored apical end – like cutting the rope of a catapult. Concurrently, the now 
unimpeded merozoite can return to performing corkscrew-like rotations. This then 
allows the merozoite to begin driving itself into the host cell, as soon as it has 
orientated itself to an optimal angle to do so. Thus, by this model, a combination of 
ligand binding and then cleavage steps, along with continuous motor activity, drives 
re-orientation and host cell entry.  
However, going forwards, the production and analysis of further P. knowlesi 
conditional KO lines will be required to investigate this theory and the molecular steps 
surrounding re-orientation more fully. To begin, the first logical step would be to 
attempt to generate a P. knowlesi line which could be conditionally induced to delete a 
core component of the parasite’s acto-myosin motor, such as PkACT1 or PkGAP45, as 
has previously been achieved for P. falciparum (Das et al., 2017; Perrin et al., 2018). 
This would be preferable to relying on treating parasites with cytochalasin D, as this 
Figure 5.2. Continuous motor activity may drive re-orientation. Gliding is required for 
deformation (RBCs 1&2). However, forward motion pauses as the merozoite becomes pinned 
to the erythrocyte surface, by both its basal and apical ends, towards the end of deformation 
(RBC 2). While paused, the merozoite’s molecular motor continues to run, building tension at 
the merozoite’s apical end (RBC 3). Cleavage of adhesins between the merozoite’s basal end 
(depicted in yellow, inset, and RBCs 4-5) by proteases, may release the merozoite’s basal end 
from the erythrocyte surface, and allow the zoite to pivot on its apically anchored pivot point 
(green dots). Simultaneous helical rotation drives host cell entry (RBCs 5-8).  
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drug is known to have off-target, invasion inhibitory effects (Das et al., 2017). 
PkGAP45 would likely be the best target for this, as deleting PfGAP45 does not 
appear to impact the morphology of merozoites, unlike deletion of PfACT1, which is 
reported to leave P. falciparum merozoites with a ruffled appearance, and prevent 
them from dispersing properly after egress (Das et al., 2017; Perrin et al., 2018). 
Conditional deletion of PfGAP45, like treating merozoites with cytochalasin D, 
prevents host cell deformation, but not echinocytosis or early junction formation 
(Weiss et al., 2015; Perrin et al., 2018; Yahata and Hart et al., 2020).  However, if 
PkGAP45 null parasites cannot pivot on their apical ends, this would provide strong 
evidence for the merozoite’s molecular motor being required for re-orientation, even if 
it is not required for precursory apical interactions, such as the calcium flux, or moving 
junction assembly.  
Next, which ligand (or ligands) holds the merozoite in place on the erythrocyte surface 
before the release of the merozoite’s basal end? Could this be a role for PkDBPα, 
which once secreted, is conveniently concentrated around the widest part of the 
merozoite as well as its basal end? One possibility is that forward motion is impeded 
when PkDBPα binds to DARC. This in turn could allow the merozoite’s apical end 
time to firmly attach to the erythrocyte surface, possibly by the actions of the 
PkPTRAMP complex. As discussed above, The PkPTRAMP complex is potentially 
functionally equivalent to the PfRh5 complex (Knuepfer et al., 2019) and may 
facilitate a fusion event between the merozoite’s apical tip and the erythrocyte surface 
(Weiss et al., 2015; Volz et al., 2016; Knuepfer et al., 2019). If PkDBPα binding to 
DARC is responsible for pinning the merozoite to the host cell surface, this could 
explain why anti-DARC treated merozoites do not pause extra-cellular motility but 
continue to glide until they leave the erythrocyte surface. Conversely, if PkPTRAMP 
acts downstream of PkDBPα, then PkPTRAMP null parasites might exhibit periods of 
stasis on the erythrocyte surface, even if they are not capable of performing committed 
apical interactions. Thus a careful analysis of the recently published conditional 
PkPTRAMP KO line (Knuepfer et al., 2019) may shed some light on these matters.  
Finally, which ligand-receptor combinations are responsible for committed apical 
attachments, and thus, creating a pivot point for the re-orientating merozoite? We, like 
others, hypothesize that junction formation occurs after the calcium flux (Weiss et al., 
2015; Volz et al., 2016; Introini et al., 2018). However, is junction formation occurring 
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before or after re-orientation, and if it does normally occur before re-orientation, could 
the junction form the basis of the apical pivot point? Interestingly, Treeck et al., (2009) 
reported that blocking the interactions of PfAMA-1 and PfRON2 with the R1 peptide 
does not inhibit re-orientation. However, a closer examination of the video used to 
specifically demonstrate re-orientation, showed an R1 blocked merozoite interacting 
with a host cell via its pointed basal tip, which we now know is not indicative of re-
orientation.  Additional videos from the same study, though, did show R1 blocked 
parasites strongly deforming host cells, for extended periods of time, which lead firstly 
to echinocytosis, and finally to host cell lysis. Merozoites remained stuck to the 
surface of these lysed cells, indicating that even though re-orientation may not have 
occurred, committed apical attachment very likely did (Treeck et al., 2009). Likewise, 
Weiss and colleagues (2015) observed similar results. In theory, though, just as for 
cytochalasin treatment, all of these events could occur without apical pivoting, and if a 
pore were formed between merozoite and host cell, which was never sealed, this would 
explain lysis events. However, analysing conditional PkRON2 or PkAMA-1 null 
parasites should enable us to address this question more definitively, especially since 
re-orientation is a much more obvious event for P. knowlesi compared to P. 
falciparum. Alternatively, if PkAMA-1 or PkRON2 null parasites can pivot on their 
apical ends, this would indicate that junction formation is not required for re-
orientation. Another option is that the actions of the PkPTRAMP complex may 
facilitate this role instead. Thus, the overall order of molecular events leading to 
internalisation could be PkNBPXa causing deformation, PkDBPα pinning the 
merozoite to the erythrocyte surface, and finally, PkTRAMP interactions/junction 
formation providing an apical anchor for re-orientation.  
So overall, while these hypotheses are merely speculative at this point and need to be 
investigated with reverse genetics studies, the results from our work have opened up 
many intriguing possibilities as to how the early steps of invasion might be achieved. 
Going forwards, a thorough, systematic approach will be required to address these 
questions and to gain a more complete understanding of how merozoites commit to 
host cell entry.  
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5.2 A balancing act between the RBL and DBP ligands: when 
plan A doesn’t work 
Our work has shown that deformation is an important step for invading P. knowlesi 
merozoites. Varying degrees of deformation preceded every invasion observed in this 
study, and the strongest deformation interactions correlated with invasion success. We 
also demonstrated that PkNBPXa, but not PkDBPα, is responsible for facilitating this 
step. Yet, what is the precise purpose of deformation, and more specifically, the role of 
PkNBPXa? Before re-orientation, merozoites are immobilized on the erythrocyte 
surface. Therefore, one possibility is that PkNBPXa facilitated deformation forces the 
merozoite and RBC into closer contact and allows downstream molecular interactions, 
such as PkDBPα-DARC connections, to occur. These interactions may in turn pin the 
merozoite in place on the erythrocyte surface. PkNBPXa is a significantly larger ligand 
(~300kDa) than PkDBPα (~135kDa), and therefore likely projects much further from 
the merozoite surface than PkDBPα does (Singh et al., 2005; Meyer et al., 2009). 
Thus, a large ectodomain could make PkNBPXa the ideal facilitator of early 
merozoite-RBC interactions, and host cell wrapping may help embed the merozoite 
into the erythrocyte surface so that PkDBPα can reach DARC receptors.  
Curiously, P. knowlesi merozoites exhibit higher invasion rates in macaque 
erythrocytes when expressing only one DBP ligand, as opposed to all three (Mohring 
et al., 2019). This suggests that it may be the RBL ligands rather than the DBPs, which 
enable P. knowlesi merozoites to invade macaque erythrocytes more efficiently than 
human erythrocytes. This phenomenon could be due to several reasons. Even though 
recombinant PkNBPXb does not bind to human erythrocytes, recombinant PkNBPXa 
and PkNBPXb fragments have both been shown to bind to macaque erythrocytes 
(Meyer et al., 2009; Semenya et al., 2012). Thus P. knowlesi merozoites may use both 
RBL ligands to initiate deformation whilst invading macaque erythrocytes. Practically 
speaking, this could mean that a greater proportion of merozoite-RBC interactions 
result in strong deformation, thus increasing the chances of effective DBP-receptor 
binding and invasion. However, another explanation could be that PkNBPXb binds to 
its host cell receptor more efficiently than PkNBPXa does, or that each macaque 
erythrocyte possesses more copies of the PkNBPXb receptor. Either of these two 
scenarios could also lead to greater levels of host cell wrapping and invasion. Future 
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studies comparing wild type, PkNBPXa KO, and PkNBPXb KO parasites attempting 
to invade macaque erythrocytes will help us to address these questions, and to 
understand whether or not a “better” RBL may speed up the pre-internalisation steps. 
Interestingly, although strong deformation also correlates with invasion success for P. 
falciparum, a sizeable proportion of merozoites from some strains is capable of 
invading host cells with very little, if any deformation at all (Weiss et al., 2015). Could 
this be because certain P. falciparum DBPs bind to their respective host cell receptors 
more efficiently than the P. knowlesi DBPs do? In theory, this would mean that these 
strains are less reliant on their RBL ligands and deformation, overall. The P. 
falciparum RBL and DBP ligands are hypothesized to overlap functionally because 
W2mef parasites up-regulate PfRh4 expression when PfEBA-175 is genetically 
disrupted or when critical sialic acid residues are cleaved from its receptor, 
glycophorin A (GPA), by pre-treating host cells with neuraminidase (Dolan et al., 
1990; Stubbs et al., 2005). Whilst PfRh4 may be functioning equivalently to PfEBA-
175, another explanation could be that since the PfEBA-175-GPA pathway is hindered 
under these conditions, merozoites instead rely on less than optimal DBP-receptor 
interactions for subsequent steps. Thus, in response to this, merozoites up-regulate 
another RBL ligand to increase deformation, giving any remaining DBP-receptor 
interactions a chance to take hold. In support of this theory is evidence from Weiss and 
colleagues (2015) showing that PfEBA-175 null parasites engage with more 
erythrocytes overall before committing to invasion and that a greater proportion of 
these contacts lead to high scoring deformation events. Therefore, the P. falciparum 
DBPs and RBLs may not be functionally equivalent as previously proposed (Weiss et 
al., 2015). Instead, merozoites may attempt to compensate for weakened DBP 
interactions with increased deformation, by up-regulating additional RBL ligands.  
5.3 Using P. knowlesi to investigate non-falciparum vaccine 
candidates 
Excitingly, because P. knowlesi is a much closer relative to all of the other human 
infective species than P. falciparum is, the adaptation of P. knowlesi to growth in 
human erythrocytes has opened up opportunities to study its shared biology with these 
species (Pain et al., 2008; Moon et al., 2013). An example that is relevant to vaccine 
design is P. knowlesi and P. vivax’s shared reliance on the DBP-DARC invasion 
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pathway (Miller et al., 1975; Miller et al., 1976; Haynes et al., 1988; Barnwell et al., 
1989; Wertheimer and Barnwell et al., 1989). PvDBP is currently the lead vaccine 
candidate for P. vivax because antibodies towards this ligand confer protective 
immunity towards previously infected individuals, and Duffy negative individuals 
lacking the PvDBP receptor, DARC, are widely resistant to P. vivax infections in the 
first instance (Miller et al., 1976; King et al., 2008; Cole-Tobian et al., 2009; Nicolete 
et al., 2016).  
However, studies assessing the inhibitory properties of anti-PvDBP antibodies purified 
from animals and human volunteers vaccinated with recombinant PvDBP, have largely 
relied upon in vitro receptor binding assays, without functional growth inhibitory 
assays (GIA) to validate results across different P. vivax strains (Moreno et al., 2008; 
Payne et al., 2017a; Singh et al., 2018). A follow on study from one of the human 
vaccination trials (Payne et al., 2017a), overcame this limitation by generating 
transgenic P. knowlesi parasites expressing different variants of PvDBP in place of 
PkDBPα, which were used as surrogates for corresponding P. vivax strains in GIA 
assays. In this study, Rawlinson et al., (2019) generated a panel of recombinant 
monoclonal anti-PvDBP antibodies from vaccinated human volunteers (Payne et al., 
2017a) and assessed their ability to block recombinant PvDBP-DARC interactions, as 
well as to inhibit transgenic P. knowlesi growth in vitro. Excitingly, both assays 
identified a single monoclonal antibody (DB9) with strain-transcending inhibitory 
properties, which targets a conserved region of PvDBP, surprisingly away from its 
predicted DARC binding site. Additionally, the P. knowlesi GIA results also identified 
two further strain-specific inhibitory antibodies, which were not detected by the 
protein-protein assay. Importantly, these results were validated with P. vivax ex-vivo 
assays, demonstrating the overall reliability of transgenic P. knowlesi GIA assays as 
well as their increased sensitivity compared to relying on recombinant protein assays 
alone (Rawlinson et al., 2019).  
Going forward, this technique could be used to screen much broader panels of variant 
P. knowlesi PvDBP parasites to further validate DB9’s strain transcending potential
and to identify other conserved epitopes, which also induce potent inhibitory immune
responses (Rawlinson et al., 2019). Additionally, testing these same anti-PvDBP
antibody panels across transgenic P. knowlesi lines expressing different PkDBPα
alleles may reveal key target epitopes shared by both PkDBPα and PvDBP variants.
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Therefore, by doing so it may eventually be possible to target PkDBPα and PvDBP 
and thus, both P. knowlesi and P. vivax with a single vaccine. 
Furthermore, the results from our work have demonstrated for the very first time, that 
key P. knowlesi RBL and DBL ligands perform highly important, and sequential roles 
during invasion. Thus targeting both PkDBPα and PkNBPXa together within a single 
vaccine might be even more effective for preventing P. knowlesi infections, than 
targeting PkDBPα/PvDBP alone, as not just one, but two critical invasion steps would 
be inhibited. Thus a vaccine including components of PkDBPα/PvDBP, and PkNBPXa 
might effectively confer protection against two Plasmodium species.  
It is important to note, however, that the amino acid sequence of PkNBPXa is highly 
divergent to the P. vivax RBL ligands. Furthermore, both of the P. vivax orthologs to 
PkNBPXa and PkNBPXb (PvRBP3 and PvRBP2e, respectively) are in fact 
pseudogenes (Meyer et al., 2009; Chan et al., 2019). Therefore, it is less likely that a 
vaccine targeting PkNBPXa would also inhibit the function of the P. vivax RBLs. 
However, now that we have a conditional PkNBPXa KO background line, it may be 
possible to use this line to express the PvRBLs in the place of PkNBPXa. By doing so, 
we could firstly, determine whether any of the PvRBLs can complement the loss of 
PkNBPXa, and allow PkNBPXa null parasites to grow in either normocytes or 
reticulocytes. This in itself would be valuable information and could enable us to 
determine which PvRBPs restrict P. vivax growth to reticulocytes, a question, which 
remains outstanding for all PvRBLs, apart from PvRBP2b, which has recently been 
shown to bind to transferrin receptor 1 on reticulocytes (Gruszczyk et al., 2018; Chan 
et al., 2019). Secondly, though, a similar approach to the one applied by Rawlinson et 
al., (2019) could be used, once a suitable complementary PvRBP has been identified. 
Thus we could begin to identify PvRBP epitopes, which when presented to the 
immune system within a vaccine, might stimulate the production of highly potent, 
invasion-inhibitory antibodies.  
Finally, Knuepfer et al., (2019) recently demonstrated that although the non-
falciparum species do not express a homolog to the leading P. falciparum vaccine 
candidate, PfRh5, all do still likely rely on a divergent PkRIPR-CSS-PTRAMP 
complex to invade host erythrocytes. Antibodies targeting PkRIPR, in particular, 
potently inhibit the growth of PkA1-H.1 parasites in vitro (Knuepfer et al., 2019). 
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Therefore, in the future, P. knowlesi could potentially be used as a surrogate to express 
not just P. vivax RIPR variants, but also variants from the remaining neglected species, 
for further study. Additionally, now that we can generate marker-less transgenic lines 
using CRISPR Cas9 (Mohring et al., 2019), we could potentially express multiple 
target ligands at once from each species. This would enable us to examine whether 
antibodies against two or more targets act synergistically, and help us to decide which 
antigens could be used in multi-subunit vaccines.  
5.4 Conclusions 
In conclusion, our work has elucidated a clear order to the early, morphological steps 
of invasion leading up to parasite entry into the host erythrocyte. In particular, we have 
shown that deformation, facilitated by PkNBPXa, is a distinct step to re-orientation. 
We also highlight the importance of the parasite’s acto-myosin motor, showing that 
extra-cellular motility, although perhaps previously under-appreciated, potentially 
underpins almost every morphological step of invasion. While further work is required 
to identify the precise role of PkDBPα, we now know that this ligand likely functions 
downstream of PkNBPXa, confirming our hypothesis that the PkRBL and PkDBP 
ligands perform separate roles during invasion. This finding has important 
implications, especially when considering vaccine designs. In recent years, the P. 
falciparum RBL and DBP ligands (aside from PfRh5) have been largely abandoned as 
vaccine candidates, since these families show frustrating levels of redundancy between 
family members. Targeting one P. falciparum RBL/DBL invasion pathway simply 
gives rise to another (Beeson et al., 2016; Duffy and Patrick Gorres, 2020). However, 
our findings demonstrate that this is definitely not the case for P. knowlesi and that 
excitingly, these results may be representative of other Plasmodium species too. For 
instance, given that none of the 5 PvRBL ligands can compensate for inhibition of 
PvDBP (Miller et al., 1976; Chan et al., 2020), this suggests that like PkNBPXa, the 
PvRBLs may also be facilitating a separate step to PvDBP. Thus, as for P. knowlesi, 
targeting a critical PvRBL ligand along with PvDBP may be the key to developing an 
efficacious P. vivax vaccine. 
Additionally, the parasite lines generated from this study, including the DiCre 
background lines, tagged lines, and most importantly, the conditional PkNBPXa KO 
line will be invaluable for future work. We now have the tools to complement the 
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inducible PkNBPXa KO line with RBL constructs from different species. Future work 
will also focus on phenotyping the PkNBPXa KO lines that express additional 
fluorescently labelled invasion ligands, to investigate the fates of these proteins when 
PkNBPXa is absent. Ultimately, as this study has shown, the combined use of our 
marker-less, CRISPR cas9 system (Mohring et al., 2019), with the DiCre system 
(Andenmatten et al., 2013; Collins et al., 2013; Knuepfer et al., 2019) means that we 
have the potential to rapidly build parasite libraries, which enable us to examine 
dynamic processes in great detail using live microscopy. In our hands, the DiCre 
system is certainly not perfect, so far, and further efforts will be required to investigate 
why, for instance, we only achieved very low excision levels for the conditional 
PkDBPα KO line. However, we now have no shortage of potential target genes, which 
could be used to investigate whether these issues are commonplace, or not; and of 
course, if targeting these genes is successful, the resulting lines could also be used to 
address a whole range of biological questions. Excitingly, the results from this study 
demonstrated that phenotyping P. knowlesi lines using live microscopy can give very 
clear answers to questions that are otherwise challenging to address using P. 
falciparum.  Overall, then, using P. knowlesi to continue to systematically explore the 
roles of additional invasion ligands has the potential to greatly expand our 
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Appendix Figure 1. Generation of the PkDBPα-mNG Donor DNA plasmid. 
(A) The pPkB1 backbone contains SacII/EcoRI sites, which were used to insert 
the PkDBPα-mNG PCR product, generating (B) pL_PkDBPα-mNG, used to 
target the C-terminus of PkDBPα with an mNeonGreen (mNG) fluorescent tag. A 







Appendix Figure 2. Generation of PkNBPXa cKO Donor DNA plasmids. (A) 
PkNBPXaLoxPint1 and PkNBPXaLoxPint2 PCR products were inserted into vector 
pPkB1 (Appendix Figure 1A) via SacII/NotI sites. Sequences to the right show LoxPint1 
and LoxPint2 variants. (B) The PkNBPXaCtermHA/LoxP PCR product was inserted into 
pPkB1 also using SacII/NotI sites, generating vector pLNBPXaCtermHA/LoxP, targeting 







Appendix Figure 3. Generation of pL_floxedRecDBPα donor DNA plasmid (A) The 
recodonised PkDBPα (RecDBPα) sequence in vector pPkg5_DBPα (Mohring et al., 2019) was 
modified to introduce the PkLoxPint1 module immediately after the PkDBPα signal peptide 
(SP) and a HA tag/STOP/LoxP sequence at the C-terminal end of the gene. The PkLoxPint 
sequence was introduced via SpeI/BbvCI sites, and the C-terminal LoxP sequence was added 
via BbvCI/NotI sites. The final product (B) replaces the entire endogenous WT PkDBPα 
sequence with the recodonised floxed version.  
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Appendix Figure 4. The Cas9 plasmids used in this study. (A) All but one guide sequence 
was cloned into pCas9/sg (Mohring et al., 2019), via BtgZI. This vector contains the Cas9 
sequence, guide RNA cassette, and positive (hDHFR) and negative (FCU) selection markers. 
(B) The PkNBPXa C-terminal guide sequence was also cloned into pL11HF, which contains 
all of the above, with the exception of a high fidelity (HF) Cas9 enzyme sequence and smaller 
plasmid backbone. To insert the PkNBPXa guide, the entire sgRNA cassette was amplified by 
overlapping PCR, with primers containing the PkNBPXa guide sequence. This PCR 
product was ligated into pL11HF via BstEII/PspXI sites.
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Appendix Table 2. Primers used to insert gRNA sequences into pCas9/sg Guide sequences 






















































Appendix Table 3. Diagnostic PCR primers used in this study 
Primer 
name Primer sequence Description 
MH890 TGCTAGAAAAAGTGGCAGAGTTACATAAG RON2 Fwd 
MH909 AGTCACCACCCTACATCTGTATGC RON2 WT rev 
MH291 TTGGATTTCCTGTTCCTTGTCCAACC mNeonGreen reverse 
MH563 CGTAATCTGGAACATCGTATGGG HA tag reverse 
MH892 GTAATGATTGGGAAAACAAGTGCCC AMA-1 Fwd 
MH904 GCTTCCCCACTCAGTAGTAAGG AMA-1 WT rev 
MH835 GGCAAGATAGAAGCATATATCGAAAACATTTC NBPXaC-term Fwd (1) 
MH1128 
CTTTTTGTATAAACTTCTATCCCCCTTACTCATAT
ATATTC NBPXa C-term WT rev 
MH959 CCCCTTTCCCAGGAACAAATTG NBPXa N term Fwd 
MH1353 ATGCCATATAGATCAGCCCTAATTG NBPXa LoxP1 WT rev 
MH1171 TCAGCCCATAACTTCGTATAATGTATGC 
NBPXa LoxP1 Integration 
rev 




NBPXa LoxP2 Integration 
rev 
MH1129 GAAGGCATATACGAAATATGGAAAAGAGC NBPXa Cterm Fwd (2) 
FM421 TTCATGCGGAACAGCAACAG RecPkDBPa Fwd 
MH225 CGGGGCTAATTTGTCCGTGTA RecPkDBPa WT rev 
CH193 ATGAAGAAATATTACACCATTCTGCATTATTCC WT PkDBPa Fwd 
MH562 CCATACGATGTTCCAGATTACGC HA tag Fwd 
MH1041 GTAGGGAACATTTCTTTCTGCGG PkDBPa C-term rev 
RM75 CCCGGGGCGTTTTCGCGTATCTGCGCTTTTTC Control Fwd 
RM76 
CCTAGGGGACAATATATCCTCACAGAACAACTT
G Control Rev 
MH1160 CTTGAAGCGCATGAACTCCTTG mCherry Rev 
FM49 GAAGATTCCGCAAAGCTTTGTCGGTTA p230p WT Fwd 
FM50 ACGCTATGGAAGCAGTTGTCTGGAT p230p WT Rev 
FM32 
CCTAATCATGTAAATCTTAAATTTTTCTTTTTAA
ACATATG p230p Integration Rev 
FM90 TGGGAAATACAGGAAATAACGGTGTTATGT p230p Integration Fwd 
